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Abstract
This thesis presents research into the development of a novel conjugate-addition/cyclisation
methodology for the synthesis of isoindole derived nitrones. To begin, a review of the prin-
ciple methods for synthesising nitrones is reported, followed by a discussion of the current
uses of nitrones and the requirement for straightforward syntheses of nitrones contained
within an isoindole scaffold.
The synthesis of an aryl cyclisation substrate possessing the key ortho- relationship
between an α,β-unsaturated ester and formyl group is then described. The planned
conjugate-addition/cyclisation reaction using hydroxylamine was carried to afford a dif-
ferent nitrone structure to that expected, which was later confirmed by X-ray crystallog-
raphy. A full discussion of the work undertaken to elucidate the compound structure and
to probe the reaction mechanism is reported.
A monocyclic nitrone reported in the literature was thought to have been synthesised
according to a 1,3-azaprotio cyclotransfer mechanism. Application of the newly discov-
ered conjugate-addition/cyclisation protocol to a linear substrate successfully afforded
this monocyclic nitrone, leading us to propose our mechanism as a plausible alternative.
Exploration of the scope and limitation of the nitrone forming reaction afforded total of
fourteen isoindole derived nitrones. Applying the protocol to modified cyclisation sub-
strates afforded five dihydroisoquinoline derived nitrones and a bicyclic hydroxamic acid
also.
Research into the reactivity of isoindole derived nitrones is then presented. Varying de-
grees of success were obtained, largely due to the fact that the substrate does not react as
a nitrone, but as its isoindole tautomer. An attempted 1,3-dipolar cycloaddition reaction
with tert-butyl acrylate instead afforded a bridged hydroxylamine product, synthesised
by a [4+2] Diels-Alder cycloaddition reaction.
The final part of this thesis reports the application of the [4+2] cycloaddition reaction be-
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Nitrones were first reported by Migrdichian et al. in the mid 1950’s.1 Since this time,
there has been a huge amount of research into the chemistry of nitrones and they have
found widespread use in a number of areas. The nitrone functional group can be formally





Figure 1.1: Formal representation of a nitrone functional group
Traditionally, nitrones are well known as radical spin traps for probing chemical reactions.
They react with free radical intermediates to form more stable nitroxide free radicals, as
shown in Figure 1.2. These are more easily characterised and can be used to provide












Figure 1.2: Reaction between a nitrone and a hydroxyl radical to afford a spin
adduct
This area of research has been widely used in biochemistry and pharmacology and has
contributed significantly to the understanding of free radical reactions taking place in the
body. As a result, the therapeutic effect of nitrones has received much interest, partic-
ularly in ageing diseases such as stroke, Parkinson’s disease and cancer development.2–8
Nitrones react with the enhanced levels of free radicals associated with these diseases
and have shown potent biological activity in many experimental animal models. Most
1
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recently, the nitrone containing neuroprotectant drug Cerovive (Figure 1.3), originating
from AstraZeneca, was discontinued after Phase III trials as it "failed to demonstrate a
treatment benefit in acute ischemic stroke", although this was a serious progression to-









Figure 1.3: Structure of Cerovive, a drug candidate for the treatment of acute
ischemic stroke
1.2 Synthesis of nitrones
The methods of synthesising nitrones can be broadly categorised as either oxidative or
non-oxidative, as highlighted in Figure 1.4. The literature review that follows will briefly



























Figure 1.4: Commonly employed methods for the synthesis of nitrones
UHP: urea hydrogen peroxide, MTO: methyl rhenium trioxide.
1.3 Oxidative methods
1.3.1 Oxidation of imines
Numerous oxidants can be employed to transform imines into nitrones. Typically, an
imine is oxidised to an oxaziridine that then rearranges to the nitrone under the reaction




A representative example of this type of chemistry is the oxidation of imine 2 using
meta-chloroperoxy benzoic acid (mCPBA), as shown in Scheme 1.1.11 As part of their re-
search into novel nitroxides for use in nitroxide mediated radical polymerisation reactions,
Braslau et al. synthesised the adamantyl based nitrone 4. In this example, rearrangement
of the oxaziridine 3 did not take place spontaneously, and so the rearrangement was in-
duced thermally by refluxing the oxaziridine in acetonitrile. The mechanism for formation
of an oxaziridine using mCPBA mirrors the mechanism for epoxide synthesis, while the
















Scheme 1.1: Braslau’s synthesis of an adamantyl nitrone
Busque et al. used a trifluoromethyl dioxirane to carry out a direct imine to nitrone oxi-
dation in their synthesis of the protected (S)-3,4-dihydro-2-pivaloyloxymethyl-2H -pyrrole
1-oxide 10, which was the first reported synthesis of an enantiopure C(5) monosubstituted
aldonitrone (Scheme 1.2).12 Starting from ethyl L-glutamate 5, the group synthesised thi-
olactam 6 by treatment with Lawesson’s reagent followed by ester reduction with lithium
borohydride. This thiolactam was subsequently reacted with iodomethane and base to
afford the imidothiolate 7. The primary alcohol group of 7 was protected as the pivaloyl
ester and the carbon-sulfur bond cleaved using Raney-Ni which gave the imine 8 in low
yield.
At this point, the group attempted to oxidise the imine using mCPBA, however a diastere-
omeric mixture of oxaziridines was obtained, and all attempts to isomerise this mixture
of oxaziridines to the nitrone either proved ineffective or gave decomposition products.
Using methyltrifluoro(methyl) dioxirane 9 as the oxidant however, afforded the pivaloyl
protected nitrone 10 directly from the imine. Nitrone 10 was obtained in 12% overall
yield from L-pyroglutamate.
A 1,3 dipolar cycloaddition reaction with dimethyl acetylene dicarboxylate (DMAD) was
then carried out with analysis by NOE NMR experiments confirming that a single cy-
3
Chapter 1. Literature Review






i) tBuCOCl, DMAP, py,
DCM, rt, 1 d, 92%
ii) W-2 Raney-Ni, acetone,
1 h, 34%






















THF, rt, 1 h, 90%
















Scheme 1.2: Busque’s synthesis of a 2H -pyrrole-N -oxide
Transition metal catalysts have also been employed for the oxidation of imines to nitrones.
For example, Soldaini et al. first reported the use of a catalytic amount of methyl triox-
orhenium (MTO) in the presence of a urea hydrogen peroxide (UHP) complex, to chemo-
and regioselectively oxidise imines directly to nitrones.13 Diez-Martinez et al. found suc-
cess using this methodology more recently to synthesise nitrones containing oxygenated
functionality at their β- positions as shown in Scheme 1.3.14 Fifteen C -aryl nitrones were
synthesised in 65-92% yields.
4
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N CO2Et N CO2Et
O-
MeReO3 (2 mol%), UHP (3.0 eq.),
MeOH, rt, 16 h, 92%
N CO2Me N CO2Me
O-
MeReO3 (2 mol%), UHP (3.0 eq.),
MeOH, rt, 48 h, 65%
N CO2Me N CO2Me
O-
MeReO3 (2 mol%), UHP (3.0 eq.),





Scheme 1.3: Diez-Martinez oxidative synthesis of nitrones
In recent years, the use of the MTO/UHP oxidation system for imine oxidation has ad-
vanced significantly. Singh et al. developed a silica supported oxo-rhenium catalyst,
which allowed for nitrones 15 to be synthesised in a one-pot procedure from an aldehyde
12 and primary amine 13, rather than synthesising and isolating the imine separately
(Scheme 1.4).15 The two major advantages of their system were the ease of recyclability
of their immobilised catalyst, with none of the catalyst leaching seen previously using

















UHP, MeOH, rt, 3-8 h, 40-76%
R = Ph, 4-MeOC6H4, 4-NO2C6H4, 2-furyl, (CH2)2CH3




Scheme 1.4: Singh’s immobilised rhenium catalyst for nitrone formation
Lin et al. have developed an improved biphasic procedure for the oxidation of nitrones
from imines using molecular oxygen and a cobalt catalyst, that employs isobutryaldehyde
as a co-reductant (Scheme 1.5). Oxidation of imine 16 affords a mixture of diastereomeric
oxaziridine intermediates 17 and 18, which upon treatment with acid results in nitrone
product 19.16
5
















i) TFA, DCM, rt, 1 h
ii) 2:1 Hexanes:EtOAc, benzaldehyde,
3Å M.S., rt, 18 h, 64%
CoCl2, KHCO3, iPrCHO,




Scheme 1.5: Lin’s oxidative synthesis of nitrones
Martiny and Jorgensen first reported this oxidation system, however they only obtained
high yielding results from imines that contained tertiary alkyl groups.17 The mechanism,
shown below in Scheme 1.6, is thought to proceed via an acyl-cobalt(III) species 20 (which
is obtained from a sequence of radical steps initiated by the abstraction of the formyl pro-
ton of isobutyraldehyde by cobalt chloride). In the presence of oxygen, the acyl-cobalt(III)
species 20 is oxidised to the acyl-peroxo-cobalt species 21. Reaction of this species with
the imine 16 affords complex 22 which rearranges to the oxaziridine 17 and the cobalt
carboxylate 23. It is thought that the catalytic cycle is then completed by reaction of the





































Scheme 1.6: Proposed cobalt chloride/molecular oxygen catalytic cycle for the
oxidation of imines to oxaziridines
Lin et al. discovered that water was necessary for active catalyst formation, a fact which
6
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was alluded to in their earlier research due to the observation that the reaction gave a
higher yield of oxaziridine, "if rigorously dry conditions are avoided." It is now thought
that the small addition of water at the catalyst formation stage serves to increase the
solubility of cobalt chloride in the reaction solvent (DCM).
1.3.2 Oxidation of amines
Only secondary amines can be used as substrates for the direct oxidative synthesis of
nitrones. Primary amines can undergo imine formation and then oxidation, as discussed
above, or they can be oxidized to hydroxylamines, from which nitrones may then be syn-
thesised (Section 1.3.3).
Hydrogen peroxide (H2O2) has been used extensively for the oxidation of secondary amines
to nitrones. Typically this reaction also employs a catalyst; sodium tungstate has proven
to be the most efficient catalyst for this purpose.
For example, Murahashi et al. developed a successful tungstate-catalysed oxidation pro-
tocol, shown in Scheme 1.7. Their research focused on simulating the action of naturally
occurring enzyme-catalysed oxidation reactions of secondary amines, to afford a range of











H2O2, 5 mol% Na2WO4.2H2O,
MeOH, rt, 3 h, 74%
H2O2, 5 mol% Na2WO4.2H2O,
MeOH, rt, 3 h, 62%
Scheme 1.7: Murahashi’s tungstate catalysed oxidation of amines to nitrones18
Mechanistically, Murahashi et al. have shown that the active species in the oxidation is
derived from a complex of tungstate and hydrogen peroxide shown in Scheme 1.8. This is
supported by oxidation experiments on dibutylamine, which showed that oxidation does
not take place in the presence of H2O2 or Na2WO4 alone. Murahashi’s results showed
the active species to be peroxytungstates, HOOWO3- and HOOWO6- (abbreviated to
w-OOH, where w = WO3- or WO6-). The peroxytungstate (w-OOH) 24 attacks the sec-
ondary amine 25, which undergoes rearrangement to hydroxylamine 27 (via intermediate
26). Further oxidation of hydroxylamine 27 with peroxytungstate followed by dehydra-
tion, then affords nitrone 28.
7











































Scheme 1.8: Proposed tungstate/H2O2 catalytic cycle for the oxidation of
amines to nitrones
More recently, Coşkun and Parlar applied this oxidation method to the synthesis of novel,
stable 3,4-dihydroisoquinolinium N -ylides (Scheme 1.9). The primary amines 29 were
reacted with benzaldehydes in the presence of acid to form bicyclic secondary amines
30, which were oxidised using a catalytic amount of tungstate and four equivalents of
hydrogen peroxide to afford the isoquinoline derived nitrones 31 in up to 69% yield.
The group then carried out one of the most common reactions of nitrones, a 1,3-dipolar
cycloaddition, using DMAD as the dipolarophile. Carrying out the reaction at room tem-
perature afforded the isoxazolidine 32, which rearranged on refluxing in toluene to afford
the 3,4-dihydroisoquinolinium N -ylide 35. The group suggested that this new structure
is obtained by homolysis of the N-O bond of the isoxazolidine 32, followed by cyclisation






5 mol% Na2WO4.2H2O, 4 eq. H2O2
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Scheme 1.9: Coskun’s tungstate/H2O2 mediated oxidative synthesis of nitrones
Coşkun et al. also developed a one-pot synthesis of acyclic nitrones starting from aro-
matic aldehydes 36 using related peroxide/tungstate methodology (Scheme 1.10). Firstly,
secondary amines 37 were formed by reductive amination using an amine and sodium










O-RCH2NH2, NaBH4,MeOH, rt, 10 min
4 eq. H2O2, 5 mol% Na2WO4,
MeOH, rt, 1 h
36 37 38
Scheme 1.10: Coskun’s one-pot synthesis of nitrones
Alternative oxidants, such as mCPBA and Davis oxaziridines have also proved highly
9
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effective for secondary amine oxidation. The Trigalo group selectively used mCPBA in
their synthesis of the seco-curane type indoline alkaloid 39 (Scheme 1.11).21 The perben-
zoic acid selectively oxidised the secondary amine over the enamine double bond and the
















Scheme 1.11: mCPBA mediated oxidation of an amine to nitrone 39
Davis N -sulfonyl oxaziridines, such as the camphor derivative shown in Figure 1.5, are
well-known oxidising reagents that have been applied to the synthesis of cyclic nitrones
(often from oxidation of substituted piperidines and pyrrolidines). The general mecha-
nism of the reagent is thought to proceed via nucleophilic attack of an amino group on
the electrophilic oxaziridine oxygen, with simultaneous N-O bond cleavage. The resultant



























Scheme 1.12: Proposed mechanism for the oxidation of amines to nitrones using
a Davis oxaziridine
Oxidation using this camphor derived oxaziridine reagent was employed in Brandi’s syn-
thesis of a protected dihydroxyindolizidinone (Scheme 1.13).22 The starting material 40,
derived from commercially available (4R)-hydroxy-(2S)-hydroxymethylpyrrolidine, was
treated with trifluoroacetic anhydride, triethylamine and sodium hydroxide to provide
10
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the ring expanded substituted piperidine 41 using methodology first developed by Cossy
et al.23 The free hydroxyl group of piperidine 41 was protected as a silyl ether using
tert-butyldimethylsilyl chloride (TBDMSCl) to provide the symmetric piperidine 42. Re-
ductive debenzylation afforded the amine precursor 43, which was oxidised with Davis
































Scheme 1.13: Brandi’s synthesis of protected dihydroxyindolizidinone 45
Methyltrioxorhenium (MTO) is an oxidation catalyst that can also be used to oxidise
secondary amines to nitrones. The Sebesta group have recently progressed this oxidative
method further using ionic liquids as the reaction solvent, in the presence of ultrasound to
faciliate the reaction (Scheme 1.14).24 Using 1-butyl-3-methylimidazolium tetrafluorobo-
rate ([bmim]BF4) as the solvent, dibenzylamine nitrone 47 was afforded in 66% yield as
the sole reaction product. When the oxidation reaction was repeated in an ultrasound
bath, the reaction yield was increased significantly, however hydroxylamine 48 was also
formed as an unwanted minor reaction product.
11
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Scheme 1.14: Synthesis of nitrones in ionic solvent
After carrying out the H2O2-MTO oxidation of dibenzylamine in various ionic liquids,
the group then selected the best performing reaction to investigate the recyclability of
the catalyst. In general, it was found that the combined yield of nitrone and hydroxy-
lamine decreased as subsequent runs were carried out, as did the selectivity for the nitrone
product. However, the group reported some inconsistencies within their data set (see Ta-
ble 1.1) which they attribute to possible leaching of the MTO, as well as decomposition
of MTO catalysed by proton donors and hydrogen peroxide.
N
H









Table 1.1: Sebesta’s catalyst recycling data for the synthesis of nitrones in ionic
solvent





1.3.3 Oxidation of hydroxylamines
Oxidation of hydroxylamines is the third and final general oxidative method for synthe-
sising nitrones. It often employs mild conditions for the oxidation of hydroxylamines
that contain at least one proton at their α- carbon position. During the reaction, hy-
droxylamines are oxidised to nitroxyl radicals, and these radical species then undergo
disproportionation to afford the product nitrones. Many of the oxidants used in this




Methyl trioxorhenium in the presence of hydrogen peroxide is just one combination of
reagents that can be applied to the oxidation of hydroxylamines. Saladino et al. em-
ployed polymer supported heterogeneous MTO catalysts, 49 and 50, to oxidise a range
of secondary hydroxylamines to their corresponding nitrones in high percentage conver-
sions and isolated yields. The group applied six different polystyrene (PS) and polyvinyl
pyridine (PVP) supported MTO catalysts to the oxidation of symmetrically substituted
hydroxylamines and non-symmetrical 3-substituted and 2-substituted hydroxypyrrolidines
(Scheme 1.15). All of their experiments afforded higher yields and/or greater conversion
to product nitrones than a standard H2O2-MTO peroxide procedure, and the catalysts
could be recycled up to five times without loss of efficiency.25
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Scheme 1.15: Nitrone synthesis using polymer supported MTO catalysts
Cicchi et al. have long used mercury oxide to oxidise cyclic hydroxylamines to nitrones.
Using this methodology they have synthesised functionalised racemic and enantiopure five
membered cyclic nitrones from tartaric,26 malic,27 aspartic28 and citramalic29 acids. The
focucs of their research is to employ enantiopure nitrones as building blocks in the synthe-
sis of natural products, and they have recently reported two reviews on this subject.30,31
Scheme 1.16 shows a representative synthesis of a necine base (–)-hastanecine.32
In this case the benzyloxy-dimesylate 52 was synthesised in high yield from the pri-
mary alcohol 51 using a Mitsunobu reaction. The dimesylate 52 was then reacted with
hydroxylamine in a double nucleophilic displacement/cyclisation reaction to afford the
cyclic hydroxylamine intermediate 53. Nitrone 54 was synthesised in the second stage of
this one-pot procedure through oxidation of 53 using mercury oxide. A 1,3-dipolar cy-
14
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cloaddition reaction of nitrone 54 with dimethylmaleate gave the major adduct 55 which
was isolated in a moderate 56% yield and then refluxed in acetonitrile in the presence
of Mo(CO)6. This induced a N-O cleavage/lactamisation reaction to afford intermedi-
ate 56 in 95% yield. Following a procedure by Denmark et al., the total synthesis of
(–)-hastanecine was then completed in twelve steps in an 8.7% overall yield. The group
have employed related pyrroline based hydroxylamine oxidation methodology for the total




































Scheme 1.16: Oxidation of hydroxylamine 53 to nitrone 54 for the synthesis of
(–)-hastanecine 321
In a separate report, the Cicchi group have described the enantioselective synthesis of
tri-substituted isoxazolidines (Scheme 1.17). For this work, they used another transition
metal based oxidant, manganese dioxide, to synthesise the required nitrone precursors.34
The group began by synthesising the requisite hydroxylamine 58 through the reaction of
N -benzyl hydroxylamine with the free -OH group at the anomeric carbon of a protected
pentose 57. Hydroxylamine 58 was then oxidised using manganese dioxide to yield the
N -glycosyl aldonitrone 59. Cycloaddition of 59 with dimethyl maleate afforded the isox-
azolidine 60 in 77% yield with high diastereoselectivity, due to the sugar moiety acting
as a chiral auxiliary for control of facial selectivity.
15
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Scheme 1.17: Oxidative formation of N -glycosyl aldonitrone 59 for the synthesis
of tri-substituted isoxazolidine 60
1.4 Non-oxidative methods
1.4.1 Condensation of mono substituted hydroxylamines with carbonyl
compounds
The condensation of mono substituted hydroxylamines with carbonyl compounds is the
first of two key non-oxidative methods for directly synthesising nitrones. Condensation
can be carried out with mild reagents, allowing the presence of a wide range of functional
groups within the two reaction components.35
Knobloch et al. synthesised conjugated acyclic nitrones in 57-88% yield using conden-
sation methodology for the synthesis of azepin-3-one derivatives (Scheme 1.18).36 The
synthesis began with a Sonogashira alkynylation reaction of 3-bromo aldehyde 61 with 3-
phenyl-1-propyne to afford propargyl compound 62 in 36% yield. Treatment of 62 with N -
methylhydroxylamine hydrochloride and sodium acetate provided the conjugated nitrone
63, which was subsequently dissolved in methanol and treated with sodium methoxide
to yield dihydroazepinone 68. This transformation was thought to proceed via an allene
intermediate 64 which underwent a 1,7-dipolar cyclisation reaction to afford the methyle-
neoxazepine 65. Cleavage of the N-O bond of 65 gave the diradical 66 which recombined
to afford the azadienylcyclopropanone 67. Cyclisation of this unstable intermediate then
yielded the dihydroazepinone 68. Heating dihydroazepinone 68 in toluene at reflux set
up an equilibrium that furnished the desired conjugated cyclic azepinone 69, albeit in a
16
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Scheme 1.18: Condensation methodology used in Knobloch’s synthesis of
azepin-3-ones
17
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A range of optically active β-hydroxy-nitrones were synthesised by Bøgevig et al. through
the condensation of aldol products with N -substituted hydroxylamines (Scheme 1.19).
An L-proline catalysed aldol reaction between aldehydes 70 and activated carbonyl com-
pounds, such as α-keto acid 71, provided intermediate aldol products 72. This step was
followed by an in-situ reaction with N -alkyhydroxylamines,37 to afford nitrones 73 in
































Scheme 1.19: Bøgevig’s use of condensation methology for the synthesis of op-
tically active β-hydroxy-nitrones 73
Yang et al. used condensation methodology for their stereodivergent syntheses of highly
substituted 1-aza-7-oxabicyclo[2.2.1]heptanes.38 Stereodefined homoallylic amines 74 were
reacted with benzoyl peroxide to afford the O-benzoyl hydroxylamines 75, which were
subsequently deprotected with hydrazine to afford the homoallylic hydroxylamines 76
(Scheme 1.20). Condensation with formaldehyde initially led to formation of nitrones 77,
followed by a [3,3]-sigmatropic rearrangement to yield the isolable nitrones 78. Reflux-
ing these nitrones in toluene induced an intramolecular 1,3-dipolar cycloaddition reaction
that led to the synthesis of a range of 1-aza-7-oxabicyclo[2.2.1]heptanes 79, all with >20:1
diastereoselectivity. Alternatively, reacting the homoallylic hydroxylamines 76 with ethyl
glyoxolate afforded nitrones 80, which were stable to sigmatropic rearrangement. They
subsequently underwent an intramolecular 1,3-dipolar cycloaddition leading to heptanes



















































DMF, rt, 4 h
Toluene, 4 Å M.S.,
50 °C, 2 h, 67%
Toluene, 4 Å M.S.,
120 °C, 4 h, 74%
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Scheme 1.20: Yang’s synthesis of 1-aza-7-oxabicyclo[2.2.1]heptanes
1.4.2 Syntheses from oximes
The method of synthesising nitrones from oximes is considered to be a facile route, partic-
ularly when using electron poor alkenes as the alkylating reagent.35 Grigg and co-workers
developed this field significantly, with their synthetic methods normally incorporating a
subsequent 1,3-dipolar cycloaddition reaction, due to the instability of the resultant ni-
trones.39–42
19
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Nitrones formed via 1,2-prototropy of oximes
The less frequently used method for synthesising nitrones from oximes employs a 1,2-
prototropic reaction, which involves heating an oxime to set up an equilibrium with its
nitrone form, as shown in Figure 1.6. The small concentration of nitrone present can then
take part in a 1,3-dipolar cycloaddition reaction (Scheme 1.21).40


















Scheme 1.21: 1,2-prototropic reaction of oxime 82
Nitrones formed via oxime N -alkylation
The more common methods to synthesise nitrones from oximes are via Michael addition
and 1,3-azaprotio cyclotransfer reactions, (shown in Figure 1.7), which can be conveniently









Figure 1.7: Example of a 1,3-azaprotio cyclotransfer reaction
Classes I & II:
Both Class I and II reactions are based on a nitrone being synthesised from N -alkylation
of an oxime with an electron deficient alkene, with the resultant nitrones then partici-
pating in subsequent dipolar cycloaddition reactions. Classes I and II refer to inter- and
intramolecular dipolar cycloadditions reactions, respectively.
Scheme 1.22 shows an example of a class I nitrone synthesis/cycloaddition reaction, where
the alkylating reagent and the dipolarophile are the same (in this case benzyl acrylate
86). Conjugate N -alkylation of the oxime with benzyl acrylate 86 affords a nitrone that
then undergoes an intermolecular 1,3-dipolar cycloaddition with excess benzyl acrylate.
20
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Scheme 1.23 provides an example where the alkylating reagent and dipolarophile are dif-













Scheme 1.22: A Grigg class I reaction where the alkylating reagent and dipo-



















Scheme 1.23: A Grigg class I reaction where the alkylating reagent and dipo-
larophile are different
Examples of Class II reactions are shown in Scheme 1.24 and Scheme 1.25. In the first
example, the dipolarophile fragment is derived from the oxime 91, and so the intramolec-


















Xylene, reflux, 11 h, 71%
91 92 93
Scheme 1.24: A Grigg class II reaction proceeding via a C-alkyl nitrone inter-
mediate
In Scheme 1.25, the dipolarophile fragment is generated by alkylation of divinyl sulfone
by the oxime 94, to afford an N -alkyl nitrone 95 that undergoes an intramolecular 1,3-
dipolar cycloaddition reaction in-situ.
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Xylene, reflux, 2.5 h, 75%
94 95 96
Scheme 1.25: A Grigg class II reaction proceeding via a N -alkyl nitrone inter-
mediate
In the first instance, it was assumed that the N -alkylation reaction of oximes with the
electronegatively substituted alkenes proceeded via conjugate addition reactions. How-
ever, during the course of their research into class III and class IV reactions, the Grigg
group began to propose an alternative 1,3-azaprotio cyclotransfer mechanism (Figure 1.7).
Classes III & IV:
For Class III and IV nitrone syntheses, oxime substrates underwent intramolecular cycli-
sation onto alkenes to afford nitrones that could undergo further 1,3-dipolar cycloaddition
reactions, allowing a wider range of acyclic scaffolds to be accessed. During this part of
the research programme it was also possible to isolate and confirm the structure of some
of the proposed nitrone intermediates.
Scheme 1.26 shows a Class III intramolecular reaction of a pyrrole derived oxime 97 on
to an unactivated alkene bond to form the nitrone intermediate 98. This subsequently
underwent an intermolecular 1,3-dipolar cycloaddition reaction with the alkene fragment
of another molecule of the oxime 97, to afford the cycloadduct 99. This study revealed
the existence of an alternative "ene" like mechanism which the group concluded to be the
dominating mechanism for these type of cyclisation reactions. The mechanistic arrows
that they proposed are shown for the pyrrole based reaction drawn in Scheme 1.26, with













Xylene, 140 °C, 16 h, 52% 97
97 98 99
Scheme 1.26: A Grigg Class III reaction; intramolecular nitrone synthesis fol-
lowed by intermolecular cycloaddition
Both Scheme 1.27 and Scheme 1.28 demonstrate intramolecular Class IV reactions. In
the first example, oxime 100 cyclised to afford nitrone 101 that underwent a thermal
22
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1,3-dipolar cycloaddition reaction with its alkene fragment to afford tricycle 102. In
the second example, the cyclisation substrate contained two terminal unactivated alkene
groups, with initial oxime cyclisation occuring to afford the six membered ring of nitrone





















Scheme 1.27: A Grigg class IV reaction where both the alkylating agent and


























Scheme 1.28: A Grigg Class IV reaction where both the alkylating agent and
dipolarophile are terminal alkenes
Chakrabarty et al. serendipitously incorporated 1,3-azaprotio cyclotransfer methodology
into their intermolecular synthesis of indole-nitrones from oximes. Having had previous
success with a [4+2] cycloaddition reaction of furfuraldoxime and N,N -dimethylhydrazone,
the group initially attempted to form the hetero Diels-Alder product from indole-oxime
105 and substituted alkenes. However, as shown in Scheme 1.29, reaction of indol-oxime
105 with methyl acrylate, methyl vinyl ketone and N -methylmaleimide yielded the cor-
responding indole-nitrones 106.43
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Benzene, reflux, 12 h;
R = CN, 85%; R=CONH2, 80%
+
105 106
Scheme 1.29: Chakrabarty’s synthesis of indole-nitrones
In summary, whilst it is apparent that the addition of nitrones to unactivated alkenes
must proceed via an "ene" type 1,3-azaprotio cyclotransfer reaction, it is possible that the
corresponding reactions of alkenes containing electron withdrawing groups may proceed





















(b) Unactivated alkene: 1,3-azaprotio cyclotransfer reaction mechanism
Figure 1.8: The different methods for nitrone synthesis from the reactions of
oximes with activated and unactivated alkenes
1.5 Conclusion
This review has presented relevant literature regarding the five most widely used meth-
ods for synthesising nitrones. Imines, amines and hydroxylamines can all be oxidised,
using a variety of oxidants and catalysts, to their corresponding nitrones. Condensation
of N -mono substituted hydroxylamines with carbonyl compounds, and the alkylation of
oximes are the two most popular non-oxidative routes for the synthesis of nitrones. This
review has highlighted, in many cases, the origins of different methods combined with
progress made in recent years to improve reaction scope, efficiencies, and efforts to de-
velop sustainable methodologies. In the following chapters, we will discuss the relevance




Discovery & Mechanism of Cyclisation
Reaction for Formation of Isoindole
Derived Nitrones
2.1 Introduction
As discussed in Chapter 1, nitrones are commonly synthesised via metal catalysed per-acid
oxidation of secondary amines and imines (Scheme 2.1). Non-oxidative methods include





























Scheme 2.1: Common methods of nitrone synthesis
These methods typically require preparation of the nitrone precursors e.g. imine, hydrox-
ylamine, oxime etc., and as many nitrones are unstable, they are often synthesised and
reacted in-situ. An example of this is illustrated by the synthesis of (S)-(+)-cocaine by
Theddu et al. As shown in Scheme 2.2, imine 107 was oxidised, using standard conditions,
to afford the pyrroline nitrone 108. The group reported that attempted purification of
this nitrone resulted in decomposition. Instead, they carried out a highly stereoselective
25
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Lewis acid catalysed intramolecular 1,3-dipolar cycloaddition reaction on the crude mate-
rial to provide the bicyclic cycloadduct 109. After reacting cycloadduct 109 with methyl
methanesulfonate, the resultant salt underwent N-O bond cleavage using palladium catal-
ysed hydrogenation to yield alcohol 110. (S)-(+)-cocaine 111 was finally afforded after















15 h, rt, (100%)
Al(O-t-Bu)3, toluene,
110 °C, 96 h
(S)-(+)-cocaine
i) Methyl methanesulfonate,
toluene, reflux, 24 h, 49%
ii) Pd/C, H2 (1 atm.), MeOH,














Scheme 2.2: In-situ cycloaddition reaction of nitrone 108 for the synthesis of
(S)-(+)-cocaine 111
In other fields however, stable nitrones have been isolated and employed as spin trap
probes in electron paramagnetic resonance (EPR) spectroscopy research, which is a tech-
nique used to analyse materials possessing unpaired electrons.
Using nitrone spin traps, such asN -tertiary-butyl nitrone (PBN) and 5,5-dimethyl-pyrroline
N -oxide (DMPO) (Figure 2.1), short lived free radical species can be trapped. The resul-
tant spin-adducts have an increased half life relative to the parent free radical, meaning





















Figure 2.1: Nitrone derived radical spin traps and adducts
2.1.1 Electron Paramagnetic Resonance research using 5,5-dimethyl-
pyrroline N -oxide
EPR spectroscopy has been employed as a research tool in many scientific fields, with the
pyrroline based nitrone trap, DMPO, and its derivatives,45,46 having become standard
radical spin traps over the last few decades (Figure 2.6).47,48
In recent years, the application of spin traps and EPR spectroscopy in biological and
pharmacological environments has gained increasing interest. Certain diseases, such as
Parkinson’s, are associated with high levels of free radicals. EPR studies therefore con-
tinue to be used to help understand disease cause and mechanism.48–50
For example, peroxynitrite, a potent oxidising and nitrating anion formed in vivo from the
reaction of superoxide free radicals with nitric oxide free radicals, is cytotoxic and causes
oxidative DNA strand breakage.51 It is also implicated in neurodegenerative diseases52 as
it decomposes to form reactive oxygen species, such as hydroxyl and superoxide radicals.
Using EPR analysis and DMPO as the spin trap, peroxynitrite can be detected via for-
mation of its DMPO-hydroxyl (DMPO-OH) spin adduct, which gives diagnostic signals
in the EPR spectrum. For example, a recent report by Chen et al. employed EPR to
prove that myricitrin (a naturally occuring flavonoid) acts as a hydroxyl radical scavenger
to reduce the amount of DMPO-OH adduct produced (Figure 2.2c). Thus, myricitrin
can potentially protect against both the DNA damage and cytotoxicity of peroxynitrite
decomposition, opening up the field for further neuroprotection research.53
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(a) Synthesis of peroxynitrite an-
ion
O
N O OH OH + NO2
(b) Decomposition of peroxyni-

























(c) Scavenging of hydroxide radical by myricitrin
Figure 2.2: Chemistry of peroxynitrite
Peroxynitrite is also known to contribute to cancer progression, and research into cancer
treatments includes the use of scavengers to inhibit the damaging effect of peroxynitrite.
Sufferers of ulcerative colitis are at a higher risk of developing colorectal carcinoma, and
it was found that patients taking mesalamine (5-aminosalicylic acid, 5-ASA, Figure 2.3)














Figure 2.3: Mesalamine - a peroxynitrite scavenger
In EPR studies of peroxynitrite-mediated generation of hydroxyl radicals, the Graham
group reported that use of a 1 mM concentration of mesalamine resulted in significant
inhibition of the formation of the DMPO-OH spin adduct signal.54 Using other tech-
niques, they also proved 5-ASA’s ability to prevent DNA strand breakage in the presence
of peroxynitrite, thus potentially affording a dual action medication for the sufferers of
ulcerative colitis.
EPR has also found use in the structural and conformational elucidation of proteins,55–57
nucleic acids,58 and other biological macromolecules.59,60 An example of this is the work
by Yang et al., whose combination of EPR techniques and NMR analysis allowed for
the global 3D structure of the protein homodimer Dsy0195 to be resolved (Figure 2.4).55
To obtain EPR data (1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)methanethiosulfonate
(MTSL) was used to spin label the thiol unit of a free cysteine that had been introduced

























Figure 2.4: Spin labelling of cysteine within the Dsy0915 protein
The experimental results were processed by an automatic NMR-based structure determi-
nation programme, to produce a network of interchain nuclear Overhauser effect (NOE)
constraints. It is these constraints that enabled both the homodimer interface and the
global homodimer structure to be mapped.
2.1.2 5,5-dimethyl-pyrroline N -oxide limitations
However, there are several problems associated with the use of pyrroline-based spin traps
such as DMPO. For example, the -OH adduct has a relatively short lifetime, and issues
with DMPO-OH detection in biological studies arise, as •OH radicals are also formed from
the decomposition of superoxide radicals that may also be present.61 DMPO is also par-
ticularly slow to react with superoxide and alkylperoxide radicals.62 Non-radical reactions
such as hydrolysis of DMPO based spin-adducts can take place, and for DMPO itself, the
presence of a hydrogen on the α carbon makes it and it’s spin adducts more susceptible
to disproportionation.63 It has also been demonstrated that •NO radicals can form from
degradation of DMPO.64
All of these factors add complexity to the interpretation of experimental results, in partic-
ular the detection and identification of •OH and superoxide radicals in biological systems.
Many of the undesired side reactions can produce new free radical species which can com-
plicate interpretation of the EPR spectrum and inhibit DMPO from trapping the species
of interest. Therefore, in order to obtain reliable and accurate EPR data, there is a bal-
ance to strike with spin traps between specificity for a free radical species and the stability
of the resulting spin-adduct.
Several approaches have been carried out to address the issues that can complicate studies
on DMPO-adducts. For example, substitution at the α-carbon of trimethyl-pyrroline-N -
oxide, M3PO (Figure 2.5), helps prevent disproportionation of its hydroxyl radical adduct.
The resultant M3PO-OH adduct has been shown to be significantly more persistent than
the corresponding DMPO-OH adduct.65
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Figure 2.5: M3PO spin trap
Numerous analogues of DMPO have been synthesised (Figure 2.6) and it has been re-
ported that replacement of one of the gem-dimethyl groups with an electron withdrawing
substituent, [e.g. ester (EMPO), phospho (DEPMPO)] resulted in a significant increase

























Figure 2.6: DMPO analogues
Villamena et al. reported that the amide analogue (AMPO, Figure 2.7) is also more
reactive with superoxide, as the amide group increases the electrophilicity of the nitrone
carbon. Computer modelling has shown that intramolecular hydrogen bonding between








Figure 2.7: Intramolecular hydrogen bonding of AMPO spin trap increases the
electrophilicity of the nitrone carbon
Cyclodextrins (CDs) have previously been incorporated into spin traps due to their ability
to stabilise and protect the corresponding spin adducts. Han et al. synthesised a bifunc-
tionalised AMPO derived nitrone spin trap, containing a hydrophilic cyclodextrin-amide
30
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arm and a second amide group bonded to a lipophilic dodecyl chain (Figure 2.8). This
probe was designed to ensure that: a) the amide functionality would create a reactive su-
peroxide radical trap, b) the cyclodextrin would give a stable adduct for analysis by EPR,





































Amphiphilic nitrone spin trap
β-cyclodextrin
Figure 2.8: Amphiphilic cyclodextrin derived pyrroline based spin trap
In order to synthesise this nitrone spin trap, the enolate of nitroester 112 was alkylated
with ethyl bromoacetate to yield the nitro-bis-ester 113 (Scheme 2.3). Conjugate ad-
dition of the enolate of bis-ester 113 onto acrolein then afforded aldehyde intermediate
114 which was used in the subsequent zinc mediated reductive cyclisation step to give
the known diester nitrone spin trap, 5,5-diethoxycarbonyl-1-pyrroline N -oxide (DECPO)
115. Base-catalysed hydrolysis of DECPO to the diacid 116 occurred in a moderate 50%
yield. Coupling of diacid 116 with dodecylamine afforded the two structural isomers of
monosubstituted nitrone, 117 and 118, that they were unable to separate.
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Scheme 2.3: Synthesis of bifunctional nitrone spin trap
The spin trap synthesis was completed by coupling the mixture of nitrones 117 and 118
with amino-β-cyclodextrin. The two constitutional racemic isomers of the product spin
traps, 119 and 120, were then separated by preparative HPLC. 119 was subjected to
EPR studies and was found to be highly specific for superoxide radical. The resultant
superoxide spin adduct also took longer to decay than the spin adducts of common pyrro-
line based spin traps, as well as other classes of spin trap containing cyclodextrins.
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2.1.3 Isoindole spin traps
As an alternative means to overcome the issues faced with using pyrroline based traps,
bicyclic nitrone compounds began to be investigated. In 2003, Bottle et al. reported
the first bicyclic nitrone spin trap, 1,1,3-trimethylisoindole-N -oxide (TMINO), which was
synthesised in low yield by carrying out flash vacuum pyrolysis (FVP) of 1,1,3,3-tetra-
methylisoindolin-2-yloxyl (TMIO, Figure 2.9).63 This new isoindole based species proved
to be less problematic than the more commonly used pyrroline-based spin traps. This was
due to increased stability, and therefore half lives, of it’s spin adducts and it’s selectivity
for the •OH radical with respect to superoxide. The group carried out research into the
use of TMINO in trapping biologically important radicals, such as the hydroxyl radical,






Figure 2.9: First synthesis of 1,1,3-trimethylisoindole-N -oxide - TMINO
In 2007, Hatano et al. published the first synthetic route to TMINO, shown in Scheme 2.4.67
Beginning with 2-chlorobenzoic acid, they carried out an acid catalysed esterification reac-
tion with methanol, followed by double Grignard addition and dehydration of the resultant
alcohol to afford the chloro-styrene derivative 121. Treatment with magnesium and N,N -
dimethylformamide (DMF) resulted in formylation to give an aryl aldehyde functionality,
which was then reacted with hydroxylamine to give the oxime 123. Reduction to the
hydroxylamine using sodium cyanoborohydride under acidic conditions resulted in a for-
mal reverse Cope cyclisation reaction to afford the cyclic hydroxylamine 125.68 Copper
catalysed oxidation in air then yielded 1,1-dimethyl nitrone 126, which upon Grignard
addition and a further oxidation step (Cu(OAc)2, air) gave the desired nitrone: 1,1,3-
trimethylisoindole N -oxide 127.
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Scheme 2.4: First synthetic route to the spin trap TMINO 127
Employing the same first four steps, Hatano later synthesised the 3-trifluoromethyl deriva-
tive of TMINO (3-TF-TMINO), and subjected this novel compound to a set of EPR stud-
ies to demonstrate its efficiency at forming stable radical adducts (Scheme 2.5).69 Taking
aldehyde 128, addition of the trifluoromethyl nucleophile gave alcohol 129, which, upon
Dess-Martin periodinane (DMP) mediated oxidation, gave ketone 130 that proved to be
unstable and decomposed quickly. To overcome this issue, the group synthesised the ke-
tone using the same procedure, but reacted the crude material with hydroxylamine to
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Scheme 2.5: Synthesis of 3-TF-TMINO 131
This last step in the synthesis was a surprising result. In their original TMINO synthesis
(Scheme 2.4), treatment of the parent aldehyde with hydroxylamine yielded an oxime 123.
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2.1. Introduction
Cyclisation to form the nitrone spin trap only occurred upon reduction of this oxime to
the hydroxylamine. With the latter 3-CF3 example shown in Scheme 2.5 however, oxime
forming reaction conditions yielded a cyclised nitrone directly from the ketone.
Condensation of mono substituted hydroxylamines with carbonyl groups is a well known
method to form nitrones.35 However, here an intramolecular cyclisation has occurred,
therefore a different pathway must be operating. The group proposed that attack of the
hydroxylamine forms the N,O-acetal 132, which undergoes a formal reverse Cope cycli-
sation reaction at 80 ◦C to give cyclic hydroxylamine 133 (Scheme 2.6). Proton transfer





















Scheme 2.6: Proposed mechanism for formation of 3-TF-TMINO 131 from ke-
tone 130
Encouraged by this spontaneous reaction of a γ,δ-unsaturated carbonyl compound with
hydroxylamine to afford a cyclic nitrone (without the need to isolate an intermediate
oxime or hydroxylamine), we carried out a literature review which revealed that this
methodology seemed little utilised. The only evidence of a related reaction was reported
by Grigg et al. in the early 1990s, which will be discussed in the following section.
2.1.4 1,3-Azaprotiotransfer reactions for the synthesis of nitrones
As discussed in the introduction, the Grigg group have reported a lengthy discussion of
their research into the synthesis of nitrones from oximes, and the subsequent 1,3-dipolar
cycloaddition of these nitrones on to alkene acceptors in an intra- and intermolecular
manner. In doing so, they also proposed a new ene like mechanism, dubbed a "1,3-
azaprotio cyclotransfer", for the synthesis of a variety of nitrone cycloadducts derived
from oximes.39–42,70,71
Interestingly, in a few examples of the Class III reaction (intramolecular nitrone forma-
tion - intermolecular cycloaddition),70 the reaction to form the oxime starting material
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was reported to yield a nitrone product directly. An example of this type of reaction is
shown in Scheme 2.7, whereby aldehyde 134 cyclises to afford the pyrroline based nitrone
135. However, unlike the terminal alkene of Hatano’s work, this set of results from Grigg
possessed an activated alkene, containing an electron withdrawing ester group.








Scheme 2.7: Grigg’s synthesis of nitrone 135
To recap, the group proposed that these reactions proceeded through unisolated oxime
intermediates 136, which underwent 1,3-azaprotiotransfer reactions to give the product
nitrones (Scheme 2.8, pathway A). They also presented the possibility in these tranforma-
tions that a conjugate addition/condensation strategy might also have occurred (pathway
B). The group subsequently explored the synthetic chemistry of the resultant nitrones by


































Scheme 2.8: Grigg’s proposed mechanisms for formation of nitrone 135
2.1.5 Methodology for the synthesis of isoindole derived nitrones
We were interested in the fact that two groups had separately synthesised cyclic nitrones
by subjecting γ,δ-unsaturated aldehydes or ketones to "classic" oxime forming conditions.
Hatano et al. had proposed that their bicyclic nitrone 131 was formed by a reverse
Cope cyclisation reaction of an intermediate hydroxylamine 132. Grigg et al. reported a
1,3-azaprotiotransfer mechanism of an intermediate oxime 136, to form pyrroline based
















Hatano: reverse Cope cyclisation reaction mechanism














Scheme 2.9: Summary of reaction mechanisms to afford cyclic nitrones
We envisaged combining both of these methodologies into a single protocol to devise a
short synthetic route to novel, functionalised, stable isoindole derived nitrones, which
could potentially find use in synthesis and as spin traps in EPR studies (Figure 2.10).
Whilst isoindole scaffolds are useful for their readiness to undergo [4+2] cycloaddition re-
actions, their fluorescent and electroluminescent properties72 and their incorporation into
biologically active compounds,73 the synthetic chemistry of the corresponding nitrones










Figure 2.10: Proposed methodology for the synthesis of novel isoindole nitrones
The following sections and chapters describe my investigations and discoveries in this area.
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2.2 Synthesis of a suitable cyclisation substrate
To begin investigating the proposed chemistry, we needed to prepare an appropriate start-
ing material. Inspired by the previous examples described by Grigg et al. shown in
Scheme 2.7, it was proposed that my research would commence with investigation of
the cyclisation reaction of hydroxylamine with an aromatic aldehyde containing an α,β-
























Figure 2.11: Proposed new syntheses of nitrone products
Due to the presence of the activated alkene, we tentatively proposed that upon reaction
with hydroxylamine, an oxime would be generated from the aldehyde fragment. This
fragment would then undergo a formal intramolecular 5-exo-trig cyclisation reaction onto
the activated alkene group of the α,β-unsaturated ester fragment to provide an isoindole
derived nitrone. The presence of the aromatic ring, as well as providing the desired isoin-
dole scaffold, would also faciliate the reaction by restricting the conformational freedom
of the cyclisation transition state. This starting material could be readily synthesised by
a coupling reaction between commercially available 2-bromobenzaldehyde and an acrylate.
2.2.1 Acetal protection
Key to the synthesis of the envisaged nitrones was the ortho arrangement of the alkene
bond relative to the aldehyde functionality on the aromatic ring, which we intended to
set up using a Heck reaction. The Heck reaction is a key carbon-carbon bond formation
reaction in organic synthesis.74 The reaction involves the coupling of an aryl halide to an
olefin using a palladium catalyst and a phosphine ligand. Unlike in many other cross-
coupling reactions, a base is necessary for the Heck reaction to proceed.
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2.2. Synthesis of a suitable cyclisation substrate
It was quickly discovered that the Heck reaction using 2-bromobenzaldehyde 137 and
benzyl acrylate led to the desired ester product 138, and significant amounts of a by-
product (Scheme 2.10). The 1H NMR spectrum of the crude material indicated that the
by-product was the doubly substituted deformylated product 139.
Pd(OAc)2, P(o-Tol)3, Et3N,
















Scheme 2.10: Heck reaction of unprotected 2-bromobenzaldehyde 137
Meegalla et al. have reported formation of the same type of by-product in their phase-
transfer catalysed Heck process.75 They carried out extensive labelling studies and showed
that the hydrogen atom of the formyl group is transferred intramolecularly and regiospecif-














































Scheme 2.11: Meegalla mechanism for formation of biester 146
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The Heck reaction between the aldehyde and the acrylate proceeds via the known catalytic
cycle to produce palladated intermediate 140, which can undergo reductive elimination
to give the desired α,β-unsaturated ester 141. Once formed, this product is unable to
re-enter the catalytic cycle. This is thought to be due to the excess base present in the
reaction.
Formation of the bis-ester 146 from palladated intermediate 140 can proceed via two
possible pathways:
1. Oxidative addition of PdII to the C-D bond of 140 gives the PdIV complex 142,
followed by β-hydride elimination to afford compound 143.
2. The Pd0L2 species generated in the formation of 141 can oxidatively insert into the
C-D bond of the formyl group, to form 143.
Deuteration of the double bond of 143 to give compound 144 is formally a hydropalla-
dation reaction, and compound 144 then decarbonylates to provide the deuterated in-
termediate 145. This is because there is no aromatic deuteration the deuterium transfer
step must take place before the decarbonylation step. Compound 145 then undergoes
a second Heck reaction to couple with the acrylate and produces the doubly substituted
by-product 146.
As the by-product 139 was forming in a significant 31% yield, it was decided to protect
the aldehyde functional group before carrying out the Heck reaction. We opted to convert
the aldehyde 137 into the six-membered acetal 147, which would be stable under the
basic conditions of the Heck reaction. 2-bromobenzaldehyde 137 was reacted with an
excess of 1,3-propanediol and a catalytic amount of para-toluenesulfonic acid (p-TSA) in
toluene, under Dean-Stark conditions. After several hours, the reaction was quenched
with sodium hydrogen carbonate and water. Recrystallisation of the crude product from
petrol and ether yielded the protected acetal, 2-(2-bromophenyl)-1,3-dioxane 147 in 98%
yield as white needles (Scheme 2.12).
1,3-propanediol, cat. p-TSA,








Scheme 2.12: Acetal protection reaction
2.2.2 Heck reaction
To carry out the desired cross coupling between 2-(2-bromophenyl)-1,3-dioxane 147 with
benzyl acrylate 86, a procedure by Zhang et al. was used (Scheme 2.13).76 This method
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is carried out under air rather than inertly, and uses DMF as the solvent allowing the
reaction to be heated to 120 ◦C. Using this procedure, the reaction reached 100% conver-















Scheme 2.13: Heck cross coupling reaction
The work up procedure involved adding diethyl ether to the cooled reaction mixture to
precipitate out the palladium and ligand, which was then filtered off. The combined or-
ganic solution was washed three times with water and then concentrated to low volume
under reduced pressure. After column chromatography, the purified Heck product 148
was obtained as a yellow oil in 55% yield. The yield could be increased by using a 1:1 mix-
ture of diethyl ether:hexane for extraction, or by filtering the reaction and then removing
the solvent under a stream of nitrogen overnight. After optimisation of these purification
steps, the product could be obtained in yields of up to 80%.
2.2.3 Acetal deprotection
The acetal protecting group of α,β-unsaturated ester 148 was then removed via treat-
ment with 7:3 glacial acetic acid:water to afford aldehyde 138, with the reaction being
monitored by TLC to determine when all of the starting material had been consumed
(Scheme 2.14). To decrease the reaction time, experiments at different temperatures were
carried out to drive the hydrolysis equilibrium towards the product 138. Acetal 148 was
fully deprotected to aldehyde 138, without hydrolysis of the ester in 67% yield, after four








60 °C, 4 h, 67%
148 138
Scheme 2.14: Acetal deprotection of ester 148
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2.3 Synthesis of an isoindole nitrone
Our overall goal was to develop a one-pot procedure whereby our aldehyde starting mate-
rial 138 would react with hydroxylamine to form a bicyclic nitrone. This involved oxime







1 eq. NH2OH⋅HCl, 2 eq. NaOAc






Scheme 2.15: Planned nitrone formation
Having successfully synthesised the formyl acrylate 138, we turned our attention to the
nitrone synthesis. Using standard oxime forming conditions, hydroxylamine hydrochloride
and sodium acetate were reacted with 138 in a 5:1 mixture of ethanol and water for three
hours at room temperature.77 Two equivalents of base were required, one equivalent re-
leasing the hydroxylamine from its hydrochloride salt, and the second equivalent required
to facilitate the oxime formation/cyclisation reaction.
The reaction was worked up by removing the ethanol solvent under reduced pressure. The
crude reaction product was dissolved in dichloromethane (DCM), extracted with water,
and the DCM removed under reduced pressure to yield a red oil. On obtaining the 1H
NMR spectrum of the crude product, it was obvious that the reaction had not formed the
expected nitrone 150. The 1H NMR spectrum also showed no sign of oxime intermediate
149 or the acrylate starting material 138; instead, the reaction had cleanly formed a dif-
ferent and unexpected product. The following section details elucidation of the structure
of this new product.
2.4 Structural determination of unidentified product
2.4.1 Analysis
After completing full spectroscopic analysis of the unidentified product of the nitrone re-
action, it was determined that the red oil was indeed a nitrone, whose structure could









2.4. Structural determination of unidentified product
Figure 2.12: Possible structures of unidentified product
High resolution mass spectroscopy confirmed that the product had the same molecular
formula as the expected oxime; C17H15NO3, therefore suggesting that the reaction had
formed an oxime which had reacted further to give a nitrone containing eleven double
bond equivalents.
The 1H NMR spectrum (displayed in the HMQC spectrum shown in Figure 2.13) showed
three singlets, each integrating to two protons, and a multiplet at δ 7.30-7.17 ppm in-
tegrating to nine aromatic protons. The multiplet confirmed that both aryl rings were
still present, with no further substitution having occurred. An infra red spectrum of
the compound showed a peak at 1725 cm-1, and the 13C NMR spectrum showed a peak
at δ 167.49 ppm, confirming the presence of the carbonyl (D) of the ester functional group.
The first singlet in the 1H NMR spectrum at δ 5.12 ppm corresponded to a CH2 group
of a benzyl ester (E), and was confirmed by the HMQC spectrum via a cross peak with
a carbon peak at δ 67.34 ppm.
The second singlet peak at δ 4.94 ppm resonated at a frequency downfield compared to
where a benzylic CH2 group would resonate. Due to its chemical shift and the structure
of the expected oxime, this CH2 group was assigned as being bonded to a heteroatom; in
this case the nitrogen atom of the nitrone functionality. The singlet at δ 4.94 ppm was
therefore potentially assigned to protons at the (A) position of nitrones 151 and 152,
respectively.
The protons from the third singlet peak in the 1H NMR spectrum appeared at δ 3.89
ppm. Using the structure of the expected oxime intermediate, this CH2 group (B) was
assigned as either the benzylic position of nitrone 151, or α- to the ester group of nitrone
152. NOE spectroscopic analysis showed that both the singlets at δ 4.94 and 3.89 ppm
had through-space interactions with protons of their corresponding aromatic rings.
Long range HMBC spectroscopic analysis showed that the methylene group (A) at δ 4.94
ppm interacts with the carbonyl carbon (D). This would represent a four-bond interac-
tion in the six-membered structure 151, but a five-bond interaction for the five-membered
structure 152. Unfortunately, this piece of data was not substantial enough to distinguish
which nitrone structure was obtained; further evidence was required to assign its structure.
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Figure 2.14: Possible structures of unidentified nitrone product - labelled
2.4.2 Literature precedence for formation of cyclic nitrones
Due to the inconclusiveness over the exact structure of the nitrone product from spectro-
scopic analysis, we conducted a review of the literature to help determine which of the
two structures (nitrone 151 and nitrone 152) formation was most plausible. Given the
similarity between our starting material and that of Grigg et al., we proposed that an
oxime intermediate could have undergone a formal 1,3-azaprotiotransfer reaction (or con-
jugate addition reaction) to afford the five membered structure 152. However, assuming
an oxime intermediate, it was proposed that an alternative electrocylisation reaction of
this oxime might also have occurred to form the six-membered nitrone 151 (Scheme 2.16).
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Scheme 2.16: Possible pathways for nitrone formation
Possible precedent for formation of nitrone 151
The occurence of 6pi-aza-hexatriene electrocyclisation reactions are well known in synthe-
sis. For example, Qiang et al. employed electrocyclic methodology of o-vinyl imines for
the synthesis of substituted quinolines 157 (Scheme 2.17).78 The starting anilines 153
were reacted with substituted benzaldehydes to provide the corresponding imines 154 in
high yields. These imines underwent 6pi-electrocyclisation reactions to afford quinolines
157 in yields varying from 38% to 86%.
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Scheme 2.17: Qiang 6pi-aza electrocyclisation synthesis of quinolines 157
The group proposed that, subsequent to the 6pi-electrocyclisation reaction, the interme-
diates 155 undergo a [1,5]-hydride shift to afford dihydroquinolines 156 that were then
oxidised in air to afford the final quinoline products 157. This mechanism was substanti-
ated by the isolation of a number of the dihydroisoquinolines when the electrocyclisation
reactions were carried out in degassed solvent under an inert atmosphere.
In this respect it was possible that oxime 166 had undergone a 6pi-aza-hexatriene electro-
cyclisation reaction to afford intermediate 158, which then rearranged to its corresponding


















Scheme 2.18: Suggested mechanism for formation of six-membered nitrone 151
Precedent for formation of nitrone 152
However, there was also significant literature evidence to suggest that the five membered
nitrone 152 could have been formed. As discussed in Chapter 1, reaction of the aldehyde
with hydroxylamine would afford an oxime intermediate which, following on from Grigg’s
precedent, would undergo a 1,3-azaprotiotransfer reaction followed by a tautomerisation
event to yield nitrone 152.
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Scheme 2.19: Proposed 1,3-azaprotio cyclisation mechanism for formation of
five-membered nitrone 152
—
However, nitrone 152 could also be synthesised by the direct intramolecular conjugate ad-
dition of the nitrogen atom of oxime 149 to its activated alkene functionality (Scheme 2.20).
This would represent a formal 5-exo-trig ring closure reaction, which would be allowed
according to Baldwin’s rules. Rearrangement by tautomerisation would then afford the





















Scheme 2.20: Potential conjugate-addition mechanism for formation of nitrone
152
Precedent for this type of conjugate addition reaction has been reported by Nakama
et al. who showed that Lewis-acid catalysed conjugate addition of aldoximes 159 to α,β-
unsaturated carbonyl acceptors 160 could be used to afford N -alkylated nitrones 161
(Scheme 2.21).79 In this case, the carbonyl group of the α,β-unsaturated carbonyl com-
pound 160 coordinates to a Lewis acid (50:50 mix of zinc(II) iodide and boron trifluoride
etherate), resulting in conjugate addition of the aldoxime 159 to yield the nitrone product
161. An array of N -alkylated nitrones were formed in high yield, with aliphatic oximes
(E)-crotonaldoxime and 2-furan carboxaldehyde oxime showing good reactivity.
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X = Me, OMe, H,
2-Oxo-3-oxazolidinyl
DCM, rt or reflux, 4-24 h,




Scheme 2.21: Intermolecular conjugate addition reaction of oximes to form ni-
trones 161
2.4.3 X-Ray crystal structure of unknown nitrone
As will be described in the following chapter, this cyclisation/nitrone formation method-
ology was applied to a range of substituted 2-bromobenzaldehydes. The 1H NMR spectra
for all of these nitrone analogues showed the same pattern of three singlet peaks integrat-
ing to two protons each, as the parent nitrone 152 (peaks A, B and E; see Figure 2.13).
During the course of my research, the nitrone derived from 2-bromo-6-fluoro-benzaldehyde
was isolated as a solid. After recrystallisation from dichloromethane (DCM) and hexane to
provide colourless needles, a crystal structure of this nitrone was obtained (Figure 2.15a).
The crystallographic data confirmed that a new five-membered ring had been formed in
the reaction. It also confirmed the presence of the nitrone functionality with the C1-N
bond length, at 1.4894 Å, being greater than the C8-N bond length of 1.3142 Å. Full
crystallographic data for this compound is available in the appendix.







Figure 2.15: Confirmation of the isoindole nitrone structure by X-ray crystal-
lography
Redissolving the solid six-fluoro nitrone in CDCl3 resulted in a 1H NMR spectrum that
matched that of the parent nitrone 152, suggesting that the same structure exists in the
liquid form as it does in the solid state. Thus, we conclude that reaction of aldehyde with
hydroxylamine afforded nitrone 152 (Scheme 2.22), and all of the chemistry discussed
from this point onwards, is based on the assumption that an isoindole skeleton is formed
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1 eq. NH2OH⋅HCl, 2 eq. NaOAc
5:1 EtOH:H2O, rt, 3 h, 78% N+ O-
CO2Bn
138 152
Scheme 2.22: Product of nitrone formation reaction
2.5 Mechanistic investigations
As we had synthesised a novel isoindole based nitrone 152, we wanted to investigate
the mechanism of its formation. Up until now, it appeared reasonable to make two
assumptions. Firstly, that an oxime could form in-situ which underwent cyclisation, and
secondly, that it could do so either via a 1,3-azaprotiotransfer or via a conjugate addition
mechanism. However, in order to establish a mechanism, we thought it informative to
ignore these assumptions, and start with a "blank canvas" for our investigations. We felt
that there were three key questions that needed to be explored:
1. What is the structure of the compound/reaction intermediate that undergoes cycli-
sation?
2. What is the mechanism of cyclisation?
3. How is the substituted nitrone functionality formed post cyclisation?
2.5.1 Identity of cyclisation precursor
It seemed reasonable to assume that an oxime had been formed as a reaction intermediate,
so this was the first postulate to be investigated. At this point, the key aldehyde substrate
was re-synthesised using ethyl acrylate 162 instead of benzyl acrylate 86 (Scheme 2.23).
Therefore, aldehyde 164 was prepared in 87% yield using our previously optimised 3 step
procedure, employing ethyl acrylate 162 as a coupling partner. The aldehyde 164 was
reacted with hydroxylamine hydrochloride and sodium acetate for twelve hours, to afford
the corresponding nitrone 165 in 75% yield.
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50 °C, 4 h, 87%
1.5 eq.
1 eq. NH2OH⋅HCl, 2 eq. NaOAc





Scheme 2.23: Identity of nitrone 165
Importantly, it was found that working the reaction up at three hours, as we had with
the previous example, gave a 1H NMR spectrum that revealed peaks corresponding to the
presence of an oxime intermediate, as well as the expected nitrone product 165.
Noting that this oxime was likely to be a potential reaction intermediate, we wanted to
determine exactly what role the second equivalent of base was playing in the cyclisation
reaction. To investigate this, we initially carried out the reaction in the absence of base to
see whether any cyclisation would occur (Scheme 2.24). The only product of the reaction
was oxime 166, which was isolated as a pale brown solid in 74% yield. Diagnostic peaks
in the 1H NMR spectrum included a singlet peak at δ 8.53 ppm corresponding to the
proton α to the C=N functionality, and two doublets at δ 8.13 and 6.34 (J = 15.9 Hz)








5:1 EtOH:H2O, rt, 3 h, 74%
164 166
Scheme 2.24: Synthesis of oxime 166
To ascertain whether cyclisation of this oxime could be induced, it was dissolved in ethanol
and water and one equivalent of base was added, with the reaction then being stirred
overnight. After working up the reaction in DCM and water, nitrone 165 was isolated
as a single reaction product, as shown in Scheme 2.25. These experiments provided ev-
idence that oxime 166 was likely to be an intermediate in the cyclisation reaction, that
its formation was relatively fast, and that the base was functioning to facilitate nitrone








5:1 EtOH:H2O, rt, o/n
166 165
Scheme 2.25: Cyclisation of oxime 166
At this point, we considered the mechanism of oxime formation, which highlighted hydrox-
yamino alcohol 167 as a potential intermediate responsible for ring-closure (Scheme 2.26).
This intermediate 167 is similar to the structure 129 that Hatano had proposed previ-
ously for the synthesis of 3-TF-TMINO (see Scheme 2.5). Due to the presence of water in
the reaction, an equilibrium will be present between the hydroxyamino alcohol 167 and
the oxime 166, and as a consequence, either intermediate could potentially be considered

















Scheme 2.26: Mechanism of cyclisation to afford nitrone 165
The sp3 atom of hydroxyamino alcohol 167 is likely to be more nucleophilic than the cor-
responding sp2 nitrogen of oxime 166, and thus, in accordance with the work of Hatano
et al., we propose that the hydroxyamino alcohol species is most likely to initiate the
cyclisation reaction. Further work discussed below in section 2.5.3 provides evidence to
support this theory.
2.5.2 Literature precedent and evidence for cyclisation mechanism
The second question to be investigated was the mechanism of cyclisation. From the
structure of the aldehyde starting material and the reagents, we assumed that cyclisation
must be initiated by nucleophilic attack of the nitrogen atom on the double bond of the
α,β-unsaturated ester group. There were two potential pathways by which this could
occur:
1. Reverse Cope cyclisation
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2. Conjugate addition
First reported simultaneously by House and Oppolzer,80–82 the reverse Cope cyclisation
reaction is a type of 1,3-azaprotio cyclotransfer reaction. It is a concerted reaction in which
an unsaturated hydroxylamine undergoes an intramolecular thermal 5-exo-trig cyclisation
to give pyrrolidine-N -oxides, or the corresponding N -hydroxy derivatives (Scheme 2.27).
Formally a 2σ + 2pi + 2n ene like cyclisation, the reaction proceeds via a planar five-
membered transition state.83–85 The labile hydroxyl proton (in blue) ends up in the β


























Scheme 2.27: Reverse Cope cyclisation mechanism
More recently, Knight et al. have carried out considerable research into the scope and
limitation of the reverse Cope cyclisation reaction,86,87 extending the methodology to
the synthesis of N -hydroxyisoindolines68 (Scheme 2.28) and 1,3-thiazolidine-N -oxides88
(Scheme 2.29) for example. Nitrones are often used as precursors to the reverse Cope
hydroxylamine starting materials, with nucleophilic addition to a nitrone, or reduction,
























Scheme 2.29: Reverse Cope cyclisations for the synthesis of 1,3-thiazolidine-N -
oxides
Generally, the reverse Cope cyclisation reaction rate is significantly enhanced by the
Thorpe-Ingold effect, when the R group is a methyl group, and by internal alkene sub-
stituents (see Scheme 2.27). However, distal alkene substituents retard the reaction rate,
and it is unusual to encounter facile cyclisation at ambient temperatures.86 Importantly,
there are few examples of reverse Cope cyclisation reactions where the alkene substituent
contains an electron withdrawing group such as an ester.
It is also possible that the five membered ring of these nitrones have been formed through
conjugate addition of a nitrogen species to the alkene bond of the α,β-unsaturated es-
ter. This conjugate addition/reverse Cope cyclisation mechanistic query was encountered
by the Liu group, in their report on the synthesis of 2,3-disubstituted piperidines from
γ-butyrolactone.89 When attempting to synthesise N -4-alkenyl nitrones 170 through con-
densation with formaldehyde, the group found that the N -4-alkenyl hydroxylamine precur-
sor 168 spontaneously cyclised to afford pyrrolidinol 169 (Scheme 2.30). This cyclisation
event was speeded up by the presence of base.
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Scheme 2.30: Liu synthesis of pyrrolidinol ester by-products 169
This group identified reverse Cope cyclisation and conjugate addition reactions as possible
mechanisms for formation of the pyrrolidinols 169. Having observed the facile nature of
the cyclisation, the group then made several other observations that led them to propose
the latter mechanism. One of which was the presence of an ester in the distal position,
which should retard a reverse Cope cyclisation. The second observation was the fact that
Z -alkene 171 gave the same product piperidine isoxazoline, 172, (after an intramolecular
1,3-dipolar cycloaddition reaction) as its corresponding E-alkene 168 (Scheme 2.31). This
was explained by proposing a reversible cyclisation/elimination reaction to equilibrate the









































Scheme 2.31: Reaction of Z-alkene 171 with formaldehyde affords the same
piperidine isoxazoline 172 as the E-alkene 168
The Liu group also reported an example from Ciganek et al., whereby N -4-alkenyl hydrox-
ylamine 173 did not undergo a reverse Cope cyclisation reaction to produce the pyrroline
175, but instead gave the piperidine N -oxide 174 instead (Scheme 2.32). The Ciganek















Scheme 2.32: Intramolecular conjugate addition of hydroxylamine 173 occurs
to afford the six-membered piperidine 174
Comparisons can be drawn between the structures of the N -4-alkenyl hydroxylamine 168
of the Liu group and our proposed amino alcohol intermediate 167, and as a consequence
we decided to investigate which reaction pathway was operating in our reaction.
Therefore, our reaction conditions were applied to two key substrates. Firstly, O-methylhy-
droxylamine was used as a nucleophile, instead of free hydroxylamine, which we reasoned
should prevent a reverse Cope cyclisation reaction from occuring, but still afford a cyclised
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product if a conjugate addition mechanism was operating.
Treatment of aldehyde 164 with O-methylhydroxylamine in the presence of excess base
was monitored by TLC analysis, which after three hours showed complete disappearance
of starting material and the presence of two new spots. The 1H NMR spectroscopic anal-
ysis of an aliquot showed the O-methyl oxime as the major product, with peaks for a
minor product that contained a cyclic structure also present. Consequently, the reaction
was allowed to continue, and TLC analysis ultimately showed complete disappearance of
the oxime after three days. The major reaction product 176, a dark purple oil, was as-
signed the cyclic structure shown in Scheme 2.33 after running NMR and HRMS analyses
(HMQC data shown in Figure 2.16). Purification proved difficult, as the crude mixture








2 eq. Et3N, 5:1 THF:H2O,































Figure 2.16: HMQC data of cyclised salt 176
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The HMQC data showed that a different regioisomer of nitrone had been formed, com-
pared to the more substituted nitrone isomer 165 observed when hydroxylamine was
employed as a nucleophile. The distinctive nitrone carbon at δ 141 ppm was no longer a
quarternary carbon, but was bonded to a proton that presents as a singlet peak at δ 8.32
ppm in the 1H NMR (A). The presence of a 1H multiplet at δ 5.52 ppm (B), was shown
by COSY interactions to be adjacent to a CH2 group multiplet at δ 2.75 ppm (D), also
supporting relocation of the double bond.
The second substrate investigated for the cyclisation mechanism was the commercially
available aldehyde 177. This compound should not cyclise if the reaction proceeds via
conjugate addition. However, we would expect to see rapid cyclisation if a reverse Cope
mechanism takes place under these conditions. Therefore, 2-vinylbenzaldehyde 177 was
treated with hydroxylamine and base in THF/H2O, which only resulted in formation of
oxime 178 (Scheme 2.34). No other products were isolated, despite varying the tempera-
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Scheme 2.34: Failed cyclisation reaction of 2-vinylbenzaldehyde
Both results presented above provide clear evidence to support a 5-exo-trig cyclisation
mechanism, in which a hydroxyamino alcohol intermediate attacks the α,β-unsaturated
ester in a 1,4 conjugate addition manner, to afford the five membered ring. The next mech-
anistic step to be investigated was how the more substituted nitrone functional group was
formed post-cyclisation, which is discussed in the following section.
2.5.3 Investigating the reaction mechanism
A full reaction mechanism is proposed in Scheme 2.35. Thus far, we had deduced that a
hydroxyamino alcohol intermediate 167 was likely to undergo a conjugate addition cycli-
sation step to afford enolate 179. Post cyclisation, a dehydration step to form a nitrone
was proposed, positioning a carbon-nitrogen double bond in the alternative N-C8 position
as seen for the O-methyl salt example (Scheme 2.33). Tautomerisation would then occur
to afford a more thermodynamically stable nitrone 165, with its nitrogen-carbon double
bond in the N-C1 position.
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Scheme 2.35: Proposed reaction mechanism for formation of nitrone 165
In order to try and confirm that the hydroxyamino alcohol intermediate 167 was the
key cyclisation precursor, we decided to employ an N -substituted hydroxylamine as a
nucleophile in the reaction (Scheme 2.36). If our mechanistic hypothesis was correct, cy-
clisation should occur, as the cyclised structure would be more stable than the initially
formed hydroxyamino alcohol, however, the subsequent dehydration step would not be
possible.
N -Methyl hydroxylamine hydrochloride was added to a solution of aldehyde 164 and
base affording the cyclised product 182 as a mixture of diastereomers. NMR and HRMS
analyses fully support this structure; the proton adjacent to the -OH group in the ma-
jor diastereomer appears as a singlet at δ 5.71 ppm, in contrast to the singlet observed
at δ 8.32 ppm for the nitrone proton of the O-methyl cyclised salt 176. Similarly, the
presence of a 1H multiplet at δ 4.26 ppm corresponding to the other benzylic proton,
and diastereotopic AB quartets (JAB = 16.0, 5.8 Hz) at δ 3.09 and δ 2.45 support this
structure. NOE analysis revealed a correlation between the proton adjacent to the -OH
group and the protons of the methyl group.
This result supports our proposition, that the conjugate addition cyclisation reaction is
initiated by the sp3 nitrogen of the more nucleophilic hydroxyamino alcohol intermediate







2 eq. Et3N, 5:1 THF:H2O,







Scheme 2.36: Reaction of aldehyde 164 with N -Methylhydroxylamine
In the next step of the reaction mechanism, a dehydration reaction is proposed to afford a
kinetic nitrone product 180. Previously, when using O-methyl hydroxylamine hydrochlo-
ride in the reaction, the salt isolated had the carbon-nitrogen double bond at the upper
N-C8 position of the five membered ring. We wanted to determine whether it would
be possible to form a stable nitrone with the double bond in this position, and so the
structure of the aldehyde starting material was redesigned to incorporate a β-substituted
alkene, since this would prevent isomerisation of the nitrone from the N-C8 position into
its N-C1 position.
Therefore, acetal 147 was Heck cross-coupled with ethyl crotonate to afford acetal 184,
which was then deprotected under acidic conditions to furnish the corresponding aldehyde















50 °C, 4 h, 69%
1.5 equiv.
147 184 185
Scheme 2.37: Synthesis of β,β-di-substituted ester 185
This β,β-di substituted ester was then subjected to the cyclisation reaction conditions
and afforded the predicted nitrone product 186, which contained a N-C8 double bond, as







1 eq. NH2OH⋅HCl, 2 eq. Et3N
5:1 THF:H2O, rt, 3 h
185 186
Scheme 2.38: Cyclisation reaction of β,β-di-substituted ester
This result proved that cyclisation could occur to afford a N-C8 nitrone when the N-C1
double bond position was blocked. The next logical step, therefore, was to explore the re-
action outcome when a substrate with carbon substitution at the C8 position was present.
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Therefore, ethyl acrylate 162 was directly coupled to 2-bromoacetophenone using a Heck
cross coupling reaction (Scheme 2.39) to afford ketone 188 in 90% yield as a yellow oil.
No acetal protecting group step was required in this reaction because the C-H insertion
reaction observed for aldehydes could not occur.
Pd(OAc)2, P(o-Tol)3, Et3N,













Scheme 2.39: Synthesis of ketone 188
After subjecting ketone 188 to the standard cyclisation reaction conditions, nitrone 189
was isolated as a major product containing an N-C8 nitrone double bond (Scheme 3.13).
Analysis of the 1H spectrum of the crude reaction product revealed peaks for a minor
product, which corresponded to a nitrone whereby the double bond was present in the al-
ternative N-C1 position β- to the ester functionality. Leaving the reaction to stir overnight
gave no change in the proton NMR spectrum, implying that this was the thermodynamic




1.1 eq. NH2OH in H2O, 











Scheme 2.40: Cyclisation reaction of ketone 188
These results confirmed our theory that the N-C8 tautomers of nitrones are formed ini-
tially from aldehyde substrates, and we suggest these undergo a fast tautomerisation step
to the thermodynamically more stable structure 165. To confirm this, we carried out a
deuterium incorporation experiment as shown in Scheme 2.41, which involved dissolving
aldehyde 164 in a 5:1 mix of THF and D2O, and reacting under the standard cyclisation





1 eq. NH2OH⋅HCl, 2 eq. Et3N,








Scheme 2.41: Deuteration experiment for exploring mechanism of cyclisation of
ester 164
1H NMR spectroscopic analysis showed that the resonances for both the benzylic CH2
group and the CH2 group α- to the ester were no longer present with the correct integra-
tion. Singlet peaks corresponding to these groups were observed in the corresponding 2H
NMR spectrum, however. After a reaction time of 30 minutes, the acidic position adjacent
to the ester group showed 77% deuterium incorporation, whilst the benzylic CH2 position
showed 60% deuterium incorporation. Incorporation of deuterium at the CH2 group α- to
the ester can be explained by a series of fast enolate formation/deuteration steps. Deu-
terium incorporation at the benzylic CH2 is less simple to explain. We propose that an
equilibrium exists between three tautomeric forms in solution (165, 181 and 180), thus


























Scheme 2.42: Nitrone tautomerisation leading to deuterated nitrone 190
To test this proposal, nitrone 165 was synthesised under optimised conditions and then
added to a solution of base in a 5:1 mixture of THF:D2O. The solution was stirred for
thirty minutes at room temperature before being worked up and evaporated to yield a red
oil (Scheme 2.43). Both 1H and 2H NMR spectra were obtained and both CH2 positions
showed an increase in deuterium incorporation (> 90% in both cases). This demonstrates








1 eq. Et3N, 5:1 THF:D2O,
rt, 30 min
165 190
Scheme 2.43: Deuteration experiment of nitrone 165
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2.6 Proposed reaction mechanism for nitrone formation
Using the evidence gained from the key mechanistic experiments above, we conclude
a mechanism for nitrone formation, shown in Scheme 2.44. We believe that reaction of
aldehyde 164 with hydroxylamine forms a hydroxyamino alcohol intermediate 167, which
undergoes a 5-exo-trig cyclisation reaction via conjugate addition to the α,β-unsaturated
ester, to yield enolate 179. Subsequent to this cyclisation event, loss of a molecule of
water yields nitrone 180, which undergoes an extremely facile tautomerisation step to the




































Scheme 2.44: Proposed reaction mechanism for reaction of ester 164 with hy-
droxylamine
2.7 Synthesis of monocyclic nitrone
Based on the extensive mechanistic work discussed in section 2.5, we wanted to deter-
mine whether the few examples of aldehydes reacting with hydroxylamine to form cyclic
nitrones reported by Grigg, were also proceeding via a conjugate addition mechanism
(Scheme 2.45).
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Scheme 2.45: Grigg’s synthesis of monocylic nitrone
A number of other literature examples have been reported where a hydroxylamine and an
aldehyde are reacted together to give a cyclic nitrone. In these cases either:
1. A mechanism is not disclosed
2. A 1,3-azaprotiotransfer mechanism of an intermediate oxime is suggested, or
3. The authors state that the reaction proceeds via a non-isolable oxime intermediate,
which undergoes a conjugate addition/cyclisation reaction
For example, in their synthesis of hydroxylated pyrrolizidines, Hall et al. reacted cis-
alkene 191 with hydroxylamine and base to form nitrone 192, but did not discuss any






















EtOH-H2O, rt, 18 h, 83%
191 192
Scheme 2.46: Hall’s synthesis of 192
Interestingly, the Argyropoulos group reacted an almost identical starting material, alde-
hyde 193, with hydroxylamine and base to afford nitrone 195, as part of their synthesis
of hydroxylated pyrroline-N -oxides derived from D-ribose (Scheme 2.47).91 This group
proposed that the reaction took place via formation of an oxime intermediate 194, which






















Scheme 2.47: Argyropoulos’ synthesis of nitrone 195
In their research on asymmetric cycloaddition reactions of nitrones, Ishikawa et al. re-
acted aldehyde 196, under similar conditions, to yield nitrone 198 (Scheme 2.48). It
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was proposed that the nitrogen of an unisolable intermediate oxime, 197, added to the
unsaturated ester in a 1,4 conjugate addition manner to yield the product.92
NH2OH⋅HCl,
Et3N, DCM,


















Scheme 2.48: Ishikawa’s synthesis of nitrone 198
Given the almost identical nature of all three starting materials and products to each
other and to Grigg’s monocyclic example, it was logical to assume that the mechanism of
formation for all four nitrones was the same. In order to determine whether they followed
one of the literature mechanisms discussed or our proposed hydroxyamino alcohol mecha-
nism, it was decided to repeat Grigg’s cyclisation chemistry under our reaction conditions.
2.7.1 Synthesis of a suitable acyclic substrate
To begin this piece of work, the aldehyde starting material had to be synthesised. Sev-
eral literature methods were available; either multi step syntheses,93 89 one step methods
affording low yields,94,95 or methods requiring the use of ozone.96 We chose to employ a
direct method involving cross metathesis of aldehyde 4-pentenal 199 with ethyl acrylate
162, using Grubbs I catalyst under standard conditions (Scheme 2.49).97 Aldehyde 200
was obtained as a colourless oil in 87% yield, after purification by column chromatography.
O O CO2Et
Grubbs I (5 mol%),














Scheme 2.49: Cross metathesis reaction of 4-pentenal with ethyl acrylate
2.7.2 Cyclisation efforts to afford a monocyclic product
We then subjected aldehyde 200 to our optimised reaction conditions, to afford a white
solid which was confirmed to be nitrone 201 by comparison of the NMR spectra with that
reported in the literature (Scheme 2.50). Nitrone 201 was isolated as a yellow oil.
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O CO2Et
1.1 eq. NH2OH in H2O, 
THF, -20 °C, 30 min, 91% N+ O-
CO2Et
200 201
Scheme 2.50: Synthesis of monocylic nitrone 201
Therefore, we propose that the hydroxyaminoalcohol intermediate 202, formed after ini-
tial attack of hydroxylamine on the formyl group, adds in a 1,4 fashion to the α,β un-
saturated ester to give cyclised pyrrolidine 203, with loss of water affording nitrone 201


























Scheme 2.51: Proposed mechanism for formation of nitrone 201
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2.8 Conclusion
In this chapter we have presented a new method for the synthesis of isoindole derived ni-
trones whose mechanism has been elucidated as the conjugate addition cyclisation/tautomerisation




































Scheme 2.52: Proposed reaction mechanism for the synthesis of novel isoindole
N -oxide 165
Previous literature reports by on related cyclisations by Hall, Argyropoulos and Ishikawa
are likely to proceed via this mechanism, and not by 1,3-azaprotio cyclotransfers of oxime
intermediates as previously proposed.
The following chapter describes optimisation of this nitrone forming conjugate addi-
tion/cyclisation reaction, its scope and limitation, and application of these optimal con-
ditions to other classes of cyclisation substrate.
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Chapter3
Reaction Optimisation & Exploration of
Scope & Limitation of Nitrone Cyclisation
Reaction
3.1 Introduction
In the previous chapter a novel route for the synthesis of bicyclic, isoindole based nitrones
was presented. This chapter discusses optimisation of this reaction and its application for
the synthesis of a wide range of isoindole nitrones.
3.2 Reaction optimisation
The nitrone forming methodology described in the previous chapter involved the reaction
of aldehyde 164 with hydroxylamine and sodium acetate in EtOH/H2O, which required
fourteen hours to go to completion (Scheme 3.1). We wanted to shorten this time, and
began our optimisation work by picking an arbitrary time of 30 minutes for the screening
experiments. Using the same reagents and solvents, the original reaction was carried out
for this length of time, and after work up the 1H NMR spectrum showed that there was
a 100% conversion from aldehyde to oxime and that 47% of this oxime had rearranged to
nitrone (Table 3.1, entry 1). This result confirmed our earlier theory that the synthesis
of the oxime cyclisation precursor was a fast step, whilst the cyclisation of the oxime






1 eq. NH2OH⋅HCl, 2 eq. NaOAc
5:1 EtOH:H2O, rt, 14 h, 74%
164 165
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Scheme 3.1: Synthesis of nitrone 165 using original conditions
3.2.1 Base screen
It was rationalised that using a stronger base might increase the rate of the reaction, and
so a small base screen was performed, with all other reaction conditions remaining the
same. Using a strong base such as potassium tert-butoxide (Scheme 3.2, Table 3.1, entry
2) gave an unexpected result. All of the starting material was consumed, however there
was neither oxime nor nitrone present. The product of the reaction had formed cleanly
and in 100% conversion. After carrying out NMR analyses, we determined that the prod-
uct of the reaction was the cyclised hydroxylamine 205, whose diastereomers were present




1 eq. NH2OH⋅HCl, 2 eq. tBuOK





Scheme 3.2: Reaction using tBuOK base
We continued the screen, using bases with an intermediate strength between sodium ac-
etate and potassium tert-butoxide. Caesium carbonate gave a mixture of compounds, not
all of which could be identified. Triethylamine and potassium carbonate both gave high
conversions to nitrone however, and the reaction using triethylamine was carried forward
as it gave the highest yield of nitrone product (entry 4).
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Table 3.1: Base screen for nitrone cyclisation reaction






Conditions: Aldehyde 164 (1 mmol), 1 eq. NH2OH·HCl, 2 eq. base, 5:1 EtOH:H2O (10
mL/g), 30 min. All entries showed 100% consumption of aldehyde starting material. %
product determined from 1H NMR spectra.
3.2.2 Solvent screen
The second variable investigated was the choice of reaction solvent. Whilst changing the
base had given us a system that proceeded to completion within half an hour, the cur-
rent solvent system was from the original oxime preparation.77 We wanted to investigate
whether the polar protic nature of the solvent was required for our reaction, and to find out
if a mixed solvent system was required. At the time we also wanted to identify conditions
that would enable us to investigate deuterium incorporation as part of the mechanistic
investigation described in Chapter 2, Section 2.5. Therefore, a short solvent screen was
carried out using the aldehyde substrate 164 (Table 3.2).
Initially, the reaction was carried out in ethanol and water separately to determine whether
both solvents were required for the reaction to proceed (entries 1 and 2). Although both
reactions went to 100% conversion (i.e no aldehyde starting material was remaining), nei-
ther gave 100% nitrone 165. Interestingly, the reaction with solely ethanol showed nitrone
165 and also hydroxyamino alcohol 206, in a 1:2 ratio (Scheme 3.3). The reaction in wa-
ter alone gave a mixture of products, not all of which could be identified.
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Scheme 3.3: Reaction of aldehyde 164 and hydroxylamine in ethanol
These results suggested that a dual solvent system was indeed necessary for the nitrone
to form cleanly as the sole product. We then wanted to determine whether both solvents
had to be polar and protic. We began by investigating aprotic polar solvents that are also
miscible with water.
Table 3.2: Solvent screen for nitrone cyclisation reaction
Entry Solvent % Product
1 5:1 EtOH:H2O 98
2 EtOH 33
3 H2O –a
4 5:1 Et2O:H2O –a
5 5:1 THF:H2O 100
6 THF –a
Conditions: Aldehyde 164 (1 mmol), 1 eq. NH2OH·HCl, 2 eq. Et3N, solvent (10 mL/g),
30 min. All entries showed 100% consumption of the aldehyde starting material. %
product determined from 1H NMR spectra. a% product could not be determined due to
presence of an unidentifiable mixture of compounds in the 1H NMR spectra.
A mixture of diethyl ether and water gave an unidentifiable mixture of compounds by
1H NMR spectroscopic analysis (entry 4). However, the last solvent system we screened
gave optimal results, with a 5:1 THF:H2O solvent system giving a 100% conversion to
nitrone 165 within the 30 minute screening time frame. For completeness, and to confirm
our earlier results that water plays a key part in the reaction, we carried out the reaction
solely in THF (Table 3.2, entry 6), which gave a complex 1H NMR spectrum. We chose to
continue using THF:H2O as the reaction solvent rather than revert back to ethanol:water,
as it was easier to remove after the reaction work-up.
3.2.3 Hydroxylamine source
The existing procedure employed the hydrochloride salt of hydroxylamine, and required
two equivalents of base (see Table 3.3, entry 1). From the results gained above, it seemed
70
3.2. Reaction optimisation
logical to repeat the reaction using a commercially available solution of hydroxylamine in
water (50 wt.%), which would simplify the protocol significantly.
We initially carried out the cyclisation reaction by substituting the hydroxylamine salt
with the aqueous solution using only one equivalent of base as there was no HCl to liberate,
and using only THF as solvent (Table 3.3). The reaction gave 100% conversion to nitrone
within the screening time, demonstrating that the lower percentage of water was sufficient
for the cyclisation reaction to proceed. We next investigated using one equivalent of the
hydroxylamine solution without added base. This reaction gave an encouraging result of
92% and when the amount of hydroxylamine was increased slightly to 1.1 equivalents,
100% conversion to nitrone was achieved in thirty minutes.
Table 3.3: Hydroxylamine screen for nitrone cyclisation reaction
Entry NH2OH source Eq. NH2OH Eq. Et3N % Product
1 NH2OH·HCl 1.0 2.0 100
2 NH2OH aq. 1.0 1.0 100
3 NH2OH aq. 1.0 – 92
4 NH2OH aq. 1.5 – 100
5 NH2OH aq. 1.1 – 100
Conditions: Aldehyde 164 (1 mmol), entry 1: 5:1 THF:H2O (10 mL/g), 30 mins;
entries 2-4: THF (10 mL/g), 30 mins. All entries showed 100% consumption of the
aldehyde starting material 164. % product determined by 1H NMR spectra.
3.2.4 Temperature
Up until this point, the original reaction conditions and all subsequent screening work
had afforded nitrone 165 as a dark red thick oil, which hardened into a dark red solid on
standing. At the beginning of the reaction, the solution was a pale yellow colour, and over
time it darkened, particularly during removal of the solvent post work-up. Now that we
had optimised conversion conditions in hand, we sought to improve the yield of nitrone
obtained after isolation.
Attempts to recrystallise the dark red solid were fruitless, so we investigated whether an-
other change of conditions could afford the nitrone as a crystalline solid at an earlier stage.
The cyclisation reaction was re-run using the newly optimised solvent/reagent system at
a range of temperatures (Table 3.4). At 10 ◦C the reaction remained a solution which
darkened over time, whilst at 0 ◦C the reaction solution remained yellow. At -10 ◦C a
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cloudy suspension formed, which when filtered gave 5 mg of a cream solid identified as
the desired nitrone product. A work up of the mother liquors revealed that the majority
of product was still present in the liquid phase. Interestingly, even at this reduced tem-
perature, nitrone 165 was the only compound present in the NMR spectrum. At -20 ◦C,
more of this cream solid precipitated out of solution, and, upon filtering after 30 minutes,
nitrone was obtained as a solid in 76% yield.
Table 3.4: Temperature screen for nitrone cyclisation reaction
Entry Temperature (◦C) Reaction Observation % Product
1 18 (rt) liquid –a
2 10 liquid –a
3 0 liquid –a
4 -10 cloudy suspension 100
5 -20 cream precipitate 100
Conditions: 164 1 mmol, 1.1 eq. NH2OH (aq.), THF (10 mL/g), 30 mins. All entries
showed 100% consumption of the aldehyde starting material. % product determined from
1H NMR spectra. aReactions not worked up, no NMR data obtained.
After a few days at room temperature, the solid began to discolour. The 1H NMR spec-
trum of a sample revealed that the nitrone was no longer clean, with the baseline having
become “grassy”. Whilst no specific alternative structures could be explicitly identified,
this degradation was assigned to its gradual polymerisation, a process that has been re-
ported previously for other reactive nitrone species. However, this instability could be
resolved by storing the solid nitrone in the freezer, where it could be stored indefinitely
without signs of degradation/polymerisation.
3.2.5 Reaction scale up
Having developed reaction conditions to afford an easy to handle solid nitrone in a short
time, we scaled up the reaction to assess the yield. To a solution of aldehyde (10 mmol)
in THF at -20 ◦C hydroxylamine was added as a 50% solution in water (Scheme 3.4).
After thirty minutes at -20 ◦C, the suspension was vacuum filtered, the reaction flask was
rinsed with cold THF three times and added to the filter cake, and nitrone 165 isolated








NH2OH (50% in H2O),
THF, -20 °C, 30 min, 94%
164 165
Scheme 3.4: Optimised synthesis of nitrone 165
3.2.6 Conclusion
We had successfully optimised the conditions for converting formyl acrylate 164 into the
novel bicyclic nitrone 165, resulting in:
1. The reaction time being cut from 14 hours to 30 minutes.
2. Only 3 reactants being required, instead of the 5 reactants employed in the original
procedure.
3. Isolation of the nitrone product as a solid in high yield, by lowering the temperature.
3.3 Reaction scope
With the reaction optimisation complete, we next wanted to address the scope and lim-
itation of this reaction by synthesising a library of nitrones. Starting from a variety of
substituted 2-bromobenzaldehydes, each aldehyde was subjected to a four step synthesis
to afford their corresponding nitrone (Scheme 3.5). The following sections describe the













toluene, reflux, 24 h
CO2Et
7:3 AcOH:H2O,
60 °C, 4 h
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1.1 eq. NH2OH in H2O, 









Scheme 3.5: Four step synthesis of nitrones
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3.3.1 Step 1: Acetal protection reactions
Our standard acetal forming conditions were used to prepare a range of substituted aryl
acetals 147 to 147g. Therefore, each aldehyde was heated with 1,3-propanediol and a
catalytic amount of pTSA in toluene using a Dean-Stark apparatus, to afford a range of
















































Scheme 3.6: Synthesis of eight aryl acetal analogues 147 to 147g
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3.3.2 Step 2: Heck cross-coupling reactions
Heck cross-coupling of a range of acetal protected aryl aldehydes with ethyl acrylate 162
was carried out by heating eaching aldehyde with a catalytic amount of palladium acetate,
tri-o-tolyl phosphine ligand and triethylamine in DMF at 120 ◦C for three hours. This
gave a series of nine α,β-unsaturated esters 163 to 163h in 67-81% yield. This methodol-
ogy afforded α,β-unsaturated esters with both electron donating and electron withdrawing
substituents around the aromatic ring, as well as substitution at the β- position, achieved


























































Scheme 3.7: Heck reaction to afford a range of nine α,β-unsaturated esters 163
to 184
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3.3.3 Step 3: Acetal deprotection reactions
The nine acetals were deprotected using aqueous acetic acid at 60 ◦C over four hours to

























































Scheme 3.8: Synthesis of aldehyde analogues 164 to 185
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Additional α,β-unsaturated cross-coupled substrates
We also wanted to explore whether this methodology could be applied to the synthesis
of other isoindole nitrone analogues containing different types of carboxylic acid deriva-
tives. Therefore, a nitrile containing analogue was synthesised in a similar manner, using
a slightly different coupling protocol (Scheme 3.9).98 Carrying out the Pd(0)-catalysed
cross coupling of acetal 147 with acrylonitrile 207 at a lower temperature, and for a
longer period of time, afforded the protected α,β-unsaturated nitrile 208 in a moderate
59% yield. Acidic deprotection with aqueous acetic acid then gave the aldehyde product


















Scheme 3.9: Synthesis of α,β-unsaturated nitrile 209
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Amide and Weinreb amide containing analogues 210 and 211 were synthesised by Heck
reactions of the appropriate acrylamides with 2-bromobenzaldehyde (Scheme 3.10). These
reactions were carried out under microwave conditions, and used the same catalyst, ligand,
base and solvent as the original procedure. Whilst some doubly substituted deformylated
products were seen in the crude 1H NMR spectra (see Chapter 2, Section 2.2.1), these
were minor products, and both the desired cross-coupled aldehydes could be obtained in
good 76-81% yields after purification.
Pd(OAc)2, P(o-Tol)3, Et3N,




























Scheme 3.10: Synthesis of amide containing aldehyde analogues
78
3.3. Reaction scope
A thioester example was also synthesised via Wittig reaction of phosphorane 212 with
phthaldialdehyde 213.99 The phosphorane was prepared in two steps from bromoacetic
acid following a literature method,100 involving DIC mediated thioester formation, fol-
lowed by reaction with triphenylphosphine and base (Scheme 3.11). It was then added
to a dilute solution of excess phthaldialdehyde in DCM and stirred for one day at room
temperature. The solvent was removed under reduced pressure and the crude mixture










0 °C - rt, 48 h
HS+
i) PPh3, toluene, 24 h
ii) DCM, Na2CO3 (aq.), cyclohexane,









DCM, 24 h, rt, 56%
212 213
214
Scheme 3.11: Synthesis of thioester containing aldehyde analogue 214
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3.3.4 Step 4: Nitrone synthesis reactions
A series of fourteen carboxylic acid derivatives were treated with hydroxylamine (50%
wt. in water) in THF at -20 ◦C for thirty minutes. This resulted in a series of smooth
cyclisation reactions occuring to afford their corresponding isoindole derived nitrones as































1.1 eq. NH2OH (50% wt. in H2O),

































Scheme 3.12: Synthesis of isoindole nitrone analogues
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Fourteen nitrones, 165-218, were successfully synthesised in acceptable to good yields.
An array of electron donating and electron withdrawing groups were tolerated around the
aromatic ring without significant detrimental affect to the yield. The 4-methyl nitrone
165a was not formed as a solid under the reaction conditions, so the reaction was worked
up in DCM and water to afford this nitrone as a yellow oil.
As discussed in the previous chapter, using a ketone starting material for acceptor syn-




1.1 eq. NH2OH in H2O, 





Scheme 3.13: Cyclisation of ketone nitrone analogue 188
The nitrone cyclisation reaction tolerates the presence of other α,β-unsaturated electron
withdrawing functional groups with the amide and nitrile analogues, 210 and 209, both
giving the desired nitrone products. Upon carrying out the reaction of the thioester ana-
logue, we noticed that the temperature had to be very tightly controlled due to a faint
smell of thiol indicating that competitive hydrolysis was occuring, upon warming.101 We
decided to investigate this hydrolysis reaction further and so reacted the thioester alde-
hyde with hydroxylamine at room temperature and allowed the crude reaction mixture
to stir overnight (Scheme 3.14). The reaction was then taken up in DCM and water,
separated, and the aqueous layer neutralised by 1M HCl and extracted with DCM. After
removing the solvent under reduced pressure, nitrone acid 218 was afforded as a red oil
in 68% yield. This observation is useful since it affords the potential for coupling with
amines under neutral DCC coupling conditions, thus enabling bioconjugation reactions to
be carried out.
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1.1 eq. NH2OH (50% wt. in H2O),






1.1 eq. NH2OH (50% wt. in H2O),




Scheme 3.14: Nitrones synthesised from reactions of thioester 214 with hydrox-
ylamine
The Weinreb substrate example did not yield the desired product. The reaction did not
produce a solid, and so the solvent and hydroxylamine were removed under reduced pres-
sure. The 1H NMR spectrum of the crude material was very complicated, with none of
the desired nitrone peaks being present, which was disappointing as access to a Weinreb
amide product would potentially have allowed access to a nitrone aldehyde as a substrate
for reductive amination reactions.
3.4 Synthesis of dihydroisoquinoline nitrones
After completing the synthesis of a library of isoindole based nitrones, we decided to use
our novel methodology to prepare dihydroisoquinoline based nitrones, containing a six
membered nitrone ring. In order to begin this work we initially had to synthesise the
required aldehyde starting materials.
3.4.1 Synthesis of cyclisation precursor - Strategy 1
With our aim now being the synthesis of six membered cyclic nitrones, the structure of our
aldehyde starting material had to be adapted to include an extra methylene carbon. We
began by exploring the possibility of inserting this requisite carbon between the aldehyde
group and the benzene ring. Taking the commercially available 2-bromophenethyl alco-
hol 219, we carried out a Heck cross coupling reaction using our previously established
conditions (Scheme 3.15). After purification, the coupled alcohol 220 was obtained in a
low 39% yield as a yellow oil. This was then oxidised, using Dess-Martin Periodinane,
in an attempt to afford the aldehyde 221, however, despite column chromatography and
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Scheme 3.15: Unsuccessful Heck synthesis of ester 221
3.4.2 Synthesis of cyclisation precursor - Strategy 2
After carrying out a further search of potential synthetic routes, we attempted the syn-
thesis of aldehyde 223, which would incorporate the extra methylene carbon adjacent to
the α,β-unsaturated ester. An adapted Negishi cross coupling of 2-bromobenzaldehyde
137 and bromocrotonate 222 was attempted,102 as shown in scheme Scheme 3.16. How-
ever, the 1H NMR spectrum of the reaction was complicated, and peaks for the desired





LiCl, Zn, THF, Br(CH2)2Br, I2, 50 °C, 12 h,




Scheme 3.16: Unsuccessful Negishi synthesis of ester 223
We then carried out a Suzuki cross coupling reaction, where after a few attempts with
varying conditions,103 104 105 we found that refluxing in dioxane for two days gave some of
the desired product peaks in the crude 1H NMR spectrum.106 (Scheme 3.17). However,
the NMR spectra also showed a number of other products were present, and after chro-









dioxane, ∆, 48 h, 17%
224 222 223
Scheme 3.17: Suzuki synthesis of ester 223
3.4.3 Synthesis of cyclisation precursor - Strategy 3
Since our attempts to synthesise aldehyde 223 in one step had only afforded low yields
of product at best, it was decided to synthesise it in two steps using a cross metathe-
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sis protocol. Hence, a Suzuki cross coupling reaction between 2-formylphenylboronic
acid 224 and allyl bromide 225 was carried out, following a procedure by Jagdale et al.
(Scheme 3.18).103 Treatment of boronic acid 224 with allyl bromide 225, 2.5 mol% pal-
ladium chloride catalyst, triphenyl phosphine ligand and sodium carbonate base in THF





O 2.5 mol% PdCl2, PPh3, Na2CO3 (1 M aq.),
THF, reflux, 4 h, 83%
224 225 226
Scheme 3.18: Suzuki cross coupling reaction to afford 2-allylbenzaldehyde 226
The second step of the synthesis involved carrying out a cross metathesis reaction of allyl-
benzaldehyde 226 with ethyl acrylate.107 108 The allylbenzaldehyde maybe classified as a
type I olefin, and the acrylate as a type II olefin, which was predicted to provide a highly
selective cross methathesis reaction for the synthesis of aldehdye 223.97 Therefore, the
reaction was carried out in DCM at reflux, with an excess of acrylate, and a low loading
(0.5 mol%) of Grubbs I catalyst, as shown in Scheme 3.19. After leaving the reaction
to stir overnight, the reaction solvent was evaporated, and the crude mixture purified by



















Scheme 3.19: Cross metathesis reaction of 2-allylbenzaldehyde 226 with ethyl
acrylate 162
3.4.4 Cyclisation reaction
After successfully synthesising the aldehyde precursor 223, we turned our attention to
its use as a substrate for nitrone formation. Using the optimised conditions obtained
previously, we added a slight excess of aqueous hydroxylamine solution to aldehyde 223
in THF at -20 ◦C. The yellow solution became cloudy over time. After filtering, a small
amount of cream solid was obtained, however this quickly melted and as a consequence
was re-dissolved in extra THF. The combined THF extracts were dried and the solvent
removed under vacuum to yield a yellow oil. 1H NMR spectrascopic analysis revealed that
a single, clean product had formed. A singlet peak at δ 8 ppm, as well as the presence
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of three resonances with multiplicities corresponding to a CH2−CH−CH2 fragment indi-
cated formation of a dihydroisoquinoline based nitrone 227 (Scheme 3.20) with HRMS







1.1 eq. NH2OH in H2O, 
THF, -20 °C, 30 min, 100%
223 227
Scheme 3.20: Cyclisation reaction of aldehyde 223
3.4.5 Reaction mechanism
It is proposed that this six membered cyclic nitrone had been formed in an identical
manner to the isoindole based nitrones described previously (Scheme 3.21). Therefore,
reaction of hydroxylamine with the formyl group affords the hydroxyamino alcohol inter-
mediate 228, with the nitrogen atom of this intermediate then undergoing nucleophilic
attack at the α,β-unsaturated ester to form the enolate intermediate 229. Enolate proto-
nation followed by dehydration affords the dihydroisoquinoline nitrone 227. In this case,
the presence of the extra methylene group in the six membered ring means that nitrone
formation takes place and remains at the monosubstituted position conjugated to the
aromatic ring.
H
O NH2OH in H2O,




















Scheme 3.21: Proposed reaction mechanism for the synthesis of dihydroiso-
quinoline based nitrones
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3.4.6 Reaction scope
We then carried out a screen of a range of ortho-formyl phenyl boronic acid substrates
to assess the scope and limitation of this six membered cyclic nitrone forming reaction.
The relatively limited size of the screen was due to the limited number of commercially
available formyl aryl boronic acids, that had the key ortho- substitution pattern of their
formyl and boronic acid groups. During the course of the synthesis of aldehyde 223,
we found it was possible to carry out the cross metathesis reaction on the crude Suzuki
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Scheme 3.22: Synthesis of ester substrates for dihydroisoquinoline synthesis
In total, five aldehydes 223-223d were successfully synthesised in 53-76% yields. A sixth
boronic acid containing a furan backbone did not undergo any cross coupling with allyl
bromide using our conditions, and so was abandoned. The five aldehydes were then re-
acted with hydroxylamine using our standard conditions at room temperature to form the
desired cyclic nitrones 227-227d in 80-92% yield.
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1.1 eq. NH2OH (50wt. % in H2O),















Scheme 3.23: Synthesis of dihydroisoquinoline nitrones
3.5 Synthesis of a cyclic hydroxamic acid derivative
Having explored the potential to create six-membered nitrones, we next wanted to investi-
gate what would happen if a starting material containing an extra degree of unsaturation
was subjected to our cyclisation reaction conditions, i.e. if an alkyne was present in the
acceptor fragment rather than an alkene.
3.5.1 Synthesis of aldehyde precursor
To synthesise the desired starting material, we needed to couple ethyl propiolate with a 2-
halobenzaldehyde. Only two procedures were available in the literature, and attempts at
carrying out the first (Pd(0) coupling of ethyl propiolate with 2-bromobenzaldehyde 137)
by Zhou et al.,109 consistently gave a complex mixture of compounds, none of which were
the desired product. The same results were observed when these reaction conditions were
applied to acetal protected bromo-benzaldehyde 147. Attempts at a second procedure,
coupling 2-iodobenzaldehyde with the propiolate, were slightly more successful,110 how-
ever this reaction was still proving to be inconsistent. Following the reaction by LCMS
analysis revealed that after two hours the reaction mixture became extremely complex.
Working up the reaction at two hours however, enabled a 42% yield of the cross coupled
product 231 to be obtained after purification (Scheme 3.24).
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CuI, K2CO3, THF, reflux, 2 h, 42%
230 231
Scheme 3.24: Sonogashira cross coupling reaction to afford alkyne 231
3.5.2 Cyclisation reaction
With the starting material in hand, we then reacted it with hydroxylamine using the op-
timised conditions developed previously. During the course of the reaction, no solid was
formed, and so the reaction was worked up by extracting into DCM and water, before
drying and removing the solvent under vacuum. The crude 1H NMR spectrum showed a
single, clean product, however none of the peaks corresponded to those seen previously in
the spectra of previous cyclisation reactions, so full analysis was carried out to determine
the structure. HRMS analysis revealed the compound had the formula: C12H13NO4, thus
had seven double bond equivalents. Along with four aromatic protons, and the presence
of an ethyl ester group, the 1H NMR spectrum also revealed two resonances with di-
astereotopic multiplicities corresponding to a CH−CH2 fragment. Both the IR and 13C
spectra showed the compound contained two carbonyl groups; one of which was part of
the ester group, and one of which was unidentified. We assumed that the reaction had
taken place via 1,4-addition of an intermediate hydroxyamino alcohol to the alkyne frag-
ment of 231, to afford a five membered ring, which in comparison with the data from the




NH2OH in H2O, THF






Scheme 3.25: Synthesis of cyclic hydroxamic acid 232
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3.5.3 Reaction mechanism
For the reaction mechanism to form the cyclic hydroxamic acid 232 from the alkynyl
aldehyde 231, we propose that a 5-exo-trig cyclisation reaction of the intermediate hy-
droxyamino alcohol occurs to afford an enolate that is protonated to give N -hydroxy
enamine 233 (Scheme 3.26). This is in accordance with the first half of the mechanisms
proposed previously for the isoindole and dihydroisoquinoline nitrone syntheses. However,
for this reaction we propose that enamine 233 then rearranges to the nitrone compound













































Scheme 3.26: Proposed reaction mechanism for the synthesis of cyclic hydrox-
amic acid 232
Interestingly, when this cyclisation reaction was later performed at -20 ◦C, a solid precipi-
tate was formed which was filtered off and analysed by NMR spectroscopy. It was found to
correspond to the nitrone intermediate 234, shown in Figure 3.1. Therefore, the 1H NMR
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spectrum revealed the presence of diagnostic peaks at δ 8.76 ppm for an OH resonance,
δ 6.15 for the CHOH proton and an apparent AB doublet at δ 3.92 corresponding to
the CH2 group. As expected, the resonance corresponding to the OH peak of 234 disap-
peared when the 1H NMR spectrum was run in methanol. During attempts to recrystallise
the solid for X-ray crystal structure analysis, the kinetic intermediate 234 was shown to






Figure 3.1: Intermediate nitrone 234
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3.5.4 Conclusion
Extending the methodology to include alkyne containing starting materials led to the
synthesis of an unexpected class of products: cyclic hydroxamic acids. This result is syn-
thetically very interesting, due to the fact that the bicyclic backbone of this structure is
present in numerous natural products and biologically active compounds, such as those


















Figure 3.2: Potential natural products that could be synthesised using our cyclic
hydroxamic acid synthesis
Difficulties with the Sonogashira reaction used to prepare the starting alkyne substrate
for this cyclisation reaction prevented further exploration of the scope and limitation of
this methodology. However, recent work by another student within the SDB group has
identified a facile route (Scheme 3.27) to these alkyne substrates 236 and a range of cy-













Et3N, rt, 12 h, 93%
MnO2, NaCN, MeOH,





50 °C, 18 h, 96%
236
Scheme 3.27: New protocol for the synthesis of alkyne containing cyclisation
substrates
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3.6 Conclusion
In this chapter we have identified optimum conditions for carrying out novel cyclisation
reactions between aryl aldehydes and hydroxylamine to afford a range of isoindole based
nitrones. We then adapted the starting material structure to successfully synthesise a
small library of dihydroisoquinoline based nitrones. Lastly, we looked at the reaction of
an alkynyl containing cyclisation substrate, which yielded a completely different and syn-
thetically valuable hydroxamic acid scaffold. All of the final products described in this
chapter have been synthesised using short routes, in moderate to high yields (Scheme 6.1).
This highlights how our cyclisation methodology can be used to prepare a diverse library
of bicyclic heterocyclic compounds that can be accessed from small, commercially avail-




































In the previous two chapters we discussed the discovery, mechanism, and optimisation
of a novel nitrone forming reaction, and explored the scope of this methodology. In the
literature review (Chapter 1) we highlighted the fact that nitrones can partake in a wide
variety of reactions, a short selection of which are shown in Scheme 4.1.35 Due to this
precedent, we wished to explore the reactivity of our isoindole nitrones towards a number































Scheme 4.1: A summary of commonly employed nitrone reactions
All of the reactions investigated were carried out using the parent nitrone (Figure 4.1) as
a representative substrate.
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Figure 4.1: Standard substrate for investigating nitrone reactions
4.2 Reduction
A key source for an overview of nitrone reactions is a book by Henry Feuer.35 According to
this, there are two key reaction pathways available when reducing nitrones: a) reduction
to the hydroxylamine, and b) reduction to the imine via deoxygenation. We attempted
to carry out both of these transformations as well as a third, the reduction of the nitrone
























(c) Reduction to amine
Figure 4.2: Planned nitrone reductions
4.2.1 Reduction to a hydroxylamine
To investigate the reduction of nitrone 165 to the hydroxylamine, we carried out a screen
of four literature procedures. As shown in Table 4.1, the nitrone (2.00 mmol) was re-
acted, in turn, with sodium borohydride,111 sodium borohydride and methanolic hydrogen
chloride,112 sodium cyanoborohydride,112 and L-selectride.113 The reactions with sodium
borohydride and L-selectride returned solely starting material (entries 1 and 2). The
reaction containing methanolic hydrogen chloride and sodium borohydride afforded the
transesterified product, nitrone 237 (entry 3, Scheme 4.2).
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Table 4.1: Screen of nitrone reduction reactions to afford hydroxylamine
Entry Reducing agent Result
1 NaBH4 no reaction
2 L-selectride no reaction
3 NaBH4, HCl transesterification to methyl ester
4 NaBH3CN, HCl reduction to hydroxylamine
N+ O-
CO2Et
HCl in MeOH (3N), NaBH4,
MeOH, 0 °C, 73% N+ O-
CO2Me
165 237
Scheme 4.2: Transesterification of nitrone 165
Fortunately, the reaction with sodium cyanoborohydride, following the procedure of Maeda
et al.,112 was successful and afforded the desired hydroxylamine product (Scheme 4.3).
Sodium cyanoborohydride was added portionwise to a cooled solution of nitrone and
methanolic hydrogen chloride in methanol. After twenty minutes the reaction was judged
to be complete by TLC analysis, and the product, isoindolinol 238, was afforded as a
yellow oil in 86% yield after work up and purification. The compound structure was
confirmed by NMR, IR and HRMS analysis, with the diagnostic data being the CH-CH2
connectivity revealed by the 1H COSY NMR spectrum, and a broad O-H stretch in the





HCl in MeOH (3N), NaBH3CN,
MeOH, 0 °C, 20 min, 86% OH
165 238
Scheme 4.3: Reduction of nitrone 165 to hydroxylamine 238
4.2.2 Reduction to an imine
The second nitrone reduction investigated was reduction to the imine - a transformation
also referred to as a deoxygenation reaction. Generally, the reaction involves a Lewis acid
coordinating to the negatively charged nitrone oxygen atom, which increases its reactivity
towards the reducing reagent.
In order to reduce nitrone 165 to the imine, several literature procedures were attempted
as outlined in Table 4.2. Metal mediated deoxygenations using indium trichloride114
and titanium trichloride115 returned only starting material, while mixed metal systems
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such as copper iodide and zinc, and a radical based system using lithium and 4,4’-di-
tert-butylbiphenyl (DTBB),116 all showed no reaction (entries 1-4). The use of tributyl
phosphine afforded a complex mixture of compounds in the 1H NMR spectrum of the






Scheme 4.4: Attempts to deoxygenate nitrone 165 to afford imine 239
Table 4.2: Reduction to imine screen
Entry Reagents Result
1 InCl3 no reaction
2 TiCl3 no reaction
3 CuI, Zn no reaction
4 Li, DTBB no reaction
5 PBu3 unable to interpret
6 TiCl4, LiAlH4, Et3N starting material and unidentified product
7 Zn, AlCl3 · 6H2O starting material and unidentified product
8 Sm, CoCl2 · 6H2O starting material and unidentified product
There were three systems, however, that gave interesting results. These were: titanium
trichloride with lithium aluminium hydride and triethylamine,117 aluminium trichloride
and zinc,118 and cobalt choride and samarium (entries 6-8).119 All three of these exper-
iments showed starting material 165 in their crude 1H NMR spectra, however they also
revealed peaks corresponding to a single, unidentified compound. Analysis of the peaks of
this new product in the crude 1H NMR spectra did not correspond to the expected imine.
Attempts to purify the combined crude materials by column chromatography resulted in
degradation, so we decided to try and increase the conversion in each of the three proce-
dures in an effort to determine the structure of the unexpected reaction product.
The procedure employed by Taniguchi et al., which used titanium tetrachloride with
lithium aluminium hydride and triethylamine,117 showed the highest percentage of this
unidentified product by 1H NMR spectroscopic analysis. The procedure for this reaction
involved the addition of titanium tetrachloride to THF at 0 ◦C, followed by slow addition
of lithium aluminium hydride to create a black reaction mixture. This reaction was stirred
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at room temperature for fifteen minutes, then triethylamine was added and the combined
mixture added to a solution of nitrone 165 in THF. After thirty minutes the reaction was
worked up by the addition of water, filtering the reaction mixture, extracting the liquors
with DCM and removing the solvent under reduced pressure to afford crude material.
Our efforts to increase the conversion of nitrone 165 to the unidentified product began by
increasing the reaction time from the documented thirty minutes. No improvement was
seen in the reaction conversion after twenty four hours at room temperature. Experiments
in heating the reaction and the addition of extra aliquots of the titanium/hydride/base
mixture all resulted in complex 1H NMR spectra which could not be interpreted.
We then attempted to increase the conversion in the zinc and aluminium hexahydrate
mediated reduction reaction that followed the procedure by Dutta.118 This reaction in-
volved the addition of a solution of nitrone 165 in THF to a vigorously stirred solution
of zinc and aluminium trichloride hexahydrate at room temperature, followed by working
the reaction up in the same manner as the Taniguchi procedure. Initially, the zinc and
aluminium reaction was repeated and left for longer, however this yielded the same result
as previously. Heating the reaction to reflux for one hour pushed the conversion to 50%,
but the reaction stalled and no improvement was seen after 3 hours. Leaving the reaction
for longer, and increasing the equivalents of zinc and aluminium resulted in decomposition.
To investigate the cobalt based deoxygenation reaction by Zhang et al.,119 we opted to
synthesise the methyl ester containing nitrone, in an effort to simplify the crude 1H NMR
spectra. Therefore, acetal 147 was reacted with methyl acrylate in a Heck cross cou-
pling reaction (Scheme 4.5) to produce the coupled product 240. After an acid catalysed
deprotection, aldehyde 241 was afforded in 80% yield. This was then reacted with hy-
droxylamine to form nitrone 237 in 76% yield.
1.1 eq. NH2OH in H2O, 




















Scheme 4.5: Synthesis of methyl ester nitrone 237
Nitrone 237 was added to a solution of samarium and cobalt chloride in THF at room
temperature, and the reaction monitored by TLC analysis. After three hours the TLC
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plate showed that all of the nitrone starting material had been consumed and only one
spot was visible, so the reaction was worked up. The 1H NMR spectrum showed the
as yet unidentified product to be the sole compound present, and it required no further
purification.
Structural determination
HRMS analysis showed that the unidentified product had the same molecular formula
as the expected imine product, C11H11NO2, thus having seven double bond equivalents.
Alongside peaks corresponding to resonances from the four aromatic protons and the three
protons of the methyl group, 1H NMR spectroscopic analysis showed a broad peak at δ
8.24 ppm, a singlet peak at δ 5.21 ppm integrating to one proton, and a singlet peak at
δ 4.69 ppm integrating to two protons. We therefore proposed that the samarium/cobalt
reduction protocol had yielded enamine 242 as the reaction product (Scheme 4.6). This
is supported by the presence of a peak at 3422 cm-1 and a sharp peak at 1653 cm-1 in
the IR spectrum, as well as an indicative peak at δ 161.23 in the 13C pendant NMR
spectrum corresponding to a quarternary carbon. Analysis by NOE spectroscopy showed
an interaction between the enamine proton and the aromatic proton shown in Figure 4.3.
Therefore, the enamine was assigned as having a Z -configuration at its double bond. Ul-
timately the enamine compound 242 proved to be unstable, and rapid degradation was






THF, 3 h, 39%
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Figure 4.3: NOE analysis of enamine 242 revealing its Z-configuration
Mechanistic investigation
To gain an insight into how this enamine forming reaction worked, it was carried out
with solely samarium and cobalt chloride in turn. Both afforded clean starting material,
proving that the two reagents work in tandem. We propose that the cobalt acts as a
Lewis acid to coordinate the negatively charged nitrone oxygen atom, whilst reduction of
Sm3+ to Sm2+ provides an electron which attacks at the nitrone carbon atom to provide a
radical species 243. A second electron attacks the radical species to afford the anion 244
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which stabilises by forming the C=N double bond, cleaving the N-O bond in the process,
























Scheme 4.7: Proposed mechanism for the synthesis of enamine 242 from nitrone
237
4.2.3 Reduction to an amine
Finally, we attempted a third reduction reaction, to reduce nitrone 165 to the amine. A
palladium catalysed hydrogenation procedure by Racine et al. was followed as shown in
Scheme 4.8.120 A solution of nitrone 165 in methanol was added to a solution of palla-
dium on carbon catalyst in methanolic hydrogen chloride. The reaction was placed under
a hydrogen atmostphere (1 atm) and left to stir overnight. After filtering through Celite,
the crude reaction material was evaporated and purified by column chromatography to





10% Pd/C, H2 (1 atm),
HCl in MeOH (3N),
MeOH, o/n, 69%
165 246
Scheme 4.8: Reduction of nitrone 165 to amine 246
Upon working up an initial attempt at the hydrogenation reaction after six hours, the
1H NMR spectrum showed peaks corresponding to hydroxylamine 238 and amine 246,
suggesting that the hydroxylamine was an intermediate in the nitrone-to-amine trans-
formation. To investigate this result, we took nitrone 165 and the previously synthe-
sised hydroxylamine separately, and subjected them both to the hydrogenation conditions
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(Scheme 4.9). Amine 246 was the sole product from both of these reactions. We con-
clude, therefore, that under the palladium catalysed reaction conditions, the nitrone was
first reduced to the hydroxylamine by addition of hydrogen across the nitrone moiety. A
second molecule of hydrogen then added across the nitrogen-oxygen bond, cleaving it in
the process, to afford the amine 246.
H2, 10% Pd/C,











HCl in MeOH (3 N), NaBH3CN,
MeOH, 0 °C, 20 min, 86% OH
165 238
246




Scheme 4.10 summarises the three transformations described in this section. Nitrones
165 and 237 can be selectively reduced to the hydroxylamine 238 using methanolic hy-
drogen chloride and sodium cyanoborohydride, to the enamine 242 using samarium and










HCl in MeOH (3N),
NaBH3CN, MeOH,
0 °C, 20 min, 86%
Sm, CoCl2⋅6H2O,
THF, 3 h, 39%
10% Pd/C, H2 (1 atm),
HCl in MeOH (3N),
MeOH, o/n, 69%
/





Scheme 4.10: Summary of the reductive transformations of nitrones 165 and
237
4.3 1,3-Dipolar cycloaddition
1,3-dipolar cycloaddition reactions are the most widely used reactions of nitrones, whereby












Scheme 4.11: Generic 1,3-dipolar cycloaddition reaction with an alkene dipo-
larophile
An example of this chemistry is neatly demonstrated by Chatterjee et al., whose method-
ology involved reaction of a hydroxylamine with an aldehyde to afford a nitrone that then
reacts in-situ with an electron deficient alkene.121 For example, nitrones 247 were reacted
with ethyl acrylate 162 in 1,3-dipolar cycloaddition reactions to yield isoxazolidine prod-
ucts 248 and 249. Generally, formation of the five-substituted isoxazolidines 249 was
favoured over the four-substituted product 248, and in some cases the trans isomer of
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39 : 63
(100:0)
R = o-NO2C6H4 (32:68)
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Scheme 4.12: Chatterjee’s one-pot synthesis of isoxazolidines 248 and 249
CTAB: cetyl trimethylammonium bromide, a cationic surfactant.
Advances in asymmetric versions of the reaction means that isoxazolidines can now be
synthesised with good regio-, stereo- and enantioselectivity. Carmona et al. in particular,
have focussed their research in this area, employing rhodium and iridium chiral catalysts
for stereocontrol. One such example is their 1,3-dipolar cycloaddition reaction of nitrone
250 and methacrylonitrile in the presence of Rh-Prophos catalyst, which regioselectively
synthesised the five-substituted isoxazolidine 251 with a 98:2 endo:exo selectivity and


















ee of endo product: 73%
Rh-Prophos catalyst:
250 251
Scheme 4.13: Carmona’s regioselective synthesis of five-substituted isoxazolidine
251
4.3.1 Reaction of nitrone with tert-butyl acrylate
For our work, we decided to react nitrone 165 with tert-butyl acrylate. It was expected
that the nitrone would undergo a 1,3-dipolar cycloaddition reaction to afford the 4- and















Scheme 4.14: Expected 1,3-dipolar cycloaddition reaction of nitrone 165 with
tert-butyl acrylate
An excess of tert-butyl acrylate was added to a solution of nitrone 165 in THF, and the
reaction stirred overnight at room temperature. The complex crude 1H NMR spectrum
showed that all of the starting material 165 had been consumed and that more than one
product was present. Similar patterns of peaks in the 1H NMR spectrum were observed,
indicating that the products were similar in structure. HRMS analysis revealed that the
molecular formula corresponding to regiosomers 252 and 253 was present (C19H25NO5),
so purification of the crude mixture by column chromatography was attempted. Frac-
tions were collected that were one spot by TLC analysis and one peak according to the
LCMS chromatogram, yet they showed several compounds to be present in the 1H NMR
spectra. It was noted by 1H spectroscopic analysis that the ratio of these compounds
changed over time. This led us to initially conclude that we had purified one regioisomer
of the expected cycloadducts, but had been unable to separate its configurational isomers.
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4.3.2 Structural determination of unknown product
Full spectroscopic analysis was carried out on a sample that had been left to stand for
a day, and which, by 1H NMR spectroscopy, consistently showed the same ratio of com-
pounds over time. Due to the complexity of the number of peaks with similar patterns
and chemical shifts, we focussed our structural elucidation on the analysis of the peaks
corresponding to the major product.
All four protons of the aromatic ring were identified, as were both of the expected ester
groups, in the 1H NMR spectrum. The remaining peaks in the 1H NMR spectrum inte-
grated to six protons, all of which were attached to carbon atoms as verified by HSQC
analysis. We had expected to integrate peaks corresponding to seven protons for the ex-
pected isoxazolidine cycloadducts 252 and 253 (Scheme 4.14), thus we concluded that an
-OH or -NH group must be present. Also, a CH−CH2−CH connectivity was discovered
by COSY and 13C DEPT analysis which did not match with either of the expected isox-
azolidine structures.
Thus, we were surprised to discover that the expected tricyclic core of cycloadducts 252
and 253 had not been synthesised. However, knowing that the reaction product had the
same molecular formula as the expected isoxazolidine products, we knew that an alterna-
tive tricylic compound must have been synthesised. Eventually, we deduced that the the
major product of the attempted 1,3-dipolar cycloaddition reaction was an isomer of the









THF, rt, o/n, 77%
165 254
Scheme 4.15: Major product formed from reaction of nitrone 165 with tert-butyl
acrylate
This conclusion was later verified by the NMR analysis suite at GlaxoSmithKline, which
also confirmed that the minor peaks in the NMR spectra correspond to the same struc-
ture, due to the bridged hydroxylamine heterocycle 254 existing as several conformers at
room temperature. The angle with which the nitrogen-oxygen bond sits over the molecule
also affects the NMR spectra. A 1H NMR spectrum of a five day old CDCl3 sample shows
the average ratio of the different conformers present to be 9:3:2 (Figure 4.4).
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Figure 4.4: 1H NMR spectrum of the bridged hydroxylamine 254 product
4.3.3 Investigating the reaction mechanism for formation of bridged
hydroxylamine
In the reaction of nitrone 165 with tert-butyl acrylate, we predicted that a 1,3-dipolar
cycloaddition reaction would take place to form isoxazolidine products, however, a bridged
hydroxylamine scaffold 254 was formed instead. We propose that the six membered ring
of this scaffold must have been formed through a [4+2] Diels-Alder cycloaddition reac-
tion. This could only be possible if the nitrone was reacting via its isoindole tautomer
(Scheme 4.16), which we had previously proposed as a transient intermediate in the mech-






Scheme 4.16: Tautomerisation between nitrone 165 and isoindole N -oxide 255
In this [4+2] cycloaddition reaction we propose that the nitrone 165 tautomerises to the
isoindole-N -oxide 255, which then undergoes a [4+2] Diels-Alder cycloaddition reaction
with tert-butyl acrylate to afford a bicyclic adduct (Scheme 4.17).
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Scheme 4.17: Proposed [4+2] cycloaddition reaction between isoindole 255 and
tert-butyl acrylate
4.3.4 Heteroatom containing analogues
To probe our theory that bridged hydroxylamine 254 was synthesised by a [4+2] cycload-
dition reaction of an isoindole-N -oxide with the dipolarophile, we decided to synthesise
analogues of α,β-unsaturated ester 164 containing a heteroatom in the aromatic ring,
and then subject these analogues to our optimised cyclisation reaction conditions. It was
hoped that introducing a heteroatom into the pendant aromatic ring would create a sub-
strate that was electron deficient (compared to analogue featuring a benzenoid ring), and
would result in it existing preferentially as its isoindole-N -oxide tautomer.
To begin this work, we took commercially available 2-bromo-3- and 3-bromo-4-pyridinecar-
boxaldehydes and attempted to couple them with ethyl acrylate 162 using our standard
Heck conditions.76 The 2-bromo example gave no reaction under these conditions, how-
ever, we were able to isolate a small amount of the desired coupled product 256 using the
modified conditions of Song et al.123 Thus, a slurry of 2-bromo-3-pyridinecarboxaldehyde,
sodium acetate, tri(o-tolyl)phosphine, allylpalladium chloride dimer and ethyl acrylate
162 in toluene was heated to reflux under nitrogen for one day. After cooling, filter-
ing, working up the reaction and purifying by column chromatography, the cross-coupled
product 256 was synthesised as a yellow oil in a poor 11% yield (Scheme 4.18). The Heck
reaction of 3-bromo-4-pyridinecarboxaldehyde afforded a low 16% yield of cross coupled






























Scheme 4.18: Heck cross coupling reactions to afford pyridyl α,β-unsaturated
ester analogues 256 and 257
We then took each of these aldehyde analogues in turn and reacted them with aque-
ous hydroxylamine using our previously optimised cyclisation reaction conditions. The







1.1 eq. NH2OH in H2O,
THF, -20 °C, 30 min, 75%
256 258
Scheme 4.19: Reaction of pyridyl analogue 256 with hydroxylamine to afford
nitrone 258
The reaction of aldehyde 257 with hydroxylamine gave a cream solid, the major product
of which was shown to be 4-aza-isoindol-N -oxide 259 by 2D NMR spectroscopic analysis









1.1 eq. NH2OH in H2O,
THF, -20 °C, 30 min, 76%
257 259
Scheme 4.20: Reaction of pyridyl analogue 257 with hydroxylamine to afford
4-aza-isoindol-N -oxide 259
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Figure 4.5: 1H NMR spectrum of pyridin-2-ol 259 in CDCl3
In the 1H NMR spectrum of 4-aza-isoindol-N -oxide 259 in CDCl3 shown above it can
be seen that there are a series of small peaks corresponding to a minor product present;






Figure 4.6: Nitrone tautomer 260 of the 4-aza-isoindol-N -oxide 259
We decided to see if it was possible to drive this tautomerisation reaction towards one
tautomer by changing the polarity of the deuterated solvent used. Analysis of a 1H NMR
spectrum run in deuterated methanol straight after the sample was made revealed that
the alternative tautomer of nitrone 322 could be observed alongside the 4-aza-isoindol-
N -oxide structure 259 (Figure 4.7 and Figure 4.8).
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Figure 4.8: Alternative nitrone tautomer 261 of the pyridin-2-ol 259
4-aza-isoindol-N -oxide forming reaction mechanism
We propose that the mechanism for formation of the pyridin-2-ol 259 is the same as the
formation of nitrone 165 and its analogues, with the exception that the final tautomeri-
sation event of isoindole-N -oxide to nitrone does not occur (Scheme 4.21). Therefore,
aldehyde 257 reacts with hydroxylamine to afford the hydroxyamino alcohol intermediate
262, which nucleophilically attacks the α,β-unsaturated ester in a 1,4 manner resulting
in the enolate intermediate 263. The enolate extrudes water to form the lesser substi-
tuted nitrone 261 which undergoes a final tautomerisation event to afford the pyridin-2-ol
product, 259.
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Scheme 4.21: Proposed mechanism for the formation of pyridin-2-ol 259
4.3.5 Conclusion
Our attempt to carry out a 1,3-dipolar cycloaddition reaction between nitrone 165 and a
dipolarophile to afford an isoxazolidine was prevented by the the fact that a [4+2] Diels-
Alder cycloaddition reaction took place instead to afford a bridged hydroxylamine 254
(Scheme 6.1). We proposed that the nitrone 165 tautomerises to the isoindole 255, that
had then taken part in the reaction. Our proposal was supported by the fact that, when
using heteroatom containing analogues in our cyclisation reaction, the 4-pyridine analogue
257 afforded the 4-aza-isoindol-N -oxide 259 as the major product of the reaction. Run-
ning 1H NMR spectroscopic analysis showed the presence of both its nitrone tautomers
























4.4. Other reactions attempted
Scheme 4.22: [4+2] Diels-Alder cycloaddition reaction between isoindole 255
and tert-butyl acrylate
4.4 Other reactions attempted
We then decided to investigate nucleophilic addition reactions to the nitrone 165, due to
the huge amount of literature precedent available for this type of reaction, as covered in
reviews by Lombardo124 and Merino125 et al.
We began by investigating a Grignard reaction. Five equivalents of the Grignard reagent
(methyl magnesium iodide) were synthesised in-situ, by the addition of iodomethane to a
cooled solution of magnesium turnings and ground glass in THF. A solution of nitrone 165
was then added dropwise and reaction progress monitored by TLC.113 The reaction only
ever showed starting material by TLC, even when the reaction was heated to reflux and
left overnight. In accordance, the 1H NMR spectra of three separate reactions attempted
showed only the presence of starting nitrone 165. We reasoned that the Grignard reagent
must have acted as a base to deprotonate α to the ethyl ester to afford an enolate 264,













Scheme 4.23: Attempted Grignard reactions afforded solely starting material
165
To double check this theory, a Grignard reaction was carried out using commercially
available ketone, acetophenone, which yielded the expected alcohol product in 100% con-
version. We then carried out the reaction of nitrone 165 with the same Grignard reagent
for a fourth time, but used D2O instead of water in the reaction work up. 1H and 2D
NMR analysis revealed deuterium incorporation at the α- position, thus confirming our













Scheme 4.24: Working up an attempted Grignard reaction in D2O showed deu-
terium incorporation at the α- position
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Nucleophilic addition reactions using other nucleophiles such as methyl lithium also re-
turned nitrone starting material. Many other reactions of nitrone 165 were attempted
which invariably gave black crude products and were uninterpretable by NMR spectro-
scopic analysis. These included some common nitrone reactions as well as some lesser
known reactions (Scheme 4.25).
• Kinugasa [2+2] cycloaddition reactions126
• A [3+2] cycloaddition reaction with a cyclopropane diester127
• Reductive coupling reactions with aldehydes and ketones128 and ethyl acrylate129
• Barbier type alkylation reactions with alkyl halides130
• Friedel-Crafts alkylations with electron rich aromatic compounds131




































Scheme 4.25: Attempted reactions of nitrone 165 all afforded uninterpretable
crude products
With the knowledge and experience gained from the cycloaddition experiments, it became
apparent that nitrone 165 does not react as one might expect it to react based on litera-
ture precedent. Realising that each of the reactions listed above would require significant
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work to understand how the substrate is reacting, and optimisation of each set of reactions
conditions, we therefore decided to end our investigations into the above reactions and
focus on the Diels-Alder cycloaddition between nitrone 165 and alkynes as a method to
synthesise substituted naphthalenes (Chapter 5).
4.5 Tricyclic pyrrole synthesis
After carrying out [4+2] Diels-Alder cycloadditions between nitrone 165 and alkenes (this
chapter) and alkynes (Chapter 5), it was then decided to investigate the cycloaddition
reaction of the tetrahydropyridine nitrone 227 (Figure 4.9) with an alkyne. We theorised
that the nitrone moeity of this compound might react with an alkyne in a 1,3-dipolar





Figure 4.9: Tetrahydropyridine nitrone 227
Therefore, an excess of dimethylacetylenedicarboxylate (DMAD) was added to a solution
of nitrone 227 in toluene, and the reaction heated to reflux. Monitoring the reaction by
TLC revealed the reaction to be complete at three hours. After removing the solvent un-
der reduced pressure and purifying the crude material by column chromatography, NMR
spectroscopic analysis revealed that the sole product of the reaction was not the desired
isoxazole. Instead, it was found that pyrrole 265 had been synthesised as the major reac-
tion product (Scheme 4.26). Key details of this structural assignment were the C22H23NO8
formula revealed by HRMS analysis, the presence of three methyl ester singlets in the 1H







DMAD, 2.0 eq., toluene,
rt, 3 h, 42%
CO2Me
227 265
Scheme 4.26: Unexpected reaction of nitrone 227 with DMAD
This unexpected result prompted a search of the literature, which revealed several exam-
ples of pyrroles having been synthesised from nitrones. Grigg et al. were the first group
to publish the synthesis of a pyrrole by the reaction of a nitrone and an alkyne.133 In this
first paper, and all subsequent literature examples, the first step in the pyrrole forming
mechanism is proposed to be a 1,3-dipolar cycloaddition reaction to afford an isoxazole.
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To check that this mechanism for the synthesis of pyrrole 265 was operating, the reaction
between nitrone 227 and DMAD was repeated at room temperature. After three hours
the reaction showed full consumption of the nitrone starting material by TLC analysis, so
the reaction solvent was removed under reduced pressure, and the crude material purified








DMAD, 2.0 eq., toluene,
rt, 3 h, 83%
227 266
Scheme 4.27: 1,3-dipolar cycloaddition of nitrone 227 with DMAD to afford
isoxazole 266
To confirm that isoxazole 266 was an intermediate in the synthesis of pyrrole 265 from
nitrone 227, it was then dissolved in toluene and stirred with an excess of DMAD at







DMAD, 2.0 eq., toluene,
reflux, 3 h, 75%
CO2Me
266 265
Scheme 4.28: Synthesis of pyrrole 265 from isoxazole 266
Based on literature precedent, we propose the following mechanism for pyrrole formation
from nitrone 227 via isoxazole 266 (Scheme 4.29). The isoxazole 266 rearranges to aziri-
dine 267, an intermediate that Baldwin et al. had previously isolated in their synthesis of
4-oxazolines.134 The aziridine then undergoes a retro Claisen condensation to afford the
singly substituted aziridine 268. This rearranges to azomethine ylide 269 in a step first
postulated by Padwa in 1986,135 and later confirmed by Lopez-Calle et al., who showed
that stable azomethine ylides were formed during the irradiation of isoxazoles (via acyl
aziridine intermediates).136 In accordance with a later paper published by Lopez-Calle
et al.,137 we propose that, following the formation of the azomethine ylide 269, this in-
termediate undergoes a second 1,3-dipolar cycloaddition reaction with the excess DMAD
to afford the dihydropyrrole 270. This intermediate subsequently oxidises in air to afford
















































Scheme 4.29: Proposed mechanism for the synthesis of pyrrole 265
4.6 Isoindolin-2-one synthesis
We next wanted to carry out initial investigations into the cleavage of the N-O bond of
hydroxamic acid 232, the product from the cyclisation reaction of alkyne 231 with hy-
droxylamine. We wanted to investigate this cleavage reaction because the isoindolin-2-one
backbone of the resultant lactam product (Scheme 4.30) is prevalent in a range of natural
products and biologically active compounds (Figure 4.10), and would therefore be more
a more valuable synthon for natural product synthesis.
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Figure 4.10: Examples of natural products that contain the same bicyclic car-
bonyl containing backbone as desired isoindolin-2-one 271
We began by employing a common method of N-O bond cleavage using acetic acid and
zinc (Table 4.3 entry 1).89,138,139 The acid is supposed to act as a Lewis acid, coordinating
with the oxygen lone pair of the OH group, with the zinc then acting as a reductant to
cleave the activated N-O bond by single electron transfer. Initial attempts at this reac-
tion showed no conversion, with more forcing conditions showing multiple products in the
crude 1H NMR spectra.
Table 4.3: N-O bond cleavage screen
Entry Reagents Result
1 AcOH, Zn no reaction
2 Li, DTBB no reaction
3 SmI2 no reaction
4 RuCl3.3H2O, Zn-Cu lactam product
Secondly, we attempted bond cleavage using lithium and a catalytic amount of DTBB,
the same system as employed previously when we attempted to cleave the N-O bond of
nitrone 165 (entry 2).140 A solution of hydroxamic acid in anhydrous THF was added to
a mixture of lithium and DTBB, and left to stir overnight. However, upon reaction work
up, the crude 1H NMR spectrum revealed that no reaction had taken place.
The third attempt at the bond cleavage involved the use of samarium iodide, an excess
of which was added dropwise to a solution of hydroxamic acid 232 in anhydrous THF,
according to the procedure by Keck et al. (entry 3).141 This reaction, however, once again
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returned solely starting material.
Fortunately, a more recently published methodology offered promising results. In 2011,
Fukuzawa et al. published work concerning the ruthenium catalysed reduction of N -
alkoxy- and N -hydroxyamides.142 Whilst no cyclic analogues were presented, moderate
to good yields were afforded for both secondary and tertiary amides, and as a consequence
we decided to employ their metholodogy (entry 4).
A solution of cyclic hydroxamic acid 232 in dehydrated EtOH was added to catalytic
amounts of RuCl3.3H2O and Zn-Cu couple, and the reaction refluxed at 100 ◦C for three
hours (Scheme 4.31). After filtration and purification by column chromatography the bi-







EtOH, 100 °C, 24%
232 271
Scheme 4.31: Synthesis of cyclic lactam 271
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4.7 Conclusion
In this chapter we had set out to explore precedented nitrone reactions using our standard
nitrone substrate 165. Whilst reductions of nitrone 165 to the amine 246 and hydroxy-
lamine 238 proceeded relatively smoothly, our attempts to reduce the nitrone functionality
to an imine proved more challenging. After several unsuccessful efforts, three separate










HCl in MeOH (3N),
NaBH3CN, MeOH,
0 °C, 20 min, 86%
Sm, CoCl2⋅6H2O,
THF, 3 h, 39%
10% Pd/C, H2 (1 atm),
HCl in MeOH (3N),
MeOH, o/n, 69%
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Scheme 4.32: Summary of the reductive transformations of nitrones 165 and
237
The attempted 1,3-dipolar cycloaddition reaction of nitrone 165 also proceeded in an un-
expected manner (Scheme 4.33). We discovered that, instead of reacting in a 1,3-dipolar
cycloaddition reaction, the nitrone tautomerised to its isoindole form 255 and underwent





















Scheme 4.33: [4+2] cycloaddition reaction between isoindole 255 and tert-butyl
acrylate
Whilst nitrone 165 proved to react as an isoindole in the cycloaddition reaction, the
tetrahydropyridine nitrone 227 proved to react with an alkyne dipolarophile (DMAD)
via the expected 1,3-dipolar manifold to afford the isoxazole 266 at room temperature.
Heating the nitrone 227 or isoxazole 266 with excess alkyne under reflux conditions led

















CO2MeMeO2CDMAD (2.0 eq), toluene,
rt, 3 h, 83%
227 266
265
Scheme 4.34: Synthesis of isoxazole 266 and pyrrole 265 from nitrone 227
Lastly we carried out a ruthenium trichloride and zinc-copper couple mediated N-O bond
cleavage reaction on the cyclic hydroxamic acid substrate 232, to afford the bicyclic lac-







EtOH, 100 °C, 24%
232 271
Scheme 4.35: Synthesis of cyclic lactam 271
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Chapter5
Exploring Methodology for the Synthesis
of Naphthalenes
5.1 Naphthalene literature review
5.1.1 Uses of naphthalenes
There has been much scientific interest in recent years regarding efficient ways to syn-
thesise naphthalenes and their derivatives. The reason behind this interest is due to the
prevalence of highly substituted naphthalene rings in the structures of many natural prod-
ucts and pharmaceuticals.143–146
For example the pharmaceutical drug propranolol (Figure 5.1), whose starting material is
naphthol,147 is a widely used beta blocking drug and its applications include the treatment
of angina and hypertension (Figure 5.1).148 In contrast to propranolol, naphthalenediimide
(NDI) components are a common substituent in much larger molecules which are used as












Figure 5.1: Propanolol and naphthalenediimide
As well as synthetically made drugs, pharmaceutically promising naphthalene containing
compounds also occur in Nature. Both Michellamines A and B and Korupensamines A-D
are produced by a plant called Ancistrocladus korupensis found in Africa (Figure 5.2).
Michellamines A and B exhibit anti-HIV activity,150 whereas Korupensamines A-D show
antimalarial activity.151
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Figure 5.2: Generic structures of michellamines and korupensamines
Another naturally occurring naphthalene containing drug is Gossypol, shown in Figure 5.3,
which is found in cotton seeds from plants belonging to the Gossypium species.152 The
















Figure 5.3: Gossypol stereoisomers
Naphthalene molecules containing binary linkage bonds are also utilised as chiral reagents
to induce stereocontrol into reactions.153 Well known examples of this type of naph-
thalene molecules are 2,2’-bis(diphenylphosphino)-1,1’-binaphthyl (BINAP) and 1,1’-bi-2-
naphthol (BINOL), which have been used as ligands in many asymmetric reactions.154,155
A recent example of this research is the asymmetric propargylation of aldehydes reported
by Reddy using allenyl boronate ester donors.156 They screened a range of substituted BI-
NOL derived phosphoric acid catalysts and found that 3,3’-bis(2,4,6-triisopropylphenyl)-
1,1’-binaphthyl-2,2’-diyl hydrogenphosphate 272 gave full conversion and greater than
90% ee in all of the aldehyde substrates screened (Scheme 5.1).
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Scheme 5.1: Asymmetric propargylation of benzaldehyde using a BINOL de-
rived phosphoric acid catalyst
The Bull and James groups have employed (S)-BINOL in their chiral derivatization pro-
tocols. For example, 2-formylphenylboronic acid has been used to coordinate with (S)-
BINOL and chiral amines, to afford two diastereomeric imino-boronate ester products
shown in Figure 5.4. Resolution of the diastereomers in the 1H NMR spectra allowed
the diastereomeric excess to be measured, and therefore the enantiopurity of the parent









Figure 5.4: Use of BINOL for determining the enantiomeric excess of amines
Naphthalenes are also used in inorganic chemistry as they form the backbone of "proton
sponges",158 which are very basic molecules that slowly coordinate to individual pro-
tons. Figure 5.5 shows the first known proton sponge,1,8-bis(dimethylamino)naphthalene
(DMAN) reported by Alder et al. in 1968,159 and a more recent example is 1,8-bis(tetra-
methylguanidino)naphthalene (TMGN).160 Proton sponges coordinate to individual pro-
tons due to formation of intramolecular hydrogen bonds between the two nitrogen atoms
on the amine groups and the proton. This is possible due to the orientation of the nitrogen







Figure 5.5: Examples of naphthalene based proton sponges
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In addition, naphthalenes substituted with group thirteen elements have been utilised as
Lewis acids to bind halides.162 Naphthalene based boranes, for example, bind strongly to
fluorides due to a combination of the chelate effect and the lack of rotation exhibited by the





Figure 5.6: Examples of naphthalene based borane derived Lewis acids and
their coordination to dimethylpyranone
5.1.2 Synthesis of naphthalenes
The examples described in Section 5.1 outline the importance of substituted naphthalenes
and explain the interest in their synthesis. Over the past few decades, advances have been
made in the synthesis of naphthalenes, and many different synthetic pathways have been
developed. The two most widely employed methods will be described briefly in the fol-
lowing sections, based on transition metal mediated syntheses and cycloaddition based
syntheses. There are, however, numerous other methods available, such as phthalide an-
nulations, the rearrangement of strained rings and thermal cyclisation reactions. Two
extensive reviews on the subject of naphthalene synthesis are those by de Koning and van
Otterlo et al.139,166
5.1.3 Metal catalysed syntheses
A large number of transition metal catalysed protocols have been employed for the syn-
thesis of naphthalene rings, including chromium, manganese, palladium, cobalt, nickel,
copper, zinc, tin, rhodium and ruthenium. Both ene-ene and ene-yne cyclisation reac-
tions mediated by ruthenium have been reported.139 Yoshida et al. used Grubbs second
generation catalyst in the Ring Closing Enyne Metathesis (RCEM) of alkynes 273 to
form the bicyclic intermediates 274 (Scheme 5.2). Following dehydration, a range of
biaryl naphthalene compounds 275 were afforded in 74-90% yields.167
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R=R1=4,5-[1,3]dioxole, R2=H, R3=H   
R=R1=4,5-[1,3]dioxole, R2=Me, R3=H   
R=4,5-(OMe)2, R1=5-OMe, R2=Me, R3=H  












Scheme 5.2: Ring closing enyne metathesis reaction for the synthesis of biaryl
naphthalenes 275
Recently, work has been undertaken to research the affect iron has on catalysing aryl
annulation reactions to afford substituted naphthalenes. Both Adak and Yoshikai,168 and
Ilies et al.169 have reported results in this area concerning the reaction between phenyl-
magnesium bromide 276 and diphenylacetylene 277, to afford the substituted naphtha-
lene 278 in 73% yield (Scheme 5.3). It was proposed that reaction of the iron catalyst
Fe(acac)3 with phenyl magnesium bromide 276 generated iron intermediate 279. After
insertion of the alkyne 277, the vinyl iron intermediate 280 subsequently underwent an
intramolecular C-H bond activation reaction to form metallacycle 281, which then reacted
with a second equivalent of diphenylacetylene 277 to form the seven membered complex
282. Oxidatively induced elimination of iron from 282 then afforded the tetra-substituted
naphthalene 278.
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Fe(acac)3 (10 mol%), phen (10 mol%),
DCIB (3 eq.), THF, 0 °C, 1 h, 73%
276 277 278
279 280 281 282
Scheme 5.3: Iron catalysed synthesis of tetra-substituted naphthalene 278
Palladium has often been used as a catalyst in naphthalene synthesis (Scheme 5.4). Wang
et al.170 reacted arylhalide 283 and propargyl alcohol 284 together under microwave
conditions to afford bi-substituted naphthalene 285. Their synthesis proceeds via a Sono-
gashira coupling reaction to yield alkyne 286, which underwent a thermally induced iso-
merisation reaction to the α,β-unsaturated ketone 287. Geometric isomerisation to afford
the Z -alkene 288 resulted in cyclisation followed by a subsequent dehydration step to af-






















Scheme 5.4: Wang’s palladium catalysed synthesis of bi-substituted naphthalene
285
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5.1.4 Diels-Alder syntheses of napthalenes
In the late 1990s, Sugahara et al. and Ukita et al. developed methodology for the syn-
thesis of substituted naphthalenes 292 using a Diels-Alder reaction between hydroxyl
acetals 289 and dimethyl fumarate, which proceeded via isobenzofuran intermediates
290 (Scheme 5.5).171,172 In these reactions, hydroxyl acetals 289 underwent acid catal-
ysed ring-closure/dehydration reactions to afford an isobenzofuran 290 that took part in
a Diels-Alder reaction with dimethyl fumarate to give the bridged compound 291. This
was then refluxed with boron trifluoride diethyl etherate Lewis acid to induce ring opening














R1 R1 = 6,7-(OMe)2,  R2 = 3,4,5-(OMe)3PhR1 = 6,7-(OMe)2,  R2 = 3-Cl-4,5-(OMe)2Ph















Scheme 5.5: Diels-Alder reaction between isobenzofuran 290 and dimethyl fu-
marate to afford penta-substituted naphthalene 292
In 1987 Charlton and Alaludini published a paper concerning o-quinodimethanes, where
they reported their use in organic synthesis and as intermediates in naphthalene forma-
tion.173 Following this work, Andersen et al. synthesised substituted naphthalene rings via
o-quinodimethane intermediates.143 Refluxing methoxybenzocyclobutene 293 in toluene
afforded the o-quinodimethane intermediate 294, which subsequently reacted with ethyl
3-bromopropiolate 295 in a Diels-Alder reaction (Scheme 5.6), with the resultant cycload-
dition product undergoing aromatisation by elimination of methanol to yield naphthalene
296.
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Scheme 5.6: Andersen synthesis of tetra-substituted naphthalene 296 from o-
quinodimethane 294
Craig et al. also reported on a related synthesis of substituted naphthalenes through a
Diels-Alder reaction of polymer supported o-quinodimethanes,.174 This involved refluxing
polymer supported cyclobutene 297 to afford the o-quinodimethane 298, which under-
went a Diels-Alder reaction with dimethyl acetylenedicarboxylate (DMAD) 299 to give
the bicyclic product 300 (Scheme 5.7). After aromatisation and self-cleavage, naphtha-
















Scheme 5.7: Craig synthesis of naphthalene 301 from o-quinodimethanes
Diels-Alder reactions of benzynes is another potential route for the synthesis of naph-
thalenes. One example of this work is the synthesis of fluorinated BINOL precursors
by Yudin et al.175 Treatment of the pentafluoro aryl chloride 302 with butyl lithium af-
forded a benzyne intermediate 303 that underwent a Diels-Alder reaction with thiophene,
128
5.1. Naphthalene literature review
as shown in Scheme 5.8. The resulting cycloadduct then extracted sulfur in-situ to yield
the fluorinated naphthalene 304. Subsequent arene bromination, Ullman coupling and
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Scheme 5.8: Diels-Alder reaction of benzyne 303 with thiophene for the syn-
thesis of fluorinated BINOL precursors
5.1.5 Conclusion
In summary, examples of the two most researched methods for naphthalene synthesis have
been discussed. Numerous metals can be employed in metal catalysed strategies to provide
a wide variety of naphthalene products. The advantages of the Diels-Alder approaches
are that they do not have the issues regarding catalyst recyclability or cost. Both the
dipole and the dipolarophile can be changed to provide a greater number of substituted
naphthalene scaffolds. I will now describe how the synthetic methodology described in
Chapters 2, 3 and 4 enabled us to develop a promising Diels-Alder methodology for the
synthesis of naphthalenes.
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5.2 Introduction
In Chapter 4 we reported that nitrone 165 undergoes [4+2] cycloaddition reactions with
alkene dienophiles, rather than the expected 1,3-dipolar cycloaddition reaction. We pro-
posed that the nitrone 165 tautomerised to its isoindole-N -oxide form 255, and underwent
a [4+2] Diels-Alder cycloaddition with tert-butyl acrylate to form the bridged hydroxy-











THF, rt, o/n, 77%
165 255
254
Scheme 5.9: [4+2] cycloaddition of nitrone 165 with tert-butyl acrylate
5.2.1 Aim
We wanted to explore whether this [4+2] Diels-Alder cycloaddition reaction could be
further developed for the synthesis of substituted naphthalenes. An investigation of
the literature determined that the precedent for Diels-Alder cycloaddition reactions of
isoindole-N -oxides was unknown, as was their use as substrates for the direct synthesis of
naphthalenes. However, there was precedent for the cycloaddition reactions of the par-
ent isoindoles, and indeed this method has been applied for the synthesis of substituted
naphthalenes.
Tong et al. recently published their synthesis of naphthalenes starting from disubstituted
isoindoles 306, as shown in Scheme 5.10.72 These isoindoles were synthesised in five steps
and then reacted with dimethyl acetylenedicarboxylate (DMAD) 299 in a [4+2] cycload-
dition reaction to afford the bridged heterocycles 307. The group reported that oxidation
of the amine functionality with mCPBA resulted in the formation of naphthalene 309,
which was proposed to proceed via chelotropic elimination of an N -oxide intermediate 308.
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Scheme 5.10: Tong’s synthesis of tetra-substituted naphthalenes 309 from isoin-
doles 306
Using this precedent as inspiration, we envisaged that our nitrone/isoindole-N -oxide cy-
cloaddition methodology could potentially be developed for the synthesis of naphthalenes.
As outlined in Scheme 5.11, we theorised that nitrone 165 would tautomerise to the
isoindole-N -oxide 255 and then undergo a [4+2] cycloaddition reaction with DMAD 299
to form the bridged intermediate 310. Upon heating, this intermediate would undergo a























Scheme 5.11: Proposed synthesis of a tri-substituted naphthalene from nitrone
165
5.3 Synthesis of naphthalenes from nitrones
We began our work in this area by subjecting nitrone 165 to the same conditions used
by Tong et al. As shown in Scheme 5.12, DMAD 299 was added to a solution of nitrone
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165 in toluene, and the reaction stirred at reflux overnight. It was hypothesised that the
reaction would initially proceed via a [4+2] cycloaddition reaction, to afford the bridged


















165 299 310 311
Scheme 5.12: Attempted [4+2] cycloaddition reaction of nitrone 165 with
DMAD 299
The resultant 1H NMR spectrum was very complex yet the starting materials, and bridged
intermediate 310 could be discerned. Of the multitide of other peaks present, we identi-
fied a minor product we believed might correspond to the expected naphthalene product.
After two purification attempts using column chromatography, we isolated a product that
we identified as the naphthalene product 311 in 6% yield (Scheme 5.13). As well as
evidence from the IR and HRMS spectra, the 1H NMR spectrum of 311 showed diag-
nostic aromatic protons between δ 8.5 and 7.6 ppm, including a singlet at δ 8.50 ppm
corresponding to the aromatic proton β to the methyl ester. 13C DEPT NMR analysis













Scheme 5.13: Initial low yielding naphthalene synthesis
Despite the low 6% yield of naphthalene 311 obtained, this result was a significant break-
through as we had previously imagined that the bridged hydroxylamine 310 might need
to be subjected to further reaction conditions in order to synthesise the naphthalene. This






Although toluene was the most commonly used solvent for carrying out Diels-Alder re-
actions in the literature,72,143 we decided to investigate what solvent system was optimal
for running our naphthalene forming reaction. During our previous work synthesising ni-
trones, we had demonstrated that the reaction solvent played a large role in the reaction
outcome. We therefore decided to carry out a solvent screen for the naphthalene forming
reaction, with the aim of establishing whether a different solvent would facilitate both the
[4+2] cycloaddition reaction and the subsequent cheletropic elimination step, to afford
naphthalene 311 in higher yield.
The solvent screen was undertaken at room temperature (not reflux) due to the differing
boiling temperatures of the solvents. Protic and aprotic solvents with an array of polar-
ities were screened, as shown in Table 5.1. All reactions, bar the one in DMSO, were
evaporated to produce a crude product which was analysed by NMR spectroscopy. The
DMSO reaction was taken up in water and extracted five times with ether, before drying











Scheme 5.14: Reaction carried out for the solvent screen
Table 5.1: Solvent screen
Entry Solvent Observation
1 Toluene (ref) afforded same 1H NMR spectra as previouslya
2 Cyclohexane -a
3 THF naphthalene 311 = major product
4 CHCl3 -a
5 DCM -a
6 DMSO naphthalene 311 = major product
7 IPA -a
8 Methanol -a
Conditions: nitrone 165 (1.00 mmol), DMAD 299 (1.00 mmol), solvent (2 mL), rt,
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o/n. Yields not recorded. a% naphthalene product could not be determined due to
presence of a complex mixture of compounds in the 1H NMR spectra.
The 1H NMR spectra from this set of experiments gave unexpected results which did
not corroborate with the solvent polarity or protic/aprotic nature of the solvent. Whilst
some conversion of nitrone and evidence for formation of naphthalene was observed in
all solvents, it was not possible to integrate the NMRs and obtain quantifiable data due
to the majority of the 1H NMR spectra showing a complex mixture of compounds. The
reactions in DMSO and THF, however, were clearly identified as the best results, due to
the fact that both spectra showed naphthalene 311 as the major reaction product, with
no starting material 165 remaining, and no complex mixture of products as observed in
the spectra of the other solvents.
We then repeated the reaction in both DMSO and THF for just thirty minutes in an
effort to observe possible reaction intermediates. However, the 1H NMR spectra from
these reactions were identical to those run overnight. This demonstrated the facile nature
of not only the cycloaddition step, but also the subsequent chelotropic elimination step,
which we had previously anticipated might require more forcing conditions to proceed.
We decided to carry out the remaining investigations using THF as this solvent was eas-
ier to work with and remove than DMSO. Due to previous work identifying THF as the
optimum solvent in which to synthesise nitrones 165, this result opened up the intriguing
possibility of developing a one-pot reaction, involving the synthesis of naphthalenes 311










Scheme 5.15: Could the use of THF solvent open up a one-pot pathway?
5.4.2 Mechanistic study
In the reaction of nitrone 165 with an alkyne, we had suggested a mechanism whereby a
bridged hydroxylamine was formed from a [4+2] cycloaddition reaction of its isoindol-N -
oxide tautomer 255 with DMAD 299, which then underwent a chelotropic elimination to
afford naphthalene 311, as shown in Scheme 5.16. To better understand the mechanism
of the transformation of nitrone to naphthalene, we decided to carry out a 1H NMR ex-























Scheme 5.16: Proposed reaction mechanism for the synthesis of naphthalene
311 from nitrone 165
The NMR experiment was run in deuterated THF, at room temperature, using a 500 MHz
NMR spectrometer. 1H NMR spectra were recorded every five minutes over a two hour
period. Highlighted results from this experiment are shown below in both Scheme 5.17
and Figure 5.7, with key peaks colour coded for clarity.
All of the starting nitrone material 165 (red and blue peaks) was consumed around the
thirty minute mark. During this time, peaks for another compound emerged which we
assigned as the bridged hydroxylamine 310. The sp2 hybridised C2 carbon of the nitrone
became the sp3 hybridised carbon of the bridged hydroxylamine during this reaction, and
the nitrogen atom also lost its charge. The CH2 group (in green) of the hydroxylamine
intermediate is therefore shifted upfield from δ 3.8 ppm to ∼ δ 3.2 ppm, where it appears
as a multiplet peak with a diastereotopic splitting pattern rather than as a singlet peak.
The singlet peak corresponding to the CH group bonded to the nitrogen atom (in purple)
is shifted downfield slightly to δ 5.0 ppm compared to the blue CH2 group of the nitrone
at δ 4.9 ppm.
From the thirty minute mark, peaks corresponding to the naphthalene product 311 began
to emerge, with its CH2 group corresponding to a singlet peak at δ 4.1 ppm (orange).
A diagnostic singlet peak at δ 8.5 ppm (in pink) corresponding to the aromatic proton
β- to the methyl ester group was also observed. Importantly, this NMR study showed
that the emergence of naphthalene 311 occured as the hydroxylamine intermediate 310
disappeared.
The reaction did not reach completion within the two hour time frame, despite previously
reaching completion within thirty minutes in a preparative reaction in the laboratory.
This was thought to be due to a lack of stirring mechanism in the NMR tube.
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Figure 5.7: 1H NMR mechanistic study of naphthalene synthesis
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5.5. A “one-pot” synthesis of naphthalenes from aldehydes
This study provided a valuable insight into the reaction mechanism as it provided evidence
that naphthalene formation occurred via the bicyclic intermediate 310, which was stable
enough to be observed in the NMR spectrum. Peaks corresponding to the isoindol-N -oxide
tautomer were not observed in the mechanistic study. We propose that the tautomerisa-
tion event and subsequent [4+2] cycloaddition of the isoindol-N -oxide with DMAD 299
occur more quickly than the timeframe of the NMR spectrometer can observe.
5.4.3 Reaction scale up
Having successfully synthesised naphthalene 311 from nitrone 165 and identified opti-
mum reaction conditions, the reaction was run at a larger scale to obtain an accurate
yield. DMAD 299 was added to a solution of the nitrone 165 (10 mmol) in THF at room
temperature. The reaction was stirred for thirty minutes, and the solvent removed under
reduced pressure. The crude product was purified using column chromatography to afford






DMAD (1 eq.), THF,
rt, 30 min, 87%
165 311
Scheme 5.18: Synthesis of naphthalene 311 from nitrone 165
5.5 A “one-pot” synthesis of naphthalenes from aldehydes
Our research up until this point was based on a stepwise synthesis from aldehyde to ni-









DMAD       ,
THF, rt, 30 min, 77%
NH2OH in H2O, THF, 




Scheme 5.19: Stepwise synthesis of naphthalene 311
We now wanted to establish whether conditions could be developed that would allow for
naphthalene formation directly from aldehyde 164 in an efficient one-pot procedure, in-
volving in-situ nitrone/isoindol-N -oxide generation, as shown in Scheme 5.20.
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Scheme 5.20: Proposed one-pot synthesis of naphthalene 311
To begin investigating this one-pot reaction, we had to determine whether the reagents
used in synthesising the nitrone would be compatible with the subsequent naphthalene
formation. It was decided to study the effect of both water and hydroxylamine on the
subsequent nitrone to naphthalene transformation.
5.6 Reaction investigation
5.6.1 Effect of water on the Diels-Alder cycloaddition reaction
Water was present in the nitrone forming reaction as part of the hydroxylamine solution.
However, water was not present in the naphthalene forming Diels-Alder reaction discussed
above in Section 5.4.3. Therefore, our first step was to determine whether the presence of
water in the naphthalene forming reaction would negatively affect its outcome. We added
water as a co-solvent to the reaction of nitrone 165 (after tautomerisation) and DMAD






DMAD (1 eq.), 5:1 THF:H2O,
rt, 30 min
165 311
Scheme 5.21: Investigating whether water affects naphthalene synthesis form
nitrone
Both reactions resulted in naphthalene 311 in essentially the same yield, and therefore,
it was concluded that water would not inhibit the production of naphthalene in a one-pot
reaction directly from aldehyde 164.
5.6.2 Effect of hydroxylamine on the Diels-Alder cycloaddition reaction
With this new one-pot reaction aim another variable, hydroxylamine, needed to be in-
vestigated. We knew that an excess of hydroxylamine was used in the nitrone forming
reaction, and that this excess did not affect the nitrone once it had been formed. How-
ever, it was thought that a reaction between hydroxylamine and the alkyne (DMAD 299)
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5.6. Reaction investigation
might cause issues for the synthesis of naphthalene from nitrone.
It had been reported in the literature that reaction of DMAD with hydroxylamine would
form an oxime.176 Indeed, on repeating this reaction, oxime 312 was obtained in 100%
yield (Scheme 5.22). This oxime is formed via conjugate addition of hydroxylamine to
the alkyne, followed by isomerisation of the resultant N -hydroxy enamine to the oxime,
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Scheme 5.22: Reaction of DMAD with hydroxylamine
We needed to investigate whether this competing reaction would hamper the development
of our one-pot reaction. Initially we decided to determine whether hydroxylamine would
affect the reaction of nitrone 165 with the alkyne, DMAD 299, and so we added one
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Scheme 5.23: Reaction of nitrone 165, hydroxylamine and DMAD 299
The 1H NMR spectrum of the reaction showed unreacted nitrone 165 and the oxime 312
in an almost 1:1 ratio, with virtually none of the desired naphthalene being present. Thus,
hydroxylamine severely inhibits the [4+2] cycloaddition reaction and therefore the pro-
duction of naphthalene 311, as DMAD 299 reacts almost exclusively with it rather than
with the nitrone 165. This significant result would suggest that for the one-pot efforts,
the hydroxylamine used to synthesise the nitrone would have to be completely consumed
in order for the subsequent [4+2] cycloaddition reaction to be viable.
5.6.3 Effect of hydroxylamine on initial “one-pot” efforts
The results described in sections 5.6.1 and 5.6.2 showed that any unreacted hydroxylamine
from the nitrone synthesis would impact the subsequent [4+2] cycloaddition reaction,
whilst the presence of water would have no effect. So to begin investigating a one-pot
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synthesis, we chose to use one equivalent of all of the reagents. Originally when synthe-
sising the reactive nitrone, we ran the reaction at -20 ◦C to isolate it as a solid, however,
as we were now looking to consume the reactive nitrone in-situ, the low temperature was
no longer required.
At this point, we knew that reaction of hydroxylamine with aldehyde 164, and the sep-
arate reaction of hydroxylamine with alkyne 299, both took place within thirty minutes.
We did not know, however, whether the hydroxylamine had a preference to react with the
aldehyde 164 or the alkyne 299, if both were present. This was the reason for attempting
two different one-pot procedures. The first reaction involved hydroxylamine and DMAD
299 being added to the aldehyde 164 simultaneously, as shown in Scheme 5.24 (Method
A). Whereas, in the second procedure, there was a stepwise thirty minute delay between
the hydroxylamine and alkyne 299 being added (Method B). This method was analysed
by TLC to ensure complete formation of the intermediate nitrone 165, before the alkyne












Scheme 5.24: Proposed methods for the one-pot the synthesis of naphthalene
311
Conditions: aldehyde 164 (1.00 mmol), NH2OH aq. (1.00 mmol), DMAD 299 (1.00
mmol), solvent (2 mL), rt, 30 min. Yields not recorded.
The 1H NMR spectrum from method A showed oxime 312 and the aldehyde 164 starting
material present in an almost 1:1 ratio. Nitrone 165, naphthalene 311 and DMAD 299
were all present as minor products. This result showed that hydroxylamine preferentially
reacts with DMAD over the aldehyde 164. This meant that a one-pot stepwise approach




NH2OH in H2O, DMAD ,













Scheme 5.25: Method A - simultaneous addition
140
5.6. Reaction investigation
The 1H NMR spectrum from method B, the sequential method, did not match our ex-
pectations. Although naphthalene 311 was present as a major product, nitrone 165
and oxime 312 were also present, as was the aldehyde starting material 164 as a minor
product (Scheme 5.26). This suggested that the nitrone forming reaction was potentially
reversible, generating small amounts of aldehyde and hydroxylamine. The hydroxylamine










THF, rt, 30 min




















Scheme 5.26: Method B - sequential addition
5.6.4 Effect of alkyne
As DMAD could be consumed by both the hydroxylamine and the nitrone, we next inves-
tigated increasing the amount of DMAD 299 in the reaction. It was hoped that this would
increase the rate of consumption of nitrone to afford a better yield of naphthalene product.
On this basis the sequential one-pot procedure (method B) was repeated using two equiv-
alents of alkyne. The reaction using one equivalent of DMAD 299 as previously was also
carried out alongside for reference.
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Scheme 5.27: Sequential one-pot reaction using excess alkyne 299
The reference experiment gave the same crude 1H NMR spectrum as we had seen previ-
ously. The reaction using an excess of DMAD 299 afforded an 1H NMR spectrum that
showed naphthalene 311 and unreacted DMAD as the major products and oxime 312
as a minor product. When the methyl ester singlet of DMAD was integrated relative to
the aromatic singlet peak of the naphthalene, we were pleased to observe that the two
compounds were present in a 0.74:1.00 ratio (naphthalene:alkyne).
5.6.5 Reaction scale up
Due to time constraints our development work ended at this point. Although further
research is needed to fine tune the reaction, we took our optimised one-pot reaction con-
ditions from the screening work and applied them on a larger scale to determine whether
we had created a viable synthetic route from α,β-unsaturated ester 164 to naphthalene
311. Therefore, hydroxylamine (1 eq.) was added to a solution of 164 (10.00 mmol)
in THF (20 mL) at room temperature, and the reaction mixture left to stir for thirty
minutes. DMAD 299 (2 eq.) was then added, and the reaction left for a further thirty
minutes. After removal of THF under reduced pressure and purification by column chro-
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Promising preliminary work has been undertaken to establish a novel method to directly
synthesise substituted naphthalenes from both nitrones 165 and α,β-unsaturated esters
164. The reported procedure possesses many advantages when compared to current liter-
ature methods. For example; it negates the need for a metal catalyst or oxidant and does
not require high temperatures, inert conditions, or reaction work-up. In addition, the
sequential "one-pot" procedure reaches completion in a 1 hour time period, unlike many
of the syntheses in the literature which require multiple steps or longer total reaction
times. Further work is needed to fully develop the one-pot reaction conditions in order to
explore the substrate scope of the reaction. The α,β unsaturated substrates synthesised
in Chapter 3 could all be taken through the reaction to produce tri- and tetra- substi-
tuted naphthalenes, and changing the alkyne from DMAD 299 opens up the possibility
to add further functionality to the right hand side of the naphthalene scaffold. This novel
research, whilst still in its early stages, is a very promising methodology for the direct
synthesis of naphthalenes.
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Chapter6
Conclusions & Future Work
6.1 Conclusions
The development and application of a novel conjugate addition/cyclisation methodology
for the synthesis of isoindole derived nitrones has been demonstrated. Extending the
methodology to modified cyclisation substrates has also afforded dihydroisoquinoline de-
rived nitrones and a cyclic hydroxamic acid (Scheme 6.1). Each of these three end products







































Scheme 6.1: Synthesis of isoindole nitrones, dihydroisoquinoline nitrones and a
cyclic hydroxamic acid from 2-substituted benzaldehydes
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Mechanistically it has been shown that the reaction of cyclisation substrates with hydrox-
ylamine proceeds via hydroxyamino alcohol intermediates which nucleophilically attack
the α,β-unsaturated ester in a 1,4 manner, and not via oxime intermediates nor any type











































Scheme 6.2: The conjugate addition/cyclisation reaction proceeds via common
hydroxyamino alcohol intermediates
Research into the reactivity of nitrone 165 gave a mixture of results, whilst reactions of
the dihydroisoquinoline nitrone 227 and cyclic hydroxamic acid 232 successfully afforded
isoxazolidine, pyrrole and lactam scaffolds. Preliminary results regarding the synthe-
sis of naphthalenes from cyclisation substrate 323, via a [4+2] Diels-Alder cycloaddi-
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At the beginning of this thesis the use of nitrones as spin traps, and the development
of isoindole derived spin traps, was discussed. We expressed an interest in analysing a
suitable isoindole derived nitrone for its spin trapping properties. Inevitably we focussed
on the synthetic utility of the first nitrone we synthesised, nitrone 165. Hence, the first
target for any future work would be to synthesise an appropriate analogue of nitrone 165
and submit it for EPR studies to determine its potential to act as a selective spin trap.
A nitrone with increased substitution around the five membered ring would reduce the
susceptibility of its spin adducts to disproportionation. A Heck cross-coupling reaction be-
tween 2-bromoacetophenone 187 and ethyl crotonate could afford the cyclisation substrate
313, which upon reaction with hydroxylamine using our conjugate addition/cyclisation
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Scheme 6.4: Suggested synthesis of a suitable nitrone spin trap and formation
of its -OH spin adduct
It would also be interesting to utilise the conjugate addition/cyclisation methodology in
the synthesis of a natural product. In Chapter 3 we highlighted a few natural products
containing the bicyclic lactam structure that is set up in the reaction of an alkyne con-
taining cyclisation substrate with hydroxylamine. Scheme 6.5 shows the retrosynthetic
analysis of Lennoxamine, an isoindolobenzazepine alkaloid, which we have used to demon-
strate the potential incorporation of our novel methodology for natural product synthesis.
The conjugate addition/cyclisation of alkyne 320 would afford the cyclic hydroxamic acid
319, which would yield the lactam 317 upon reaction with ruthenium trichloride and
zinc-copper couple to cleave the N-O bond. N -alkylation with the benzodioxole fragment
318 followed by an intramolecular palladium catalysed cross-coupling of the aryl halide
portion with the ester enolate would afford the pentacyclic lactam 316. Reductive decar-
boxylation would provide Lennoxamine 315.
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Scheme 6.5: Retrosynthetic analysis of Lennoxamine 315
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6.2. Future work
Finally, perhaps the most promising area for further investigation is the novel [4+2]
Diels-Alder cycloaddition/chelotropic elimination methodology for the synthesis of naph-
thalenes. Further experiments to explore the robustness and scope of this methodology
are required. A key method to determine this would be to run a screen reacting nitrone
165 with different alkyne dipolarophiles, to potentially afford naphthalenes with a vari-
ety of substitution patterns around the scaffold. Results from Chapter 3 already show
the range of substituents around the aromatic ring, and the variety of α,β-unsaturated
electron withdrawing groups, that can be successfully incorporated in the nitrone starting
material.
After determining the limitations of the cycloaddition step, naphthalene synthesis from











NH2OH (aq.) R RR2
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Scheme 6.6: Potential synthesis of a library of substituted naphthalenes
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Infrared spectra (4000 cm-1 to 0 cm-1) were recorded on a Perkin Elmer Spectrum 100
FT-IR spectrometer using a Universal ATR accessory for sampling. The machine has
internal calibration and only selected peaks are quoted in ν (wavenumbers, cm-1).
Proton magnetic resonance spectra were recorded at 300.22 MHz on a Bruker Avance
300 spectrometer unless otherwise stated. Chemical shifts (δH) are quoted in parts per
million and are referenced to the residual solvent peak. The multiplicities and general as-
signments of spectroscopic data are denoted as: singlet (s), doublet (d), triplet (t), quartet
(q), doublet of doublets (dd), triplet of doublets (td), quartet of doublets (qd), triplet of
triplets (tt), multiplet (m), aromatic (Ar), and apparent (app.). Coupling constants (J )
are quoted to the nearest 0.1 Hz. Carbon magnetic resonance spectra were recorded at
75.5 MHz on a Bruker Avance 300 spectrometer unless otherwise stated. Chemical shifts
(δC) are quoted in parts per million and are referenced to the residual solvent peak. Cou-
pling constants (J ) are quoted to the nearest 0.1 Hz.
Mass spectra were recorded on a Bruker Daltonics micrOTOF electrospray time-of-flight
(ESI-TOF) mass spectrometer. Samples were introduced either by syringe pump or flow
injection using an auto-sampler. Samples were diluted in either methanol or acetonitrile.
All capillary melting point determinations were carried out using Büchi 535 melting point
apparatus and reported to the nearest degree Celsius.
Analytical thin layer chromatography was carried out using commercially available polyethy-
lene backed plates coated with Merck Kieselgel 60 GF254. Plates were visualised under
UV light (at 254 nm) or by staining with potassium permanganate, p-anisaldehyde or
phosphomolybdic acid followed by heating. Flash chromatography was performed under
medium pressure using Merck 60 H silica gel (35-75 µm). Samples were loaded as satu-
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Chapter 7. Experimental
rated solutions in an appropriate solvent.
Reactions requiring anhydrous conditions were performed under nitrogen in oven-dried ap-
paratus, which was allowed to cool under nitrogen prior to use. Anhydrous solvents were
obtained by passing through anhydrous alumina columns using an Innovative Technology
Inc. PS-400-7 solvent purification system. Petrol refers to the fraction of petroleum ether
boiling at 40-60 ◦C. Ether refers to diethyl ether. Hexanes refer to the hexane fraction of
petroleum. Solvents were evaporated on a Büchi Rotorvapor.
All commercially available compounds were used as obtained from the chemical suppliers.




7.2.1 General procedure A: Synthesis of acetal protected aldehydes
To a solution of aldehyde (5.0 mmol, 1.0 eq.) in toluene, was added 1,3-propanediol (1.5
eq.) and pTSA (0.1 eq.). The reaction was heated to reflux and left to stir for 7 hours.
After cooling to room temperature, the reaction was extracted with three portions of H2O,
dried over MgSO4 and the solvent removed under reduced pressure to afford the crude
acetal protected product.
7.2.2 General procedure B: Synthesis of Heck cross-coupled products
To a solution of acetal protected aldehyde (4.0 mmol, 1.0 eq.), Pd(OAc)2 (1.0 mol%) and
(o-Tol)3P (2.0 mol%) in DMF, were added Et3N (1.5 eq.) and ethyl acrylate 162 (1.5
eq.). The reaction was heated to 120 ◦C and monitored by TLC analysis (DCM, UV
visualisation). Upon reaction completion, a 1:1 mixture of ether:Hexanes was added and
the solution cooled to 0 ◦C for 30 minutes. Following filtration of the precipitate using a
plug of Celite R©, the combined organic solution was extracted with H2O and brine, dried
over MgSO4 and the solvent removed under reduced pressure. This afforded the crude
Heck cross-coupled product.76
7.2.3 General procedure C: Synthesis of (E)-ethyl-formylacrylates
To the Heck cross-coupled product (3.0 mmol, 1.0 eq.) was added a 7:3 mixture of glacial
acetic acid:H2O. The mixture was heated to 50 ◦C and monitored by TLC. After depro-
tection, the reaction mixture was separated between Et2O and H2O. The H2O layer was
extracted with Et2O twice and the combined organic layers were neutralised via addition
of sodium hydrogencarbonate (NaHCO3) until the gas production stopped. After separa-
tion, the organic layer was washed with H2O and brine, dried (MgSO4) and the solvent
was evaporated under reduced pressure to afford the crude ((E)-ethyl-formylacrylate).
7.2.4 General procedure D: Synthesis of (E)-ethyl-formylbutenoates
To a solution of the boronic acid (3.0 mmol) and allyl bromide (1.2 eq.) in THF (0.2 M),
were added PdCl2(PPh3)2 (2.5 mol%) and aqueous Na2CO3 (1.0 M, 2.0 eq.) solution.
The reaction mixture was heated to reflux and stirred for 4 hours. The reaction was
quenched with H2O and extracted with DCM (x3). The combined organic layers were
washed with brine, dried over MgSO4, and the solvent removed under reduced pressure,
to afford the crude Suzuki cross-coupled product.103
To a solution of the crude cross-coupled product in DCM was added Grubbs I catalyst
(5.0 mol%) and ethyl acrylate 162 (5.0 eq.). The reaction was heated to 40 ◦C and stirred




7.2.5 General procedure E: Synthesis of isoindole nitrones
To a solution of aldehyde (2.0 mmol, 1.0 eq.) in THF at -20 ◦C was added hydroxylamine
(50 wt. % in H2O) (1.1 eq.). The reaction was stirred for 30 minutes. Solids were filtered
using a Sinter funnel and dried under vacuum to afford the crude nitrone product. For
reactions where no solid was observed, the crude mixture was separated between DCM
and H2O. The H2O layer was extracted with two portions of DCM, the combined organic
layer dried (MgSO4), and the solvent was removed under reduced pressure to afford the
nitrone product.
7.2.6 General procedure F: Synthesis of dihydroisoquinoline nitrones
To a solution of aldehyde (2.0 mmol, 1.0 eq.) in THF at room temperature was added
hydroxylamine (50 wt. % in H2O) (1.1 eq.). The reaction was stirred for 30 minutes. Solids
were filtered using a Sinter funnel and dried under vacuum to afford the crude nitrone
product. For reactions where no solid was observed, the crude mixture was separated
between DCM and H2O. The H2O layer was extracted with two portions of DCM, the
combined organic layer dried (MgSO4), and the solvent was evaporated under reduced








General procedure A was followed using 2-bromobenzaldehyde 137 (925 mg, 5.00 mmol),
followed by recrystallisation from petrol:ether, to provide the title compound as white
needles in 88% yield (1.07 g, 4.40 mmol). m.p. 83-84 ◦C; 1H NMR (300 MHz, CDCl3) δH:
7.69 (1H, dd, J = 7.8, 1.7 Hz, ArH ), 7.52 (1H, dd, J = 8.0, 1.3 Hz, ArH ), 7.33 (1H, td, J
= 7.6, 1.2 Hz, ArH ), 7.19 (1H, td, J = 7.7, 1.7 Hz, ArH ), 5.76 (1H, s, CH ), 4.29 (1H, dd, J
= 5.1, 1.3 Hz, OCHAHB), 4.25 (1H, dd, J = 5.1, 1.3 Hz, OCHAHB), 4.03 (2H, td, J = 12.2,
2.4 Hz, OCH2), 2.32-2.16 (1H, m, CH2CHAHBCH2), 1.48-1.41 (1H, m, CH2CHAHBCH2);
13C{1H} NMR (75.5 MHz CDCl3) δC: 137.47, 132.57, 130.27, 128.04, 127.51, 122.27,
100.88, 67.56, 25.67; IR (thinfilm) νmax (cm-1): 1594 (ArC=C), 1570 (ArC=C); HRMS





General procedure B was followed using 2-(2-bromophenyl)-1,3-dioxane 147 (972 mg, 4.00
mmol). After 3 hours, the reaction was worked up and purified by column chromatogra-
phy (eluent: 90:10 petrol:EtOAc) to yield the title compound as a yellow oil in 80% yield
(1.04 g, 3.20 mmol). Rf (90:10 petrol:EtOAc) = 0.29; 1H NMR (300 MHz, CDCl3) δH:
8.25 (1H, d, J = 15.9 Hz, ArCH=CH), 7.73 (2H, td, J = 7.0, 1.7 Hz, ArH ), 7.51-7.40
(3H, m, ArH ), 7.33-7.28 (4H, m, ArH ), 6.37 (1H, d, J = 15.9 Hz, ArCH=CH ), 5.62 (1H,
s, CH ), 5.25 (2H, s, CH2Ar), 4.30 (1H, dd, J = 5.0, 1.3 Hz, OCHAHB), 4.24 (1H, dd,
J = 5.0, 1.3 Hz, OCHAHB), 3.95 (2H, td, J = 12.2, 2.4 Hz, OCH2), 2.35-2.18 (1H, m,
CH2CHAHBCH2), 1.49-1.42 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz CDCl3)
δC: 166.12, 142.11, 137.51, 136.43, 135.61, 133.24, 132.78, 129.99, 128.78, 128.41, 127.32,
126.48, 120.22, 100.43, 67.59, 66.45, 25.75; IR (thinfilm) νmax (cm-1): 1709 (C=O), 1634








General procedure C was followed using benzyl (E)-3-(2-(1,3-dioxan-2-yl)phenyl)acrylate
148 (973 mg, 3.00 mmol). After 4 hours, the reaction was worked up and purified by
column chromatography (eluent: 80:20 petrol:EtOAc) to provide the title compound as a
yellow oil in 67% yield (535 mg, 2.01 mmol). Rf (80:20 petrol:EtOAc) = 0.50; 1H NMR
(300 MHz, CDCl3) δH: 10.29 (1H, s, CHO), 8.50 (1H, d, J = 15.9 Hz, ArCH=CH),
7.87 (1H, d, J = 6.7, 1.4 Hz, ArH ), 7.62-7.52 (3H, m, ArH ), 7.45-7.38 (5H, m, ArH ),
6.42 (1H, d, J = 15.9 Hz, ArCH=CH ), 5.28 (2H, s, CH2Ar); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 191.69, 165.97, 141.55, 136.50, 135.89, 133.88, 132.26, 129.96, 128.60, 128.28,
127.96, 122.79, 66.55; IR (thinfilm) νmax (cm-1): 1709 (O-C=O), 1693 (H-C=O), 1632
(C=C); HRMS (ESI): m/z calculated for C17H14O3: requires: 267.1021 for [M+H]+;
found: 267.1016; requires: 289.0840 for [M+Na]+; found: 289.0828.
3-(2-(benzyloxy)-2-oxoethyl)-1H -isoindole 2-oxide 152
N+ O-
CO2Bn
General procedure E was followed at room temperature using benzyl (E)-3-(2-formylphenyl)
acrylate 138 (533 mg, 2.00 mmol). The title compound was formed as a brown oil in 78%
yield (439 mg, 1.56 mmol) and required no further purification. 1H NMR (300 MHz,
CDCl3) δH: 7.30-7.17 (9H, m, ArH ), 5.12 (2H, s, OCH2Ar), 4.94 (2H, s, ArCH2N),
3.89 (2H, s, CH2C=O); 13C{1H} NMR (75.5 MHz CDCl3) δC: 167.22, 141.69, 135.74,
135.29, 133.22, 128.57, 128.41, 128.32, 128.09, 121.62, 119.43, 67.34, 65.86, 29.92; IR
(thinfilm) νmax (cm-1): 1725 (C=O); HRMS (ESI): m/z calculated for C17H15NO3: re-






General procedure B was followed using 2-(2-bromophenyl)-1,3-dioxane 147 (972 mg, 4.00
mmol). After 3 hours, the reaction was worked up and purified by column chromatography
(eluent: 90:10 petrol:EtOAc) to yield the title compound as a yellow oil in 77% yield (808
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mg, 3.08 mmol). Rf (90:10 petrol:EtOAc) = 0.31; 1H NMR (300 MHz, CDCl3) δH: 8.23
(1H, d, J = 15.9 Hz, ArCH=CH), 7.60 (2H, td, J = 7.8, 2.0 Hz, ArH ), 7.41-7.31 (2H, m,
ArH ), 6.35 (1H, d, J = 15.9 Hz, ArCH=CH ), 5.70 (1H, s, CH ), 4.31-4.23 (4H, m, OCH2,
CH2CH3), 4.02 (2H, td, J = 12.2, 2.5 Hz, OCH2), 2.37-2.20 (1H, m, CH2CHAHBCH2),
1.50-1.43 (1H, m, CH2CHAHBCH2), 1.34 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 167.01, 142.23, 137.17, 132.90, 129.85, 129.16, 127.04, 126.78,
119.95, 100.35, 67.60, 60.49, 25.75, 14.38; IR (thinfilm) νmax (cm-1): 1708 (C=O), 1635
(C=C); HRMS (ESI): m/z calculated for C15H18O4: requires: 263.1283 for [M+H]+;





General procedure C was followed using ethyl (E)-3-(2-(1,3-dioxan-2-yl)phenyl)acrylate
163 (787 mg, 3.00 mmol). After 6 hours the reaction was worked up and purified by
column chromatography (eluent: 90:10 petrol:EtOAc), to yield the title compound as a
yellow oil in 87% (533 mg, 2.61 mmol). Rf (90:10 petrol:EtOAc) = 0.43; 1H NMR (300
MHz, CDCl3) δH: 10.20 (1H, s, CHO), 8.43 (1H, d, J = 15.8 Hz, ArCH=CH), 7.78 (1H,
d, J = 7.5 Hz, ArH ), 7.56-7.44 (3H, m, ArH ), 6.29 (1H, d, J = 15.8 Hz, ArCH=CH ),
4.20 (2H, q, J = 7.2 Hz, CH2CH3), 1.26 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 191.67, 166.05, 140.82, 136.44, 133.80, 133.74, 132.21, 129.81,
127.85, 123.05, 60.63, 14.20; IR (thinfilm) νmax (cm-1): 1705 (C=O), 1695 (C=O), 1635
(C=C); HRMS (ESI): m/z calculated for C12H12O3: requires: 227.0684 for [M+Na]+;
found: 227.0675.
3-(2-ethoxy-2-oxoethyl)-1H -isoindole 2-oxide 165
N+ O-
CO2Et
General procedure E was followed using ethyl (E)-3-(2-formylphenyl)acrylate 164 (408
mg, 2.00 mmol). The title compound was formed as a white solid in 91% yield (399 mg,
1.82 mmol) and required no further purification. m.p. 130-132 ◦C; 1H NMR (300 MHz,
CDCl3) δH: 7.41-7.28 (4H, m, ArH ), 4.99 (2H, s, ArCH2N), 4.19 (2H, q, J = 7.1 Hz,
CH2CH3), 3.89 (2H, s, CH2C=O), 1.24 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 167.49, 141.99, 136.02, 133.30, 128.71, 128.18, 121.72, 119.53,
65.98, 61.83, 30.01, 14.25; IR (thinfilm) νmax (cm-1): 1732 (C=O); HRMS (ESI): m/z
calculated for C12H13NO3: requires: 220.0973 for [M+H]+; found: 220.0955; requires:







To a solution of ethyl (E)-3-(2-formylphenyl)acrylate 164 (408 mg, 2.00 mmol) in 5:1
EtOH:H2O, was added NH2OH·HCl (278 mg, 4.00 mmol), and the reaction stirred for
3 hours at room temperature. After removal of the solvent under reduced pressure, the
crude material was taken up in DCM and H2O, separated, and the organic layer washed
with H2O twice. The organic layer was dried (MgSO4), and the solvent removed under
reduced pressure to yield the title compound as a pale brown solid in 74% yield (47.00
mg, 0.21 mmol). No further purification was necessary.77 m.p. 77-78 ◦C; 1H NMR (300
MHz, CDCl3) δH: 8.53 (1H, s, HC=N-OH), 8.13 (1H, d, J = 15.9 Hz, ArCH=CH), 7.69
(1H, dd, J = 5.5, 3.5 Hz, ArH ), 7.56 (1H, dd, J = 5.5, 3.5 Hz, ArH ), 7.37 (2H, dd, J
= 5.8, 3.5 Hz, ArH ), 6.34 (1H, d, J = 15.8 Hz, ArCH=CH ), 4.27 (2H, q, J = 7.1 Hz,
CH2CH3), 1.33 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC:
167.0, 148.42, 141.89, 133.75, 131.13, 130.04, 129.98, 127.92, 127.45, 121.31, 60.96, 14.40;
IR (thinfilm) νmax (cm-1): 3357 (O-H), 1694 (C=O), 1685 (C=N), 1631 (C=C); HRMS
(ESI): m/z calculated for C12H13NO3: requires: 242.0793 for [M+Na]+; found: 242.0795.





To a solution of ethyl (E)-3-(2-formylphenyl)acrylate 164 (613 mg, 3.00 mmol) in 5:1
THF:H2O was added O-methylhydroxylamine hydrochloride (251 mg, 3.00 mmol) and
Et3N (0.84 mL, 6.00 mmol). The reaction was left to stir at room temperature for 14
hours. The crude mixture was then taken up in DCM and H2O and separated. The aque-
ous layer was washed with DCM (3 x 20 mL), the combined organics were dried (MgSO4),
and the solvent was removed under reduced pressure to yield a yellow oil. Purification
by column chromatography (eluent: 70:30 Petrol:EtOAc) afforded the title compound as
a red oil in 39% yield. Rf (70:30 Petrol:EtOAc) = 0.28; 1H NMR (300 MHz, CDCl3) δH:
8.32 (1H, s, H -C=N+), 7.59 (1H, dd, J = 7.7, 1.0 Hz, ArH ), 7.51 (1H, dd, J = 7.5, 1.4
Hz, ArH ), 7.40 (1H, td, J = 7.5, 1.5 Hz, ArH ), 7.32 (1H, td, J = 7.4, 1.4 Hz, ArH ), 5.52
(1H, dd, J = 8.5, 4.4 Hz, CH ), 4.19 (2H, q, J = 7.1 Hz, CH2CH3), 3.99 (3H, s, OCH3),
2.86-2.71 (2H, m, CHCH2), 1.27 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 172.49, 148.72, 141.22, 130.15, 130.07, 128.96, 127.98, 126.87, 68.13, 62.32,
60.96, 42.00, 14.33; IR (thinfilm) νmax (cm-1): 1732 (C=O); HRMS (ESI): m/z calculated







To a solution of 2-vinylbenzaldehyde 177 (397 mg, 3.00 mmol) in THF was added NH2OH
(50 wt% in H2O) (0.21 mL, 3.30 mmol), and the reaction stirred for 30 minutes at room
temperature. The solvent was removed under vacuum and the crude material purified by
column chromatography (eluent: DCM) to yield the title compound as a colourless oil
in 88% yield (389 mg, 2.67 mmol). Rf (DCM) = 0.27; 1H NMR (300 MHz, CDCl3) δH:
9.44 (1H, br. s, NOH ), 8.51 (1H, s, H -C=N), 7.69 (1H, d, J = 8.7 Hz, ArH ), 7.50 (1H,
dd, J = 7.6, 0.7 Hz, ArH ), 7.38 (1H, td, J = 7.5, 1.2 Hz, ArH ), 7.30 (1H, td, J = 7.4,
1.0 Hz, ArH ), 7.08 (1H, dd, J = 17.3, 11.0 Hz, CH=CH2), 5.65 (1H, dd, J = 17.3, 1.1
= Hz, CH=CHAHB), 5.42 (1H, dd, J = 10.9, 1.1 = Hz, CH=CHAHB); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 149.02, 137.53, 134.08, 129.99, 129.18, 127.94, 127.14, 127.02,
118.05; IR (thinfilm) νmax (cm-1): 3345 (O-H), 1685 (C=N) 1651 (C=C); HRMS (ESI):







To a solution of ethyl (E)-3-(2-formylphenyl)acrylate 164 (613 mg, 3.00 mmol) in 5:1
THF:H2O was added N -methylhydroxylamine hydrochloride (251 mg, 3.00 mmol) and
Et3N (0.84 mL, 6.00 mmol). The reaction was left to stir at room temperature for 24
hours. The crude mixture was then taken up in DCM and water and separated. The
aqueous layer was washed with DCM (3 x 20 mL), the combined organics were dried
(MgSO4), and the solvent was removed under vacuum to yield a yellow oil which solid-
ified on standing. Recrystallisation from DCM:hexane afforded the title compound as a
mixture of diasteromers (1:0.2 ratio) as white needles in 59% yield. m.p. = 54-55 ◦C;
major diastereomer 1H NMR (300 MHz, CDCl3) δH: 7.34-7.26 (3H, m, ArH ), 7.12-7.09
(1H, m, ArH ), 5.71 (1H, s, CHOH), 4.26 (1H, t, J = 5.8 Hz, CHCH2), 4.16 (2H, q, J
= 7.3 Hz, CH2CH3), 4.04 (1H, br. s, OH ), 3.09 (1H, dd, J = 16.0, 6.3 Hz, CHCHAHB),
2.73 (3H, s, NCH3), 2.45 (1H, dd, J = 16.0, 5.4, CHCHAHB), 1.24 (3H, t, J = 7.1 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 172.60, 137.61, 134.43, 128.30, 127.52,
127.39, 126.33, 93.89, 60.94, 60.00, 42.06, 33.84, 14.24; minor diastereomer 1H NMR
(300 MHz, CDCl3) δH: 7.34-7.26 (3H, m, ArH ), 7.19-7.16 (1H, m, ArH ), 5.81 (1H, s,
CHOH), 4.23-4.08 (3H, m, CHCH2, CH2CH3), 4.04 (1H, br. s, OH ), 2.89 (1H, dd, J
159
Chapter 7. Experimental
= 16.6, 5.0 Hz, CHCHAHB), 2.83- 2.76 (4H, m, CHCHAHB, NCH3), 1.27-1.19 (3H, m,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 172.60, 135.65, 132.56, 128.47, 127.14,
126.67, 125.19, 94.19, 62.24, 60.99, 43.28, 33.84, 14.24; IR (thinfilm) νmax (cm-1): 1729






General procedure B was followed under inert conditions using 2-(2-bromophenyl)-1,3-
dioxane 147 (972 mg, 4.00 mmol) and ethyl crotonate 183. After 8 hours, the reaction
was worked up and purified by column chromatography (eluent: 90:10 petrol:EtOAc) to
yield the title compound as a pale yellow oil in 48% yield (531 mg, 1.92 mmol). Rf
(90:10 petrol:EtOAc) = 0.47; 1H NMR (300 MHz, CDCl3) δH: 7.70 (1H, dd, J = 7.1,
2.2 Hz, ArH ), 7.37-7.27 (2H, m, ArH ), 7.10 (1H, dd, J = 7.0, 2.2 Hz, ArH ), 5.84 (1H,
q, J = 1.4 Hz, HC=CCH3), 5.50 (1H, s, CH ), 4.25-4.18 (4H, m, OCH2, CH2CH3), 3.90
(2H, td, J = 12.3, 2.4 Hz, OCH2), 2.48 (3H, d, J = 1.4 Hz, CH=CCH3), 2.36-2.14
(1H, m, CH2CHAHBCH2), 1.43-1.37 (1H, m, CH2CHAHBCH2), 1.31 (3H, t, J = 7.2 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 166.60, 156.37, 142.47, 134.98, 128.83,
128.16, 127.07, 126.62, 120.07, 99.61, 67.42, 59.91, 25.72, 21.48, 14.39; IR (thinfilm) νmax
(cm-1): 1711 (C=O), 1638 (C=C); HRMS (ESI): m/z calculated for C16H20O4:requires:





General procedure C was followed using (E)-ethyl 3-(2-(1,3-dioxan-2-yl)phenyl)but-2-
enoate 184 (829 mg, 3.00 mmol). After 6 hours, the reaction was worked up and purified
by column chromatography (eluent: 90:10 petrol:EtOAc) to yield the title compound as a
white solid in 69% yield (452 mg, 2.07 mmol). Rf (90:10 petrol:EtOAc) = 0.58; 1H NMR
(300 MHz, CDCl3) δH: 10.09 (1H, s, CHO), 7.91 (1H, dd, J = 7.8, 1.2 Hz, ArH ), 7.57
(1H, td, J = 7.6, 1.5 Hz, ArH ), 7.48-7.42 (1H, m, ArH ), 7.27 (1H, dd, J = 7.6, 1.0 Hz,
ArH ), 5.77 (1H, q, J = 1.4 Hz, HC=CCH3), 4.20 (2H, q, J = 7.1 Hz, CH2CH3), 2.53
(3H, d, J = 1.4 Hz, CH=CCH3), 1.28 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5
MHz CDCl3) δC: 191.31, 165.89, 154.34, 147.18, 133.92, 133.04, 129.02, 128.49, 128.41,
122.01, 60.27, 21.83, 14.37; IR (thinfilm) νmax (cm-1): 1710 (C=O), 1692 (C=O), 1638
160
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(C=C); HRMS (ESI): m/z calculated for C13H14O3: requires: 241.0840 for [M+Na]+;
found: 241.0843.




General procedure E was followed using ethyl (E)-3-(2-formylphenyl)but-2-enoate 185
(437 mg, 2.00 mmol). The title compound was formed as a yellow oil in 71% yield (331
mg, 1.42 mmol) and required no further purification. 1H NMR (300 MHz, CDCl3) δH:
7.69 (1H, s, H -C=N), 7.37-7.32 (4H, m, ArH ), 4.00-3.89 (2H, m, CH2CH3), 3.01 (2H, s,
CH2C=O), 1.61 (3H, s, CH3), 1.02 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5
MHz CDCl3) δC: 168.60, 142.94, 133.29, 132.82, 128.86, 127.82, 121.58, 120.40, 60.74,
40.99, 29.80, 24.43, 13.98; IR (thinfilm) νmax (cm-1): 1730 (C=O); HRMS (ESI): m/z
calculated for C13H15NO3: requires: 234.1130 for [M+H]+; found: 234.1130; requires:





General procedure B was followed using 2-bromoacetophenone 324 (796 mg, 4.00 mmol).
After 3 hours, the reaction was worked up and purified by column chromatography (elu-
ent: 90:10 petrol:EtOAc) to provide the title compound as a yellow oil in 90% yield (786
mg, 3.60 mmol). Rf (90:10 petrol:EtOAc) = 0.69; 1H NMR (300 MHz, CDCl3) δH: 8.07
(1H, d, J = 15.9 Hz, ArCH=CH), 7.66 (1H, d, J = 7.6 Hz, ArH ), 7.49 (1H, d, J = 7.6 Hz,
ArH ), 7.44-7.34 (2H, m, ArH ), 6.19 (1H, dd, J = 15.9, 1.1 Hz, ArCH=CH ), 4.17 (2H, qd,
J = 7.2, 0.8 Hz, CH2CH3), 2.53 (3H, d, J = 3.0 Hz, CH3), 1.24 (3H, td, J = 7.2, 0.9 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 200.42, 166.13, 143.60, 137.82, 134.42,
131.64, 129.09, 128.95, 127.98, 120.54, 60.15, 28.87, 13.97; IR (thinfilm) νmax (cm-1): 1708
(CH3-C=O), 1680 (O-C=O), 1633 (C=C); HRMS (ESI): m/z calculated for C13H14O3:
requires: 219.1021 for [M+H]+; found: 219.1006; requires: 241.0840 for [M+Na]+; found:
241.0855.







General procedure E was followed using ethyl (E)-3-(2-acetylphenyl)acrylate 188 (437
mg, 2.00 mmol). The title compound was formed as the major reaction product as a
yellow oil in 87% yield (406 mg, 1.74 mmol) and required no further purification. 1H
NMR (300 MHz, CDCl3) δH: 7.34-7.22 (4H, m, ArH ), 5.03-5.00 (1H, m, ArCH -N+), 4.11
(2H, q, J = 7.1 Hz, CH2CH3), 3.37 (1H, dd, J = 16.7, 4.4 Hz, CHACHBC=O), 2.61
(1H, dd, J = 16.7, 9.0 Hz, CHAHBC=O), 2.28 (3H, d, J = 1.6 Hz, CH3C=N+), 1.16
(3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 170.00, 143.86,
137.51, 135.54, 128.76, 128.04, 121.77, 119.17, 71.14, 61.03, 36.25, 14.02, 9.32; IR (thin-
film) νmax (cm-1): 1730 (C=O); HRMS (ESI): m/z calculated for C13H15NO3: requires:
234.1130 for [M+H]+; found: 234.1119; requires: 256.0949 for [M+Na]+; found: 256.0943.
Ethyl (E)-6-oxohex-2-enoate 200
O CO2Et
To a solution of 4-pentenal (252 mg, 3.00 mmol) in DCM was added Grubbs I catalyst
(5.0 mol%) and ethyl acrylate 162 (1.64 mL, 5.0 eq.). The reaction was heated to reflux
and left to stir for 16 hours. The reaction was then cooled and the solvent removed under
reduced pressure. Purification of the crude material by column chromatography afforded
the title compound as a colourless oil in 87% yield. Rf (DCM) = 0.43; 1H NMR (300
MHz, CDCl3) δH: 9.79 (1H, s, CHO), 6.93 (1H, dt, J = 15.6, 6.5 Hz, CH2CH=CH), 5.84
(1H, dt, J = 15.6, 1.5 Hz, CH2CH=CH ), 4.17 (2H, q, J = 7.1 Hz, CH2CH3), 2.67-2.61
(2H, m, CH2CH=CH), 2.56-2.48 (2H, m, CHO-CH2), 1.27 (3H, t, J = 7.1 Hz, CH2CH3);
13C{1H} NMR (75.5 MHz CDCl3) δC: 200.55, 166.42, 146.45, 122.57, 60.49, 41.96, 24.54,
14.37; IR (thinfilm) νmax (cm-1): 1712 (C=O) 1654 (C=C); HRMS (ESI): m/z calculated
for C8H12O3: requires: 179.0684 for [M+Na]+; found: 179.0709.




General procedure E was followed using ethyl (E)-6-oxohex-2-enoate 325 (312 mg, 2.00
mmol). The title compound was formed as a white solid in 89% yield (305 mg, 1.78 mmol)
and required no further purification. m.p. 47-49 ◦C; 1H NMR (500 MHz, CDCl3) δH:
7.12 (1H, s, HC=N), 4.40 (1H, br. s, CH2CHCH2), 4.16, (2H, q, J = 7.1 Hz, CH2CH3),
3.02 (1H, dd, J = 16.6, 4.6 Hz, CHCHACHBC=O), 2.78-2.72 (3H, m, CHCHACHBC=O,
CH2C=N), 2.57-2.50 (1H, m, CH2CHACHBCH), 2.09-2.02 (1H, m, CH2CHACHBCH),
1.26 (3H, t, J = 7.0 Hz, CH2CH3); 13C{1H} NMR (125 MHz CDCl3) δC: 171.19, 141.59,
70.19, 61.92, 37.43, 27.92, 25.94, 14.42 IR (thinfilm) νmax (cm-1): 1729 (C=O); HRMS







To a solution of ethyl (E)-3-(2-formylphenyl)acrylate 164 (204 mg, 1.00 mmol) in ethanol
was added hydroxylamine hydrochloride (1.0 eq.) and Et3N (2.0 eq.). The reaction was
stirred at room temperature for 30 minutes. The mixture was taken up in DCM and H2O
and separated. The organic layer was washed twice with H2O and once with brine. The
organic layer was then dried (MgSO4) and the solvent removed under vacuum to afford
the title compound as an inseparable mixture of diastereomers in 86% yield (228 mg, 0.86
mmol). major diastereomer 1H NMR (300 MHz, CDCl3) δH: 7.41-7.34 (3H, m, ArH ),
7.28-7.21 (1H, m, ArH ), 6.15 (1H, s, OCH ), 5.55 (1H, dd, J = 7.7, 5.8 Hz, CHCH2), 4.28-
4.15 (2H, m, CO2CH2CH3), 3.90-3.60 (2H, m, OCH2CH3), 2.88-2.68 (2H, m, CHCH2),
1.31-1.22 (6H, m, CO2CH2CH3, OCH2CH3); minor diastereomer 1H NMR (300 MHz,
CDCl3) δH: 7.41-7.34 (3H, m, ArH ), 7.28-7.21 (1H, m, ArH ), 6.25 (1H, d, J = 2.4 Hz,
OCH ), 5.75 (1H, td, J = 7.1, 1.7 Hz, CHCH2, 4.28-4.15 (2H, m, CO2CH2CH3), 3.90-
3.60 (2H, m, OCH2CH3), 2.88-2.68 (2H, m, CHCH2), 1.31-1.22 (6H, m, CO2CH2CH3,
OCH2CH3); IR (thinfilm) νmax (cm-1): 3299 (O-H), 1725 (C=O); HRMS (ESI): m/z cal-






General procedure A was followed using 2-bromo-4-methylbenzaldehyde (995 mg, 5.00
mmol), followed by purification by column chromatography (eluent: DCM), to provide
the title compound as a pale yellow oil in 85% yield (1.09 g, 4.25 mmol). Rf (DCM) =
0.50; 1H NMR (300 MHz, CDCl3) δH: 7.55 (1H, d, J = 8.0 Hz, ArH ), 7.35 (1H, s, ArH ),
7.13 (1H, d, J = 7.7 Hz, ArH ), 5.72 (1H, s, CH ), 4.27 (1H, dd, J = 5.1, 1.3 Hz, OCHAHB),
4.23 (1H, dd, J = 5.1, 1.3 Hz, OCHAHB), 4.03 (2H, td, J = 12.2, 2.4 Hz, OCH2), 2.30
(3H, s, CH3), 2.28-2.15 (1H, m, CH2CHAHBCH2), 1.47-1.40 (1H, m, CH2CHAHBCH2);
13C{1H} NMR (75.5 MHz CDCl3) δC: 140.65, 134.69, 133.05, 128.45, 127.80, 122.09,
101.02, 67.67, 25.79, 20.97; IR (thinfilm) νmax (cm-1): 1610 (ArC=C), 1566 (ArC=C);










General procedure A was followed using 2-bromo-4,5-dimethoxybenzaldehyde (1.22 g, 5.00
mmol), followed by recrystallisation from petrol:ether, to provide the title compound as
cream needles in 76% yield (1.15 g, 3.80 mmol). m.p. 98-99 ◦C; 1H NMR (300 MHz,
CDCl3) δH: 7.19 (1H, s, ArH ), 6.97 (1H, s, ArH ), 5.69 (1H, s, CH ), 4.27 (1H, dd, J
= 5.1, 1.3 Hz, OCHAHB), 4.23 (1H, dd, J = 5.1, 1.3 Hz, OCHAHB), 4.01 (2H, td, J
= 12.3, 2.4 Hz, OCH2), 3.90 (3H, s, OCH3), 3.85 (3H, s, OCH3), 2.32-2.16 (1H, m,
CH2CHAHBCH2), 1.47-1.40 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz CDCl3)
δC: 149.86, 148.58, 129.88, 115.10, 112.50, 110.31, 101.04, 67.62, 56.22, 56.05, 25.69; IR
(thinfilm) νmax (cm-1): 1602 (ArC=C), 1502 (ArC=C); HRMS (ESI): m/z calculated for






General procedure A was followed using 2-bromo-5-methoxybenzaldehyde (1.08 g, 5.00
mmol), to provide the title compound as an orange oil in 96% yield (1.31 g, 4.80 mmol),
which was used without further purification. 1H NMR (300 MHz, CDCl3) δH: 7.40 (1H,
d, J = 8.9 Hz, ArH ), 7.24 (1H, d, J = 3.1 Hz, ArH ), 6.76 (1H, dd, J = 8.8, 3.3 Hz,
ArH ), 5.71 (1H, s, CH ), 4.28 (1H, dd, J = 5.1, 1.3 Hz, OCHAHB), 4.24 (1H, dd, J = 5.1,
1.3 Hz, OCHAHB), 4.02 (2H, td, J = 12.2, 2.5 Hz, OCH2), 3.80 (3H, s, OCH3), 2.32-2.16
(1H, m, CH2CHAHBCH2), 1.48-1.41 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 159.23, 138.34, 133.31, 117.23, 112.79, 112.69, 100.92, 67.66, 55.63, 25.77; IR
(thinfilm) νmax (cm-1): 1596 (ArC=C), 1575 (ArC=C); HRMS (ESI): m/z calculated for






General procedure A was followed using 2-bromo-5-(trifluoromethyl)benzaldehyde (1.27
g, 5.00 mmol), followed by purification by column chromatography (eluent: 80:20 petrol:
EtOAc), to provide the title compound as a pale yellow oil in 86% yield (1.34 g, 4.30
164
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mmol). Rf (80:20 petrol:EtOAc) = 0.80; 1H NMR (300 MHz, CDCl3) δH: 7.98 (1H, d, J
= 2.1 Hz, ArH ), 7.65 (1H, d, J = 8.3 Hz, ArH ), 7.44 (1H, dd, J = 8.4, 2.3 Hz, ArH ),
5.76 (1H, s, CH ), 4.30 (1H, dd, J = 5.0, 1.2 Hz, OCHAHB), 4.26 (1H, dd, J = 5.0, 1.2 Hz,
OCHAHB), 4.02 (2H, td, J = 12.5, 2.1 Hz, OCH2), 2.34-2.18 (1H, m, CH2CHAHBCH2),
1.49-1.42 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz CDCl3) δC: 138.53, 133.17,
130.00 (q, J = 33.1 Hz), 126.77 (q, J = 3.8 Hz), 126.12 (q, J = 1.5 Hz) 125.35 (q, J =







General procedure A was followed using 2-bromo-5-fluorobenzaldehyde (1.02 g, 5.00 mmol),
to provide the title compound as a colourless in 92% yield (1.20 g, 4.60 mmol), which was
used without further purification. 1H NMR (300 MHz, CDCl3) δH: 7.48 (1H, dd, J = 8.7,
5.1 Hz, ArH ), 7.42 (1H, dd, J = 9.3, 3.1 Hz, ArH ), 6.93 (1H, m, ArH ), 5.69 (1H, d, J =
0.6 Hz, CH ), 4.28 (1H, dd, J = 5.0, 1.0 Hz, OCHAHB), 4.24 (1H, dd, J = 5.1, 1.2 Hz,
OCHAHB), 4.02 (2H, td, J = 12.1, 2.3 Hz, OCH2), 2.32-2.15 (1H, m, CH2CHAHBCH2),
1.49-1.43 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz CDCl3) δC: 162.19 (d,
J = 247.0 Hz), 139.57 (d, J = 7.5 Hz), 133.96 (d, J = 7.7 Hz), 117.64 (d, J = 23.3
Hz), 116.33 (d, J = 3.2 Hz), 115.67 (d, J = 24.4 Hz), 100.31, 67.69, 25.71; IR (thinfilm)
νmax (cm-1): 1582 (ArC=C); HRMS (ESI): m/z calculated for C10H10BrFO2: requires:





General procedure A was followed using 2-bromo-6-fluorobenzaldehyde (1.02 g, 5.00 mmol),
followed by recrystallisation from petrol:ether, to provide the title compound as white nee-
dles in 83% yield (1.08 g, 4.15 mmol). m.p. 59-60 ◦C; 1H NMR (300 MHz, CDCl3) δH:
7.35 (1H, dd, J = 8.0, 0.9 Hz, ArH ), 7.15 (1H, td, J = 8.5, 5.6 Hz, ArH ), 7.04 (1H, td,
J = 8.5, 1.2 Hz, ArH ), 6.03 (1H, s, CH ), 4.30 (1H, dd, J = 5.0, 1.0 Hz, OCHAHB), 4.26
(1H, dd, J = 5.0, 1.2 Hz, OCHAHB), 3.98 (2H, td, J = 11.8, 1.4 Hz, OCH2), 2.41-2.25
(1H, m, CH2CHAHBCH2), 1.46-1.41 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 161.42 (d, J = 251.7 Hz), 130.92 (d, J = 9.7 Hz), 128.86 (d, J = 3.7 Hz),
125.26 (d, J = 13.9 Hz), 122.87 (d, J = 5.3 Hz), 115.88 (d, J = 22.9 Hz), 100.49 (d,
J = 1.6 Hz), 67.67, 25.47; IR (thinfilm) νmax (cm-1): 1603 (ArC=C), 1575 (ArC=C);
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General procedure A was followed using 1-bromo-2-naphthaldehyde (1.18 g, 5.00 mmol),
followed by recrystallisation from petrol:ether, to provide the title compound as white
plates in 84% yield (1.23 g, 4.20 mmol). m.p. 131-133; 1H NMR (300 MHz, CDCl3) δH:
8.37 (1H, dd, J = 8.4, 1.3 Hz, ArH ), 7.84-7.80 (3H, m, ArH ), 7.87-7.50 (2H, m, ArH )
6.11 (1H, s, CH ), 4.34 (1H, dd, J = 5.0, 1.2 Hz, OCHAHB), 4.30 (1H, dd, J = 5.0, 1.2 Hz,
OCHAHB), 4.10 (2H, td, J = 12.4, 2.5 Hz, OCH2), 2.39-2.23 (1H, m, CH2CHAHBCH2),
1.52-1.45 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz CDCl3) δC: 135.60, 134.86,
132.05, 128.21, 128.07, 127.79, 127.42, 127.07, 124.65, 123.00, 102.01, 67.73, 25.85; IR
(thinfilm) νmax (cm-1): 1597 (ArC=C), 1557 (ArC=C); HRMS (ESI): m/z calculated for





General procedure B was followed using 2-(2-bromo-4-methylphenyl)-1,3-dioxane 147a
(1.03 g, 4.00 mmol). After 4 hours, the reaction was worked up and purified by column
chromatography (eluent: 90:10 petrol:EtOAc) to yield the title compound as a yellow oil
in 69% yield (763 mg, 2.76 mmol). Rf (90:10 petrol:EtOAc) = 0.20; 1H NMR (300 MHz,
CDCl3) δH: 8.21 (1H, d, J = 15.9 Hz, ArCH=CH), 7.48 (1H, d, J = 7.9 Hz, ArH ), 7.39
(1H, s, ArH ), 7.19 (1H, d, J = 7.9 Hz, ArH ), 6.34 (1H, d, J = 15.9 Hz, ArCH=CH ),
5.67 (1H, s, CH ), 4.30-4.23 (4H, m, OCH2, CH2CH3), 4.00 (2H, td, J = 12.2, 2.1 Hz,
OCH2), 2.34 (3H, s, ArCH3), 2.34-2.19 (1H, m, CH2CHAHBCH2), 1.48-1.43 (1H, m,
CH2CHAHBCH2), 1.34 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3)
δC: 167.13, 142.43, 138.91, 134.59, 132.72, 130.68, 127.37, 127.06, 119.68, 100.43, 67.62,
60.49, 25.80, 21.27, 14.42; IR (thinfilm) νmax (cm-1): 1708 (C=O), 1636 (C=C); HRMS
(ESI): m/z calculated for C16H20O4: requires: 277.1439 for [M+H]+; found: 277.1444;








General procedure B was followed using 2-(2-bromo-4,5-dimethoxyphenyl)-1,3-dioxane
147b (1.21 g, 4.00 mmol). After 4.5 hours, the reaction was worked up and purified
by column chromatography (eluent: 70:30 petrol:EtOAc) to yield the title compound as
a yellow oil in 67% yield (864 mg, 2.68 mmol). Rf (70:30 petrol:EtOAc) = 0.36; 1H NMR
(300 MHz, CDCl3) δH: 8.07 (1H, d, J = 15.9 Hz, ArCH=CH), 7.15 (1H, s, ArH ), 7.04
(1H, s, ArH ), 6.25 (1H, d, J = 15.8 Hz, ArCH=CH ), 5.69 (1H, s, CH ), 4.27-4.20 (4H,
m, OCH2, CH2CH3), 4.00 (2H, td, J = 12.3, 2.5 Hz, OCH2), 3.90 (3H, s, OCH3), 3.87
(3H, s, OCH3), 2.32-2.16 (1H, m, CH2CHAHBCH2), 1.46-1.41 (1H, m, CH2CHAHBCH2),
1.31 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 167.05, 150.53,
149.12, 141.25, 131.17, 125.06, 117.64, 109.33, 108.66, 99.30, 67.44, 60.30, 55.88, 25.55,
14.29; IR (thinfilm) νmax (cm-1): 1701 (C=O), 1630 (C=C); HRMS (ESI): m/z calculated







General procedure B was followed using 2-(2-bromo-5-methoxyphenyl)-1,3-dioxane 147c
(1.09 g, 4.00 mmol). After 6 hours, the reaction was worked up and purified by column
chromatography (eluent: 80:20 petrol:EtOAc) to yield the title compound as a yellow oil in
74% yield (865 mg, 2.96 mmol). Rf (80:20 petrol:EtOAc) = 0.39; m.p. 43-44 ◦C; 1H NMR
(300 MHz, CDCl3) δH: 8.09 (1H, d, J = 15.9 Hz, ArCH=CH), 7.53 (1H, d, J = 8.7 Hz,
ArH ), 7.15 (1H, d, J = 2.7 Hz, ArH ), 6.84 (1H, dd, J = 8.7, 2.7 Hz, ArH ), 6.24 (1H, d, J
= 15.9 Hz, ArCH=CH ), 5.67 (1H, s, CH ), 4.28-4.19 (4H, m, OCH2, CH2CH3), 3.99 (2H,
td, J = 12.3, 2.4 Hz, OCH2), 3.79 (3H, s, OCH3), 2.32-2.16 (1H, m, CH2CHAHBCH2),
1.46-1.40 (1H, m, CH2CHAHBCH2), 1.30 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 167.25, 161.02, 141.47, 138.94, 128.22, 125.09, 117.42, 115.36,
111.55, 99.65, 67.48, 60.27, 55.38, 25.63, 14.34; IR (thinfilm) νmax (cm-1): 1702 (C=O),
1605 (C=C); HRMS (ESI): m/z calculated for C16H20O5: requires: 293.1388 for [M+H]+;








General procedure B was followed using 2-(2-bromo-5-(trifluoromethyl)phenyl)-1,3-dioxane
147d (1.24 g, 4.00 mmol). After 5 hours, the reaction was worked up and purified by
column chromatography (eluent: 90:10 petrol:EtOAc) to yield the title compound in 73%
yield (964 mg, 2.92 mmol) as a yellow oil. Rf (90:10 petrol:EtOAc) = 0.46; 1H NMR (300
MHz, CDCl3) δH: 8.13 (1H, d, J = 16.0 Hz, ArCH=CH), 7.91 (1H, t, J = 0.6 Hz, ArH ),
7.64 (1H, dd, J = 8.1, 5.5 Hz, ArH ), 7.57 (1H, dd, J = 8.4, 1.7 Hz, ArH ), 6.38 (1H, d,
J = 16.0 Hz, ArCH=CH ), 5.70 (1H, s, CH ), 4.30-4.23 (4H, m, OCH2, CH2CH3), 4.00
(2H, td, J = 12.2, 2.5 Hz, OCH2), 2.34-2.18 (1H, m, CH2CHAHBCH2), 1.49-1.43 (1H, m,
CH2CHAHBCH2), 1.33 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3)
δC: 166.29, 140.47, 137.72, 136.35 (q, J = 1.3 Hz), 131.25 (q, J = 32.8 Hz), 127.10, 125.69
(q, J = 3.8 Hz), 124.07 (q, J = 3.7 Hz), 123.19, (appt. d, J = 272.4 Hz), 122.16, 99.03,
67.44, 60.64, 25.47, 14.17; IR (thinfilm) νmax (cm-1): 1715 (C=O), 1630 (C=C); HRMS
(ESI): m/z calculated for C16H17O4F3: requires: 331.1157 for [M+H]+; found: 331.1147;






General procedure B was followed using 2-(2-bromo-6-fluorophenyl)-1,3-dioxane 147e
(1.04 g, 4.00 mmol). After 4 hours, the reaction was worked up and purified by column
chromatography (eluent: 90:10 petrol:EtOAc) to yield the title compound as a yellow oil
in 85% yield (953 mg, 3.40 mmol). Rf (90:10 petrol:EtOAc) = 0.36; 1H NMR (300 MHz,
CDCl3) δH: 8.07 (1H, d, J = 15.8 Hz, ArCH=CH), 7.57 (1H, dd, J = 8.6, 5.5 Hz, ArH ),
7.37 (1H, dd, J = 9.6, 2.7 Hz, ArH ), 7.03 (1H, td, J = 8.1, 2.7 Hz, ArH ), 6.30 (1H, d,
J = 15.8 Hz, ArCH=CH ), 5.68 (1H, s, CH ), 4.30-4.23 (4H, m, OCH2, CH2CH3), 4.02
(2H, td, J = 12.2, 2.4 Hz, OCH2), 2.34-2.18 (1H, m, CH2CHAHBCH2), 1.51-1.45 (1H, m,
CH2CHAHBCH2), 1.34 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3)
δC: 166.95, 163.66 (d, J = 250.4 Hz), 140.89, 139.69 (d, J = 7.7 Hz), 128.94 (d, J = 3.4
Hz), 128.82 (d, J = 8.3 Hz), 119.84 (d, J = 1.8), 116.29 (d, J = 22.6 Hz), 114.24 (d, J =
22.6 Hz), 98.94 (d, J = 1.5 Hz), 67.61, 60.65, 25.66, 14.43; IR (thinfilm) νmax (cm-1): 1710
(C=O), 1637 (C=O); HRMS (ESI): m/z calculated for C15H17FO4: requires: 281.1189








General procedure B was followed using 2-(2-bromo-6-fluorophenyl)-1,3-dioxane 147f (1.04
g, 4.00 mmol). After 4 hours, the reaction was worked up and purified by column chro-
matography (eluent: 80:20 petrol:EtOAc) to yield the title compound as a yellow oil in
81% yield (908 mg, 3.24 mmol). Rf (80:20 petrol:EtOAc) = 0.48; 1H NMR (300 MHz,
CDCl3) δH: 8.75 (1H, d, J = 16.1 Hz, ArCH=CH), 7.42 (1H, d, J = 8.0 Hz, ArH ),
7.30 (1H, td, J = 8.2, 5.5 Hz, ArH ), 7.04 (1H, td, J = 8.2, 1.1 Hz, ArH ), 6.31 (1H, d,
J = 16.1 Hz, ArCH=CH ), 6.05 (1H, s, CH ), 4.32-4.23 (4H, m, OCH2, CH2CH3), 3.97
(2H, td, J = 12.2, 2.3 Hz, OCH2), 2.47-2.31 (1H, m, CH2CHAHBCH2), 1.50-1.45 (1H, m,
CH2CHAHBCH2), 1.31 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3)
δC: 166.89, 160.22 (d, J = 248.3 Hz), 143.29 (d, J = 2.66 Hz), 136.33 (d, J = 2.82 Hz),
130.44 (d, J = 9.5 Hz), 124.33 (d, J = 11.26 Hz), 123.02 (d, J = 3.7 Hz), 119.61, 116.48 (d,
J = 23.46 Hz), 96.29 (d, J = 10.17 Hz, CH), 67.96, 60.40, 25.85, 14.34; IR (thinfilm) νmax
(cm-1): 1709 (C=O), 1639 (C=C); HRMS (ESI): m/z calculated for C15H17FO4: requires:





General procedure B was followed using 2-(3-bromonaphthalen-2-yl)-1,3-dioxane 147g
(1.17 g, 4.00 mmol). After 6 hours, the reaction was worked up and purified by column
chromatography (eluent: 85:15 petrol:EtOAc) to yield the title compound as a yellow
oil in 80% yield (1.00 g, 3.20 mmol). Rf (85:15 petrol:EtOAc) = 0.47; 1H NMR (300
MHz, CDCl3) δH: 8.31 (1H, d, J = 16.2 Hz, ArCH=CH), 8.03 (1H, dd, J = 6.3, 3.4
Hz, ArH ), 7.87 (2H, s, ArH ), 7.84 (1H, dd, J = 6.2, 3.4 Hz, ArH ), 7.54-7.48 (2H, m,
ArH ), 6.29 (1H, d, J = 16.2 Hz, ArCH=CH ), 5.74 (1H, s, CH ), 4.35 (2H, q, J = 7.1 Hz,
CH2CH3), 4.30-4.35 (2H, m, OCH2), 4.00 (2H, td, J = 12.2, 2.4 Hz, OCH2), 2.38-2.22
(1H, m, CH2CHAHBCH2), 1.49-1.44 (1H, m, CH2CHAHBCH2), 1.39 (3H, t, J = 7.1 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 165.15, 140.91, 133.77, 133.27, 130.98,
130.77, 128.92, 128.15, 126.47, 126.34, 126.27, 125.06, 123.40, 99.66, 67.11, 60.53, 25.50,
14.15; IR (thinfilm) νmax (cm-1): 1712 (C=O), 1639 (C=C); HRMS (ESI): m/z calculated








General procedure C was followed using (E)-ethyl 3-(2-(1,3-dioxan-2-yl)-5-methylphenyl)
acrylate 163a (829 mg, 3.00 mmol). After 4 hours, the reaction was worked up and puri-
fied by column chromatography (eluent: 90:10 petrol:EtOAc) to yield the title compound
as a yellow oil in 83% yield (543 mg, 2.49 mmol). Rf (90:10 petrol:EtOAc) = 0.40; 1H
NMR (300 MHz, CDCl3) δH: 10.23 (1H, s, CHO), 8.49 (1H, d, J = 15.9 Hz, ArCH=CH),
7.76 (1H, d, J = 7.8 Hz, ArH ), 7.42 (1H, s, ArH ), 7.34 (1H, d, J = 7.9 Hz, ArH ),
6.35 (1H, d, J = 15.9 Hz, ArCH=CH ), 4.28 (2H, q, J = 7.1 Hz, CH2CH3), 2.43 (3H,
s, ArCH3), 1.34 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC:
191.46, 166.34, 144.99, 141.19, 136.74, 132.52, 131.72, 130.70, 128.64, 123.04, 60.81, 21.85,
14.36; IR (thinfilm) νmax (cm-1): 1708 (H-C=O), 1690 (O-C=O), 1635 (C=C); HRMS






General procedure C was followed using (E)-ethyl 3-(2-(1,3-dioxan-2-yl)-4,5-dimethoxy
phenyl)acrylate 163b (967 mg, 3.00 mmol). After 14 hours, the reaction was worked
up and purified by recrystallisation (petrol:ether) to yield the title compound as cream
needles in 71% yield (563 mg, 2.13 mmol). m.p. 121-124 ◦C; 1H NMR (300 MHz, CDCl3)
δH: 10.33 (1H, s, CHO), 8.46 (1H, d, J = 15.9 Hz, ArCH=CH), 7.40 (1H, s, ArH ),
7.05 (1H, s, ArH ), 6.35 (1H, d, J = 15.9 Hz, ArCH=CH ), 4.29 (2H, q, J = 15.6 Hz,
CH2CH3), 3.99 (3H, s, OCH3), 3.97 (3H, s, OCH3), 1.35 (3H, t, J = 15.6 Hz, CH2CH3);
13C{1H} NMR (75.5 MHz CDCl3) δC: 189.07, 166.24, 153.65, 150.59, 139.29, 131.67,
127.75, 121.94, 111.04, 108.99, 60.79, 56.22, 56.18, 14.29; IR (thinfilm) νmax (cm-1): (H-
C=O), 1679 (O-C=O), 1636 (C=C); HRMS (ESI): m/z calculated for C14H16O5: requires:






General procedure C was followed using (E)-ethyl 3-(2-(1,3-dioxan-2-yl)-4-methoxyphenyl)
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acrylate 163c (877 m.o.g, 3.00 mmol). After 6 hours, the reaction was worked up and
purified by recrystallisation (petrol:ether) to yield the title compound as a yellow solid in
65% yield (457 mg, 1.95 mmol). m.p. 59-60 ◦C; 1H NMR (300 MHz, CDCl3) δH: 10.32
(1H, s, CHO), 8.41 (1H, d, J = 15.8 Hz, ArCH=CH), 7.58 (1H, d, J = 8.7 Hz, ArH ),
7.35 (1H, d, J = 2.8 Hz, ArH ), 7.12 (1H, dd, J = 8.6, 2.8 Hz, ArH ), 6.29 (1H, d, J
= 15.8 Hz, ArCH=CH ), 4.25 (2H, q, J = 7.1 Hz, CH2CH3), 3.87 (3H, s, OCH3), 1.32
(3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 190.94, 166.45,
160.95, 139.61, 135.03, 129.33, 121.27, 120.72, 114.48, 60.65, 55.64, 14.26; IR (thinfilm)
νmax (cm-1): 1709 (H-C=O), 1674 (O-C=O), 1636 (C=C); HRMS (ESI): m/z calculated






General procedure C was followed using (E)-ethyl 3-(2-(1,3-dioxan-2-yl)-4-(trifluoromethyl)
phenyl)acrylate 163d (991 mg, 3.00 mmol). After 7 hours, the reaction was worked up and
purified by recrystallisation (petrol:ether) to yield the title compound as cream needles in
68% yield (555 mg, 2.04 mmol). m.p. 65-67 ◦C; 1H NMR (300 MHz, CDCl3) δH: 10.37
(1H, s, CHO), 8.20 (1H, d, J = 15.9 Hz, ArCH=CH), 8.14 (1H, s, ArH ), 7.84 (1H, d, J =
8.0 Hz, ArH ), 7.74 (1H, d, J = 8.0 Hz, ArH ), 6.43 (1H, d, J = 15.9 Hz, ArCH=CH ), 4.30
(2H, q, J = 7.2 Hz, CH2CH3), 1.35 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR (75.5
MHz CDCl3) δC: 190.05, 165.57, 139.95 (q, J = 1.2 Hz), 139.16, 133.93, 131.95 (q, J =
33.8 Hz), 130.16 (q, J = 3.4 Hz), 128.72, 128.51 (q, J = 3.7 Hz), 125.43, 123.19, (appt. d,
J = 272.4 Hz), 61.03, 14.19; IR (thinfilm) νmax (cm-1): 1717 (C=O), 1703 (C=O), 1638
(C=C); HRMS (ESI): m/z calculated for C13H11F3O3: requires: 273.0738 for [M+H]+;






General procedure C was followed using ethyl (E)-3-(2-(1,3-dioxan-2-yl)-4-fluorophenyl)
acrylate 163e (841 mg, 3.00 mmol). After 14 hours, the reaction was worked up and
purified by recrystallisation (petrol:ether) to yield the title compound as cream needles
in 73% yield (487 mg, 2.19 mmol). m.p. 92-94 ◦C; 1H NMR (300 MHz, CDCl3) δH: 1H
NMR (300 MHz, CDCl3) δH: 10.30 (1H, s, CHO), 8.41 (1H, d, J = 15.8 Hz, ArCH=CH),
7.64 (1H, dd, J = 8.6, 5.1 Hz, ArH ), 7.58 (1H, dd, J = 8.5, 2.7 Hz, ArH ), 7.32 (1H,
td, J = 8.0, 2.7 Hz, ArH ), 6.34 (1H, d, J = 15.8 Hz, ArCH=CH ), 4.29 (2H, q, J = 7.1
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Hz, CH2CH3), 1.35 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC:
190.00, 166.11, 163.51 (d, J = 252.9 Hz), 139.31, 135.64 (d, J = 4.8 Hz), 133.12 (d, J =
4.8 Hz), 130.30 (d, J = 7.6 Hz), 123.57, 121.41 (d, J = 22.2 Hz), 117.53 (d, J = 22.2 Hz),
60.99, 14.38; IR (thinfilm) νmax (cm-1): 1719 (C=O), 1706 (C=O), 1675 (C=C); HRMS






General procedure C was followed using (E)-ethyl 3-(2-(1,3-dioxan-2-yl)-3-fluorophenyl)
acrylate 163f (841 mg, 3.00 mmol). After 5 hours the reaction was worked up and puri-
fied by recrystallisation (petrol:ether) to yield the title compound in 80% yield (533 mg,
2.40 mmol) as white needles. m.p. 88-91 ◦C; 1H NMR (300 MHz, CDCl3) δH: 10.53
(1H, s, CHO), 8.40 (1H, d, J = 15.9 Hz, ArCH=CH), 7.56 (1H, td, J = 8.2, 5.6 Hz,
ArH ), 7.37 (1H, d, J = 7.7 Hz, ArH ), 7.23-7.16 (1H, m, ArH ), 6.31 (1H, d, J = 15.9
Hz, ArCH=CH ), 4.27 (2H, q, J = 7.1 Hz, CH2CH3), 1.35 (3H, t, J = 7.1 Hz, CH2CH3);
13C{1H} NMR (75.5 MHz CDCl3) δC: 188.29 (d, J = 10.8 Hz), 166.07, 165.75 (d, J =
258.3 Hz), 141.78 (d, J = 2.8 Hz), 138.15, 135.39 (d, J = 10.4 Hz), 123.95 (d, J = 3.5
Hz), 123.51, 122.03 (d, J = 6.6 Hz), 117.22 (d, J = 21.8 Hz), 60.76, 14.26; IR (thinfilm)
νmax (cm-1): 1707 (C=O), 1686 (C=O), 1637 (C=C); HRMS (ESI): m/z calculated for





General procedure C was followed using (E)-ethyl 3-(3-(1,3-dioxan-2-yl)naphthalen-2-
yl)acrylate 163g (937 mg, 3.00 mmol). After 6 hours the reaction was worked up and
purified by column chromatography (eluent: DCM) to yield the title compound in 72%
yield (549 mg, 2.16 mmol) as a yellow oil. Rf (DCM) = 0.50; 1H NMR (400 MHz,
CDCl3) δH: 10.39 (1H, s, CHO), 8.45 (1H, d, J = 15.9 Hz, ArCH=CH), 8.14 (1H, d,
J = 8.8 Hz, ArH ), 8.01 (1H, d, J = 8.8 Hz, ArH ), 7.93 Ð 7.90 (2H, m, ArH ), 7.69 Ð
7.58 (2H, m, ArH ), 6.20 (1H, d, J = 15.9 Hz, ArCH=CH ), 4.35 (2H, q, J = 7.1 Hz,
CH2CH3), 1.38 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC:
: 191.58, 165.44, 139.27, 138.98, 135.85, 131.88, 131.25, 130.01, 129.52, 129.29, 128.79,
127.62, 126.05, 123.24, 61.27, 14.42; IR (thinfilm) νmax (cm-1): 1717 (C=O), 1678 (C=O),
1636 (C=C); HRMS (ESI): m/z calculated for C16H14O3: requires: 255.1021 for [M+H]+;
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To a solution of 2-(2-bromophenyl)-1,3-dioxane 147 (972 mg, 4.00 mmol), Pd(OAc)2 (1.0
mol%) triphenylphosphine (2.0 mol%) in DMF, was added acrylonitrile 207 (2.0 eq.) and
Et3N (2.0 eq.) The reaction was heated to 100 ◦C and stirred for 12 hours. After cooling
to room temperature, H2O was added and the solution was extracted with Et2O (x3).
Removal of the solvent under reduced pressure gave an orange oil that was purified by
column chromatography (eluent: 85:15 petrol:EtOAc) to afford the title compound as a
yellow oil in 59% yield (594 mg, 2.76 mmol).98 Rf (85:15 petrol:EtOAc) = 0.39; 1H NMR
(300 MHz, CDCl3) δH: 8.04 (1H, d, J = 17.0 Hz, ArCH=CH), 7.56 (1H, dd, J = 7.5, 1.6
Hz, ArH ), 7.47 (1H, dd, J = 7.5, 1.6 Hz, ArH ), 7.43-7.31 (2H, m, ArH ), 5.77 (1H, d, J =
17.0 Hz, ArCH=CH ), 5.58 (1H, s, CH ), 4.29 (1H, dd, J = 5.0, 1.2 Hz, OCHAHB), 4.25
(1H, dd, J = 5.0, 1.2 Hz, OCHAHB), 3.97 (2H, td, J = 12.2, 2.4 Hz, OCH2), 2.33-2.17
(1H, m, CH2CHAHBCH2), 1.50-1.43 (1H, m, CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 148.73, 136.67, 131.98, 130.57, 129.25, 127.55, 126.02, 118.35, 100.88, 97.47,
67.54, 25.54; IR (thinfilm) νmax (cm-1): 2212 (C≡N); 1617 (C=C); HRMS (ESI): m/z
calculated for C13H13NO2: requires: 216.1024 for [M+H]+; found: 216.1006; requires:





General procedure C was followed using (E)-3-(2-(1,3-dioxan-2-yl)phenyl)acrylonitrile
208 (646 mg, 3.00 mmol). After 14 hours the reaction was worked up and purified by col-
umn chromatography (eluent: 90:10 petrol:EtOAc) to yield the title compound as a white
solid in 66% yield (312.00 mg, 1.98 mmol). Rf (90:10 petrol:EtOAc) = 0.36; 1H NMR (400
MHz, CDCl3) δH: 10.13 (1H, s, CHO), 8.40 (1H, d, J = 16.6 Hz, ArCH=CH), 7.88-7.82
(1H, m, ArH ), 7.64 (2H, dd, J = 5.3, 3.6 Hz, ArH ), 7.60-7.55 (1H, m, ArH ), 5.85 (1H, d,
J = 16.6 Hz, ArCH=CH ); 13C{1H} NMR (75.5 MHz CDCl3) δC: 192.39, 148.17, 134.77,
134.58, 134.08, 133.35, 130.92, 127.34, 117.62, 100.62; IR (thinfilm) νmax (cm-1): 2210
(C≡N), 1708 (C=O), 1637 (C=C); HRMS (ESI): m/z calculated for C10H7NO: requires:







To a solution of 2-bromobenzaldehyde (0.32 mL, 2.70 mmol), Pd(OAc)2 (1.0 mol%) and
(o-Tol)3P (2.0 mol%) in DMF (5 mL) in a 20 mL microwave vial, was added N,N -
dimethylacrylamide (0.42 mL, 4.05 mmol) and Et3N (0.57 mL, 4.05 mmol). The reaction
vessel was sealed and heated to 120 ◦C in a Biotage Initiator microwave for 1 hour. After
cooling, the reaction was diluted with Et2O, filtered through Celite R© and dried (MgSO4).
The solvent was removed under reduced pressure to yield the crude product as a brown oil.
The crude material was purified using a Biotage SP4 (eluent: 30:70 cyclohexane:EtOAc;
50 g Biotage SNAP cartridge) and recrystallised from Et2O:hexane. The yellow solid was
filtered and dried under vacuum to yield the title compound in 81% yield (462 mg, 2.18
mmol). Rf (70:30 cyclohexane:EtOAc) = 0.39; 1H NMR (400 MHz, CDCl3) δH: 10.36
(1H, s, CHO), 8.34 (1H, d, J = 15.4 Hz, ArCH=CH), 7.89 (1H, d, J = 7.6 Hz, ArH ), 7.64
- 7.58 (2H, m, ArH ), 7.55 - 7.48 (1H, m, ArH ), 6.77 (1H, d, J = 15.4 Hz, ArCH=CH ),
3.18 (3H, s, NCH3ACH3B), 3.08 (3H, s, NCH3ACH3B); 13C{1H} NMR (100 MHz CDCl3)
δC: 191.39, 165.99, 138.28, 138.08, 133.91, 133.77, 130.74, 129.18, 128.03, 123.47, 37.52,
35.87; IR (thinfilm) νmax (cm-1): 1694 (C=O), 1646 (C=O), 1595 (C=C); HRMS (ESI):
m/z calculated for C12H14N1O2: requires: 204.1025 for [M+H]+; found: 204.1017.




To a solution of 2-bromobenzaldehyde (0.32 mL, 2.70 mmol), Pd(OAc)2 (1.0 mol%) and
(o-Tol)3P (2.0 mol%) in DMF (5 mL) in a 20 mL microwave vial, was added N -methoxy-
N -methylacrylamide (467 mg, 4.05 mmol) and Et3N (0.57 mL, 4.05 mmol). The reaction
vessel was sealed and heated to 90 ◦C in a Biotage Initiator microwave for 40 minutes.
After cooling, the reaction was diluted with Et2O, filtered through Celite R© and dried
(MgSO4). The solvent was removed under reduced pressure to yield the crude product as
a brown oil. The crude material was purified using a Biotage SP4 (eluent: 60:40 cyclo-
hexane:EtOAC, 50 g SNAP cartridge), to yield the title compound as a yellow oil in 76%
yield (451 mg, 2.06 mmol). Rf (60:40 cyclohexane:EtOAc) = 0.46; 1H NMR (600 MHz,
CDCl3) δH: 10.39 (1H, s, CHO), 8.48 (1H, d, J = 15.8 Hz, ArCH=CH), 7.92 (1H, d, J =
7.7 Hz, ArH ), 7.64-7.69 (1H, m, ArH ), 7.60-7.64 (1H, m, ArH ), 7.51-7.56 (1H, m, ArH ),
6.96 (1H, d, J = 15.8 Hz, ArCH=CH ), 3.77 (3H, s, OCH3), 3.34 (3H, s, NCH3); 13C{1H}
NMR (150 MHz CDCl3) δC: 191.29, 166.04, 139.37, 137.97, 134.07, 133.79, 130.77, 129.47,
128.14, 121.48, 61.97, 32.54; IR (thinfilm) νmax (cm-1): 1686 (C=O), 1646 (C=O), 1611
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To a solution of S-propyl 2-bromoethanethioate (1 g, 5.07 mmol), in toluene (10 mL)
at room temperature was added triphenylphosphine (1.397 g, 5.33 mmol) in one charge.
The reaction mixture was left to stand at room temperature for 3.5 days to yield 2.35 g
of white crystals after filtering and washing with toluene (3 x 10 mL). The crystals were
dissolved in 10 mL of DCM and stirred with 10 mL of a 10% aqueous Na2CO3 solution for
30 minutes. The layers were separated and the aqueous layer was extracted with DCM
(2 x 10 mL). The combined organic layers were partially concentrated under vacuum,
diluted with cyclohexane and allowed to stand to precipitate out colourless plate crystals.
The crystals were filtered and a second crop of precipitate acquired from the filtrate. The
crystals were dried under vacuum to yield the title compound (1.66 g, 4.39 mmol, 86%),
which was used without purification.100 m.p. 82-84 ◦C; 1H NMR (400 MHz, CDCl3) δH:
7.60-7.67 (6H, m, ArH ), 7.54-7.59 (3H, m, ArH ), 7.44-7.50 (6H, m, ArH ), 3.58-3.75 (1H,
m, Ph3P=CH ), 2.83 (2H, t, J = 7.2 Hz, CH2CH2CH3), 1.58 - 1.65 (2H, m, CH2CH2CH3),
0.97 (3H, t, J = 7.3 Hz, CH2CH2CH3); 13C{1H} NMR (100 MHz CDCl3) δC: 133.07,
132.97, 132.16, 128.93, 128.80, 127.34, 30.79, 24.52, 13.55; IR (thinfilm) νmax (cm-1): 1579
(C=O), 1566 (P=C); HRMS (ESI): m/z calculated for C23H24OPS: requires: 379.1286





To a solution of phthaldialdehyde (1.61 g, 12.00 mmol, 3.0 eq.) in DCM (5 mL) was added
S-propyl 2-(triphenylphos-phoranylidene)ethanethioate 213 (1.51 g, 4.00 mmol, 1.0 eq.)
in one portion. The reaction was left to stir at room temperature for 3 days. The solvent
was removed under reduced pressure and the crude material purified by column chro-
matopgraphy (eluent: 90:10 petrol:EtOAc), and recrystallisation to yield the title com-
pound as colourless plates in 56% yield (525 mg, 2.24 mmol).99 m.p. 34-35 ◦C; Rf (90:10
petrol:EtOAc = 0.36); 1H NMR (300 MHz, CDCl3) δH: 10.29 (1H, s, CHO), 8.48 (1H, d,
J = 15.7 Hz, ArCH=CH), 7.88 (1H, dd, J = 6.7, 1.6 Hz, ArH ), 7.67-7.54 (3H, m, ArH ),
6.63 (1H, d, J = 15.7 Hz, ArCH=CH ), 3.00 (2H, t, J = 7.2 Hz, CH2CH2CH3), 1.68 (2H,
p, J = 7.3 Hz, CH2CH2CH3), 1.01 (3H, t, J = 7.3 Hz, CH2CH2CH3); 13C{1H} NMR (75.5
MHz CDCl3) δC: 191.98, 189.94, 136.91, 136.52, 134.24, 134.04, 132.69, 130.18, 129.87,
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128.06, 31.11, 23.07, 13.56; IR (thinfilm) νmax (cm-1): 1686 (C=O), 1660 (C=O), 1609
(C=C); HRMS (ESI): m/z calculated for C13H14O2S: requires: 235.0787 for [M+H]+;
found: 235.0787.




General procedure E was followed using ethyl (E)-3-(2-formyl-5-methylphenyl)acrylate
164a (437 mg, 2.00 mmol). The title compound was formed as a brown oil in 74% yield
(345 mg, 1.48 mmol) and required no further purification. 1H NMR (500 MHz, CDCl3)
δH: 7.20 (1H, d, J = 7.6 Hz, ArH ), 7.14 (1H, d, J = 7.8 Hz, ArH ), 7.10 (1H, s, ArH ), 4.93
(2H, s, ArCH2N), 4.19 (2H, q, J = 7.1 Hz, CH2CH3), 3.86 (2H, s, CH2C=O), 2.38 (3H,
s, ArCH3), 1.24 (3H, t, J = 7.1 Hz, CH2CH3); (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H}
NMR (125 MHz CDCl3) δC: 167.42, 141.73, 138.54, 135.97, 130.28, 128.83, 121.34, 119.94,
65.69, 61.66, 29.83, 21.53, 14.11; IR (thinfilm) νmax (cm-1): 1724 (C=O); HRMS (ESI):
m/z calculated for C13H15NO3: requires: 234.1130 for [M+H]+; found: 234.1130; requires:
256.0949 for [M+Na]+; found: 256.0952.





General procedure E was followed using ethyl (E)-3-(2-formyl-4,5-dimethoxyphenyl)acrylate
164b (529 mg, 2.00 mmol). The title compound was formed as a yellow solid in 83% yield
(463 mg, 1.66 mmol) and required no further purification. m.p. 152-153 ◦C; 1H NMR
(400 MHz, CDCl3) δH: 6.93 (1H, s, ArH ), 6.84 (1H, s, ArH ), 4.95 (2H, s, ArCH2N), 4.19
(2H, q, J = 7.1 Hz, CH2CH3), 3.91 (6H, s, OCH3), 3.89 (2H, s, CH2C=O), 1.26 (3H,
t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (100 MHz CDCl3) δC: 167.44, 150.30, 149.94,
142.73, 128.18, 126.53, 105.72, 103.01, 65.49, 61.85, 56.43, 56.36, 30.22, 14.22; IR (thin-
film) νmax (cm-1): 1730 (C=O); HRMS (ESI): m/z calculated for C14H17NO5: requires:
280.1184 for [M+H]+; found: 280.1185; requires: 302.1004 for [M+Na]+; found: 302.1011.




General procedure E was followed using ethyl (E)-3-(2-formyl-4-methoxyphenyl)acrylate
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164c (469 mg, 2.00 mmol). The title compound was formed as a white solid in 79%
yield (394 mg, 1.58 mmol) and required no further purification. m.p. 143-145 ◦C; 1H
NMR (500 MHz, CDCl3) δH: 7.20 (1H, d, J = 8.3 Hz, ArH ), 6.92 (2H, dd, J = 11.5,
2.9 Hz, ArH ), 4.97 (2H, s, ArCH2N), 4.19 (2H, q, J = 7.1 Hz, CH2CH3), 3.88 (2H, s,
CH2C=O), 3.83 (3H, s, OCH3), 1.25 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR (125
MHz CDCl3) δC: 167.39, 160.63, 140.13, 135.51, 128.43, 120.72, 114.14, 108.57, 65.45,
61.77, 55.74, 30.09, 14.18; IR (thinfilm) νmax (cm-1): 1732 (C=O); HRMS (ESI): m/z
calculated for C13H15NO4: requires: 250.1079 for [M+H]+; found: 250.1075; requires:
272.0898 for [M+Na]+; found: 272.0891.




General procedure E was followed using ethyl (E)-3-(2-formyl-4-(trifluoromethyl)phenyl)
acrylate 164d (544 mg, 2.00 mmol). The title compound was formed as a pale green solid
in 83% yield (477 mg, 1.66 mmol) and required no further purification. m.p. 148-149 ◦C;
1H NMR (300 MHz, CDCl3) δH: 7.63 (1H, d, J = 7.5 Hz, ArH ), 7.56 (1H, s, ArH ), 7.38
(1H, d, J = 8.0 Hz, ArH ), 5.03 (2H, s, ArCH2N), 4.17 (2H, q, J = 7.1 Hz, CH2CH3),
3.87 (2H, s, CH2C=O), 1.23 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 167.16, 140.92, 139.42, 133.27, 129.87, 126.03 (q, J = 2.7 Hz), 124.10 (q, J =
272.3 Hz), 119.41, 118.67 (q, J = 3.9 Hz), 66.03, 61.92, 29.81, 14.14; IR (thinfilm) νmax
(cm-1): 1732 (C=O); HRMS (ESI): m/z calculated for C13H12NO3F3: requires: 288.0847
for [M+H]+; found: 288.0827; requires: 310.0666 for [M+Na]+; found: 310.0652.




General procedure E was followed using ethyl (E)-3-(4-fluoro-2-formylphenyl)acrylate
164e (444 mg, 2.00 mmol). The crude product, a green solid, was recrystallised from
DCM:hexane to yield white needles in 85% yield (403 mg, 1.70 mmol) and required no
further purification. m.p. 134-136; 1H NMR (300 MHz, CDCl3) δH: 7.29-7.25 (1H, m,
ArH ), 7.14-7.08 (2H, m, ArH ), 4.99 (2H, s, ArCH2N), 4.21 (2H, q, J = 7.1 Hz, CH2CH3),
3.90 (2H, s, CH2C=O), 1.26 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (125 MHz
CDCl3) δC: 167.38, 163.19 (d, J = 249.1 Hz), 141.12, 135.16 (d, J = 9.1 Hz), 132.16 (d,
J = 2.5 Hz), 120.82 (d, J = 8.6 Hz), 115.97 (d, J = 23.4 Hz), 110.24 (d, J = 25.2 Hz),
65.76, 61.92, 30.00, 14.25; IR (thinfilm) νmax (cm-1): 1724 (C=O); HRMS (ESI): m/z
calculated for C12H12FNO3: requires: 238.0879 for [M+H]+; found: 238.0906; requires:
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260.0698 for [M+Na]+; found: 260.0719.




General procedure E was followed using ethyl (E)-3-(3-fluoro-2-formylphenyl)acrylate
164f (444 mg, 2.00 mmol). The crude product, a purple solid, was recrystallised from
DCM:hexane to yield colourless needles in 72% yield (342 mg, 1.44 mmol). m.p. 141-144
◦C; 1H NMR (500 MHz, CDCl3) δH: 7.35 (1H, td, J = 8.0, 5.0 Hz, ArH ), 7.08 (1H, d, J
= 7.6 Hz, ArH ), 7.01 (1H, t, J = 8.6 Hz, ArH ), 5.00 (2H, s, ArCH2N), 4.16 (2H, q, J =
7.1 Hz, CH2CH3), 3.83 (2H, s, CH2C=O), 1.21 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H}
NMR (125 MHz CDCl3) δC: 167.15, 156.29 (d, J = 249.1 Hz), 141.09, 138.61 (d, J =
5.6 Hz), 130.97 (d, J = 7.2 Hz), 118.35 (d, J = 18.93), 115.52 (d, J = 3.1 Hz), 115.26
(d, J = 20.14 Hz), 63.42, 61.77, 29.95, 14.09; IR (thinfilm) νmax (cm-1): 1720 (C=O);
HRMS (ESI): m/z calculated for C12H12NO3F: requires: 260.0698 for [M+Na]+; found:
260.0697. For crystallographic data see Appendix 1.
1-(2-ethoxy-2-oxoethyl)-3H -benzo[e]isoindole 2-oxide 165g
N+ O-
CO2Et
General procedure E was followed using ethyl (E)-3-(2-formylnaphthalen-1-yl)acrylate
164g (509 mg, 2.00 mmol). The crude product, a purple solid, was recrystallised from
DCM:hexane to yield purple needles in 74% yield (399 mg, 1.48 mmol). m.p. 173-175
◦C; 1H NMR (300 MHz, CDCl3) δH: 8.03 (1H, d, J = 8.07 Hz, ArH ), 7.93-7.86 (2H, m,
ArH ), 7.60-7.50 (2H, m, ArH ), 7.46 (1H, d, J = 8.28 Hz, ArH ), 5.13 (2H, s, ArCH2N),
4.39 (2H, s, CH2C=O), 4.20 (2H, q, J = 7.1 Hz, CH2CH3), 1.20 (3H, t, J = 7.1 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 167.96, 143.58, 133.90, 132.17, 131.17,
129.58, 129.19, 127.60, 126.47, 126.39, 122.46, 119.10, 65.85, 61.96, 32.38, 14.24; IR (thin-
film) νmax (cm-1): 1731 (C=O); HRMS (ESI): m/z calculated for C16H15NO3: requires:
270.1130 for [M+H]+; found: 270.1133; requires: 292.0949 for [M+Na]+; found: 292.0951.





General procedure E was followed using (E)-3-(2-formylphenyl)-N,N -dimethylacrylamide
210 (406 mg, 2.00 mmol). The title compound was formed as a white solid in 79% yield
(345 mg, 1.58 mmol) and required no further purification. m.p. 124-126 ◦C; 1H NMR
(300 MHz, CDCl3) δH: 7.45 (1H, dd, J = 6.03, 2.13 Hz, ArH ), 7.32-7.23 (3H, m, ArH ),
4.90 (2H, s, ArCH2N), 3.88 (2H, s, CH2C=O), 3.06 (3H, s, NCH3), 2.86 (3H, s, NCH3);
13C{1H} NMR (75.5 MHz CDCl3) δC: 166.50, 143.08, 135.95, 133.03, 128.55, 127.96,
121.24, 120.43, 65.61, 37.71, 35.56, 30.26; IR (thinfilm) νmax (cm-1): 1634 (C=O), HRMS
(ESI): m/z calculated for C12H14N2O2: requires: 219.1133 for [M+H]+; found: 219.1119.
3-(2-oxo-2-(propylthio)ethyl)-1H -isoindole 2-oxide 217
N+ O-
COSPr
General procedure E was followed using S-propyl (E)-3-(2-formylphenyl)prop-2-enethioate
214 (469 mg, 2.00 mmol). The title compound was formed as colourless needles in 59%
yield (294 mg, 1.18 mmol) and required no further purification. m.p. 119-121 ◦C; 1H
NMR (300 MHz, CDCl3) δH: 7.39-7.25 (4H, m, ArH ), 4.98 (2H, s, ArCH2N), 3.85 (2H, s,
CH2C=O), 2.99 (2H, t, J = 7.2 Hz, CH2CH2CH3), 1.65 (2H, p, J = 7.3 Hz, CH2CH2CH3),
1.00 (3H, t, J = 7.3 Hz, CH2CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 190.20,
142.18, 136.05, 133.43, 128.47, 127.95, 121.61, 119.64, 65.57, 31.09, 30.13, 23.21, 13.55;
IR (thinfilm) νmax (cm-1): 1683 (C=O); HRMS (ESI): m/z calculated for C13H15NO2S:
requires: 250.0874 for [M+H]+; found: 250.0839.
3-(carboxymethyl)-1H -isoindole 2-oxide 218
N+ O-
CO2H
General procedure E was followed using S-propyl (E)-3-(2-formylphenyl)prop-2-enethioate
214 (469 mg, 2.00 mmol) at room temperature. The title compound was formed as a red
oil in 68% yield (260 mg, 1.36 mmol) and required no further purification. 1H NMR
(300 MHz, DMSO-d6) δH: 7.45-7.33 (4H, m, ArH ), 5.06 (2H, s, ArCH2N), 3.58 (2H,
s, CH2C=O); 13C{1H} NMR (75.5 MHz DMSO-d6) δC: 163.58, 140.92, 136.35, 133.67,
127.94, 127.22, 121.58, 119.42, 65.77, 28.30; IR (thinfilm) νmax (cm-1): 1722 (C=O);







General procedure B was followed using 2-(2-bromophenyl)ethan-1-ol 219 (804 mg, 4.00
mmol). After 4 hours, the reaction was worked up and purified by column chromatog-
raphy (eluent: 70:30 petrol:EtOAc) to yield the title compound as a pale yellow oil in
39% yield (344 mg, 1.56 mmol). Rf (70:30 Petrol:EtOAc) = 0.25; 1H NMR (300 MHz,
CDCl3) δH: 8.00 (1H, d, J = 15.8 Hz, ArCH=CH), 7.58-7.55 (1H, m, ArH ), 7.34-7.28
(1H, m, ArH ), 7.26-7.21 (2H, m, ArH ), 6.35 (1H, d, J = 15.8 Hz, ArCH=CH ), 4.24 (2H,
q, J = 7.1 Hz, CH2CH3), 3.81-3.76 (2H, m, CH2OH), 3.01 (3H, t, J = 4.2 Hz), 2.31 (1H,
br. s, OH ), 1.32 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC:
167.22, 142.05, 138.26, 133.59, 130.92, 130.19, 127.14, 126.79, 119.84, 63.39, 60.71, 36.54,
14.39; IR (thinfilm) νmax (cm-1): 3383 (O-H), 1707 (C=O), 1630 (C=C); HRMS (ESI):





General procedure D was followed using 2-formylphenyl boronic acid 224 (450 mg, 3.0
mmol), followed by purification by column chromatography (eluent: 95:5 petrol:EtOAc),
to yield the title compound as colourless oil in 52% yield (340 mg, 1.56 mmol). Rf (95:5
Petrol:EtOAc) = 0.46; 1H NMR (300 MHz, CDCl3) δH: 10.15 (1H, s, CHO), 7.83 (1H,
dd, J = 7.5, 1.4 Hz, ArH ), 7.54 (1H, td, J = 7.4, 1.5 Hz, ArH ), 7.46 (1H, td, J = 7.4, 1.2
Hz, ArH ), 7.28-7.26 (1H, m, CH2CH=CH), 7.13 (1H, dt, J = 15.6, 6.3 Hz, ArH ), 5.71
(1H, dt, J = 15.6, 1.7 Hz, CH2CH=CH ), 4.15 (2H, q, J = 7.1 Hz, CH2CH3), 3.98 (2H,
dd, J = 6.4, 1.4 Hz, ArCH2), 1.26 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5
MHz CDCl3) δC: 192.62, 166.48, 146.78, 139.90, 134.19, 133.98, 133.81, 131.61, 127.66,
122.82, 60.46, 35.36, 14.36; IR (thinfilm) νmax (cm-1): 1712 (C=O), 1695 (C=O), 1651





To a solution of 2-formylphenyl boronic acid 224 (450 mg, 3.0 mmol) and allyl bromide
(1.2 eq.) in THF (0.2 M), were added PdCl2(PPh3)2(2.5 mol%) and aqueous Na2CO3 (1
M, 2.0 eq.) solution. The reaction mixture was heated to reflux and stirred for 4 hours.
The reaction was quenched with H2O and extracted with DCM (x3). The combined or-
ganic layers were washed with brine, dried over MgSO4, and the solvent removed under
reduced pressure. The crude material was purified by column chromatography (eluent:
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95:5 petrol:EtOAc) to afford the title compound in 83% yield (364 mg, 2.49 mmol).103
Rf (95:5 Petrol:EtOAc) = 0.49; 1H NMR (300 MHz, CDCl3) δH: 10.24 (1H, s, CHO),
7.84 (1H, dd, J = 7.6, 1.3 Hz, ArH ), 7.5 (1H, td, J = 7.4, 1.4 Hz, ArH ), 7.39 (1H, td,
J = 7.5, 1.0 Hz, ArH ), 7.29 (1H, d, J = 7.5 Hz, ArH ), 6.03 (1H, ddt, J = 16.9, 10.2,
6.1 Hz, CHCH2), 5.08 (1H, dq, 10.1, 1.4 Hz, CH=CHAHB), 4.98 (1H, dq, J = 17.0, 1.6
Hz, CH=CHAHB), 3.82 (2H, d, J = 6.1 Hz, CH2CH=CH2); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 192.41, 142.34, 137.03, 134.05, 133.96, 131.68, 131.16, 127.00, 116.50, 36.61;
IR (thinfilm) νmax (cm-1): 1692 (C=O), 1598 (C=C), 752 (C=C); HRMS (ESI): m/z





General procedure F was followed using ethyl (E)-4-(2-formylphenyl)but-2-enoate 223
(437 mg, 2.00 mmol). The title compound was formed as a colourless oil in 92% yield
(429 mg, 1.87 mmol) and required no further purification. 1H NMR (300 MHz, CDCl3)
δH: 7.71 (1H, s, H -C=N+), 7.28-7.25 (2H, m, ArH ), 7.21-7.18 (1H, m, ArH ), 7.12-7.09
(1H, m, ArH ), 4.50 (1H, m, CH ), 4.23-4.08 (2H, m, CH2CH3), 3.36 (1H, dd, J = 16.5, 6.0
Hz, ArCHAHB), 3.13-3.05 (2H, m, ArCHAHB, CHACHBCO2Et), 2.59 (1H, dd, J = 16.1,
8.7 Hz, CHAHBCO2Et), 1.25 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 170.36, 133.88, 129.70, 128.90, 127.94, 127.80, 125.35, 64.36, 61.042, 35.37,
32.45, 14.16; IR (thinfilm) νmax (cm-1): 1726 (C=O); HRMS (ESI): m/z calculated for







General procedure D was followed using (6-formylbenzo[d][1,3]dioxol-5-yl)boronic acid
(582 mg, 3.0 mmol), followed by purification by column chromatography (eluent: 95:5
petrol:EtOAc), to yield the title compound as colourless oil in 72% yield (566 mg, 2.16
mmol). Rf (95:5 Petrol:EtOAc) = 0.40; 1H NMR (300 MHz, CDCl3) δH: 10.09 (1H, s,
CHO), 7.30 (1H, s, ArH ), 7.12 (1H, dt, J = 15.6, 6.4 Hz, CH2CH=CH), 6.72 (1H, s,
ArH ), 5.98 (2H, s, OCH2), 5.68 (1H, dt, J = 15.6, 1.6 Hz, CH2CH=CH ), 4.16 (2H, q,
J = 7.1 Hz, CH2CH3), 3.86 (2H, dd, J = 6.4, 1.6 Hz, ArCH2), 1.27 (3H, t, J = 7.1
Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 189.47, 166.25, 152.59, 147.42,
146.58, 137.15, 128.49, 122.92, 111.07, 110.25, 102.24, 60.45, 34.71, 14.28; IR (thinfilm)
νmax (cm-1): 1713 (C=O), 1677 (C=O), 1652 (C=C); HRMS (ESI): m/z calculated for








General procedure D was followed using (4-formylthiophen-3-yl)boronic acid (468 mg, 3.0
mmol), followed by purification by column chromatography (eluent: DCM), to yield the
title compound as a yellow oil in 54% yield (363 mg, 1.62 mmol). Rf (DCM) = 0.32; 1H
NMR (300 MHz, CDCl3) δH: 9.96 (1H, s, CHO), 8.12 (1H, d, J = 3.1 Hz, ArH ), 7.16-7.05
(2H, m, CH2CH=CH, ArH ), 5.80 (1H, dt, J = 15.5, 1.6 Hz, CH2CH=CH ), 4.17 (2H, q,
J = 7.1 Hz, CH2CH3), 3.84 (2H, dt, J = 6.6, 1.2 Hz, ArCH2), 1.27 (3H, t, J = 7.1 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 185.65, 166.57, 145.95, 140.68, 140.05,
137.85, 124.96, 122.87, 60.48, 31.95, 14.38; IR (thinfilm) νmax (cm-1): 1716 (C=O), 1684







General procedure D was followed using (2-formyl-4-methoxyphenyl)boronic acid (540 mg,
3.0 mmol), followed by purification by column chromatography (eluent: DCM), to yield
the title compound as a pale green oil in 63% yield (469 mg, 1.89 mmol). Rf (DCM) =
0.27; 1H NMR (300 MHz, CDCl3) δH: 10.14 (1H, s, CHO), 7.36 (1H, d, J = 2.7 Hz, ArH ),
7.19-7.07 (3H, m, ArH, CH2CH=CH), 5.67 (1H, dt, J = 15.6, 1.7 Hz, CH2CH=CH ), 4.15
(2H, q, J = 7.1 Hz, CH2CH3), 3.89 (2H, dd, J = 6.2, 1.7 Hz, ArCH2), 3.86 (3H, s, OCH3),
1.25 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 191.85, 166.48,
159.08, 147.30, 134.78, 132.81, 132.11, 122.66, 120.76, 116.38, 60.46, 55.71, 34.32, 14.36;
IR (thinfilm) νmax (cm-1): 1708 (C=O), 1693 (C=O), 1651 (C=C); HRMS (ESI): m/z





General procedure D was followed using (2-formyl-5-methoxyphenyl)boronic acid (540 mg,
3.0 mmol), followed by purification by column chromatography (eluent: DCM), to yield
the title compound as a pale green oil in 67% yield (499 mg, 2.01 mmol). Rf (DCM)
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= 0.27; 1H NMR (300 MHz, CDCl3) δH: 10.00 (1H, s, CHO), 7.78 (1H, d, J = 8.5 Hz,
ArH ), 7.11 (1H, dt, J = 15.6, 6.4 Hz, CH2CH=CH), 6.92 (1H, dd, J = 8.5, 2.5 Hz, ArH ),
6.74 (1H, d, J = 2.4 Hz, ArH ), 5.73 (1H, dt, J = 15.6, 1.7 Hz, CH2CH=CH ), 4.15 (2H,
q, J = 7.1 Hz, CH2CH3), 3.95 (2H, dd, J = 6.4, 1.6 Hz, ArCH2), 3.87 (3H, s, OCH3),
1.25 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 191.04, 166.47,
164.03, 146.59, 142.46, 136.61, 127.54, 122.81, 117.31, 112.24, 60.43, 55.69, 35.51, 14.34;
IR (thinfilm) νmax (cm-1): 1716 (C=O), 1686 (C=O), 1652 (C=C); HRMS (ESI): m/z






General procedure F was followed using ethyl (E)-4-(4-formylthiophen-3-yl)but-2-enoate
223b (449 mg, 2.00 mmol). The title compound was formed as an orange oil in 77% yield
(368 mg, 1.54 mmol) and required no further purification. 1H NMR (300 MHz, CDCl3)
δH: 7.85 (1H, s, H -C=N+), 7.30 (1H, s, ArH ), 7.04 (1H, s, ArH ), 4.60-4.46 (1H, m, CH ),
4.24-4.10 (2H, m, CH2CH3), 3.32 (1H, dd, J = 16.0, 6.2 Hz, ArCHAHB), 3.18-3.02 (2H, m,
ArCHAHB, CHACHBCO2Et), 2.61 (1H, dd, J = 16.0, 8.8 Hz, CHAHBCO2Et), 1.26 (3H,
t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 170.33, 130.62, 129.85,
129.48, 122.73, 121.87, 65.63, 61.22, 36.01, 28.86,14.26; IR (thinfilm) νmax (cm-1): 1719







General procedure F was followed using ethyl (E)-4-(2-formyl-4-methoxyphenyl)but-2-
enoate 223c (497 mg, 2.00 mmol). The title compound was formed as a pale brown oil in
86% yield (453 mg, 1.72 mmol) and required no further purification. 1H NMR (300 MHz,
CDCl3) δH: 7.66 (1H, s, H -C=N+), 7.08 (1H, d, J = 8.2 Hz, ArH ), 6.78 (1H, dd, J =
8.2, 2.5 Hz, ArH ), 6.61 (1H, d, J = 2.4 Hz, ArH ), 4.51-4.44 (1H, m, CH ), 4.20-4.05 (2H,
m, CH2CH3), 3.76 (3H, s, OCH3), 3.26 (1H, dd, J = 16.4, 6.1 Hz, ArCHAHB), 3.07-2.95
(2H, m, ArCHAHB, CHACHBCO2Et), 2.56 (1H, dd, J = 16.1, 8.8 Hz, CHAHBCO2Et),
1.22 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 170.39, 159.09,
133.95, 128.93, 128.83, 120.82, 115.23, 110.54, 64.74, 61.01, 55.49, 35.30, 31.60, 14.14;
IR (thinfilm) νmax (cm-1): 1726 (C=O); HRMS (ESI): m/z calculated for C14H17NO4:







General procedure F was followed using ethyl (E)-4-(2-formyl-5-methoxyphenyl)but-2-
enoate 223d (497 mg, 2.00 mmol). The title compound was formed as a pale brown oil in
82% yield (432 mg, 1.64 mmol) and required no further purification. 1H NMR (300 MHz,
CDCl3) δH: 7.79 (1H, s, H -C=N+), 7.13 (8.3H, d, J = , Hz, ArH ) 6.81 (8.3, 2.7H, dd, J
= , Hz, ArH ) 6.74 (1H, s, ArH ), 4.53-4.41 (1H, m, CH ), 4.21-4.08 (2H, m, CH2CH3), 3.81
(3H, s, OCH3), 3.34 (1H, dd, J = 16.5, 6.1 Hz, ArCHAHB), 3.12-2.95 (2H, m, ArCHAHB,
CHACHBCO2Et), 2.57 (1H, dd, J = 16.0, 8.7 Hz, CHAHBCO2Et), 1.24 (3H, t, J = 7.1 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 170.36, 161.43, 135.35, 131.31, 127.71,
125.59, 120.52, 114.44, 113.00, 63.46, 61.13, 55.61, 35.17, 32.63, 14.22; IR (thinfilm) νmax
(cm-1): 1728 (C=O); HRMS (ESI): m/z calculated for C14H17NO4: requires: 264.1235





To a solution of 2-iodobenzaldehyde 230 (928 mg, 4.00 mmol) and ethyl propiolate (1.62
mL, 16 mmol) in THF were added Pd(PPh3)2C12 (2.0 mol%), CuI (4.0 mol%) and K2C03
(1.11 g, 8 mmol). The reaction was stirred at 65 ◦C for 2 hours. After cooling to room
temperature, the solvent was removed under reduced pressure, and the remaining black
oil was extracted with Et2O (x3). The Et2O solution was dried (MgSO4), and the solvent
removed under reduced pressure. The crude material was purified by column chromatog-
raphy (eluent: DCM) to afford the title compound as a yellow solid in 42% yield (340 mg,
1.68 mmol).110 Rf (DCM) = 0.67; m.p. 43-45 ◦C; 1H NMR (300 MHz, CDCl3) δH: 10.46
(1H, s, CHO), 7.96-7.93 (1H, m, ArH ), 7.70-7.67 (1H, m, ArH ), 7.63-7.53 (2H, m, ArH ),
4.30 (2H, q, J = 7.1 Hz, CH2CH3), 1.34 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 190.43, 153.51, 137.25, 134.58, 133.94, 130.99, 127.85, 122.72,
86.57, 81.11, 62.57, 14.14; IR (thinfilm) νmax (cm-1): 2212 (C≡C), 1694 (C=O), 1660









General procedure F was followed using ethyl 3-(2-formylphenyl)propiolate 231 (404 mg,
2.00 mmol). The title compound was afforded as an orange oil in 81% yield (381 mg,
1.62 mmol) and required no further purification. 1H NMR (300 MHz, CDCl3) δH: 11.15
(1H, br. s, OH ), 7.73 (1H, d, J = 7.2 Hz, ArH ), 7.54-7.41 (3H, m, ArH ), 5.13 (1H, dd,
J = 8.4, 4.4 Hz, CH ), 4.20 (2H, q, J = 7.1 Hz, CH2CH3), 3.31 (1H, dd J = 16.3, 4.4
Hz CHCHAHB, 2.62 (1H, dd J = 16.3, 8.6 Hz, CHCHAHB), 1.25 (3H, t, J = 7.1 Hz,
CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 170.54, 164.87, 141.86, 132.10, 129.80,
128.76, 123.44, 122.77, 61.19, 59.13, 36.12, 14.22; IR (thinfilm) νmax (cm-1): 3311 (O-H),
2969 (C-H), 1732 (O-C=O), 1693 (C=O); HRMS (ESI): m/z calculated for C12H13NO4:





To a solution of 3-(2-ethoxy-2-oxoethyl)-1H -isoindole 2-oxide 165 (438 mg, 2.0 mmol)
in anhydrous MeOH under nitrogen at 0 ◦C, was added 3 M HCl in MeOH (1.33 mL,
4.0 mmol, 2.0 eq.) and NaBH3CN (103 mg, 1.64 mmol, 0.8 eq.). The reaction was
stirred at 0 ◦C for 30 minutes, before quenching with ice and NaHCO3 solution. EtOAc
was added, the layers separated, and the aqueous layer extracted with EtOAc. The
combined organics were extracted with H2O and brine, dried (MgSO4), and the solvent
removed under reduced pressure. Purification by column chromatography (eluent: 75:25
petrol:EtOAc)afforded the title compound as a yellow oil in 86% yield (381 mg, 1.72
mmol).112 Rf (75:25 Petrol:EtOAc) = 0.34; 1H NMR (300 MHz, CDCl3) δH: 7.26-7.18
(3H, m, ArH ), 7.16-7.14 (1H, m, ArH ), 4.63 (1H, t, J = 6.5 Hz, CHCH2), 4.43 (1H, d, J
= 13.5 Hz, CHAHBN), 4.24-4.17 (3H, m, CHAHBN, CH2CH3), 2.92-2.77 (2H, m, CHCH2),
1.27 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 172.14, 139.87,
137.18, 127.98, 127.68, 122.76, 122.43, 69.77, 62.13, 60.92, 38.01, 14.29; IR (thinfilm) νmax
(cm-1): 3343 (O-H), 1729 (C=O); HRMS (ESI): m/z calculated for C12H15NO3: requires:







General procedure B was followed using 2-(2-bromophenyl)-1,3-dioxane 147 (972 mg, 4.00
mmol). After 3.5 hours, the reaction was worked up and purified by column chromatog-
raphy (eluent: 90:10 petrol:EtOAc) to yield the title compound as a yellow oil in 80%
yield (794 mg, 3.20 mmol). Rf (90:10 Petrol:EtOAc) = 0.29; 1H NMR (300 MHz, CDCl3)
δH: 8.23 (1H, d, J = 15.9 Hz, ArH ), 7.62-7.55 (2H, m, ArH ), 7.39-7.29 (2H, m, ArH ),
6.35 (1H, d, J = 15.9 Hz, ArCH=CH), 5.68 (1H, s, CH ), 4.27 (1H, dd, J = 4.9, 1.0
Hz, OCHAHB), 4.23 (1H, dd, J = 5.0, 1.1 Hz, OCHAHB), 3.98 (2H, td, J = 12.2, 2.3
Hz, OCH2), 3.79 (3H, s, CH3), 2.33-2.17 (1H, m, CH2CHAHBCH2), 1.46-1.39 (1H, m,
CH2CHAHBCH2); 13C{1H} NMR (75.5 MHz CDCl3) δC: 167.31, 142.44, 137.17, 132.74,
129.81, 129.07, 126.99, 126.71, 119.38, 100.22, 67.48, 51.61, 25.65; IR (thinfilm) νmax
(cm-1): 1713 (C=O), 1634 (C=C); HRMS (ESI): m/z calculated for C14H16O4: requires:





General procedure C was followed using ethyl methyl (E)-3-(2-(1,3-dioxan-2-yl)phenyl)
acrylate 240 (745 mg, 3.00 mmol). After 14 hours the reaction was worked up and puri-
fied by column chromatography (eluent: DCM), to yield the title compound as a yellow
oil in 80% (456 mg, 2.40 mmol). Rf (DCM) = 0.61; 1H NMR (300 MHz, CDCl3) δH: 10.26
(1H, s, CHO), 8.51 (1H, d, J = 15.9 Hz, ArCH=CH), 7.87-7.84 (1H, m, ArH ), 7.62-7.53
(3H, m, ArH ), 6.36 (1H, d, J = 15.9 Hz, ArCH=CH ), 3.81 (3H, s, CH3); 13C{1H} NMR
(75.5 MHz CDCl3) δC: 191.91, 166.74, 141.36, 136.59, 133.99, 133.93, 132.51, 130.02,
128.05, 122.79, 51.99; IR (thinfilm) νmax (cm-1): 1705 (C=O), 1632 (C=C); HRMS (ESI):
m/z calculated for C11H10O3: requires: 191.0572 for [M+H]+; found: 191.0561.
3-(2-methoxy-2-oxoethyl)-1H -isoindole 2-oxide 237
N+ O-
CO2Me
General procedure E was followed using methyl (E)-3-(2-formylphenyl)acrylate 241 (380
mg, 2.00 mmol). The title compound was formed as a white solid in 76% yield (312 mg,
1.82 mmol) and required no further purification. m.p. 66-67 ◦C; 1H NMR (300 MHz,
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CDCl3) δH: 7.43-7.29 (4H, m, ArH ), 5.00 (2H, s, ArCH2N), 3.91 (2H, s, CH2C=O), 3.74
(3H, s, CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 167.90, 141.51, 135.92, 133.20, 128.71,
128.15, 121.71, 119.36, 65.95, 52.72, 29.69; IR (thinfilm) νmax (cm-1): 1726 (C=O); HRMS
(ESI): m/z calculated for C11H11NO3: requires: 206.0817 for [M+H]+; found: 206.0827;




To a mixture of Sm powder (4.0 mmol) and CoCl2·6H2O (4.0 mmol) under nitrogen, was
added anhydrous THF (10 mL) and 3-(2-ethoxy-2-oxoethyl)-1H -isoindole 2-oxide 165
(438 mg, 2.0 mmol). The reaction was stirred at room temperature for 3 hours. The re-
action mixture was poured into saturated NH4Cl aqueous solution (50 mL) and extracted
with Et2O (3x20 mL). The combined extracts were washed with saturated aqueous so-
lution of Na2S2O3 (20 mL), saturated brine (20 mL) and dried (MgSO4). Removal of
the solvent under reduced pressure afforded the title compound as an orange oil in 39%
yield which required no further purification. (148 mg, 0.78 mmol).119 1H NMR (300
MHz, CDCl3) δH: 8.24 (1H, br. s, NH ), 7.64 (1H, d, J = 7.4 Hz, ArH ), 7.47-7.46 (2H,
m, ArH ), 7.44-7.38 (1H, m, ArH ), 5.21 (1H, s, C=CH ), 4.69 (2H, s, CH2), 3.72 (3H,
s, CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 171.74, 161.23, 141.51, 135.34, 130.40,
127.70, 122.85, 121.78, 74.72, 51.40, 50.45; IR (thinfilm) νmax (cm-1): 3299 (N-H), 1692





A solution of 3-(2-ethoxy-2-oxoethyl)-1H -isoindole 2-oxide 165 (438 mg, 2.0 mmol) in
MeOH (10 mL) was added to a suspension of 10% Pd/C (22 mg) in a 3 M solution of
HCl in MeOH (20 mL). The suspension was stirred under a hydrogen atmosphere (1 atm)
overnight, and then filtered under Celite R©. The Celite R© was rinsed with MeOH and
the filtrate concentrated under reduced pressure to afford a red oil. This was dissolved
in methanol:DMSO (1:1) (2 x 1 mL) and purified using a Mass Directed Autoprepara-
tion (MDAP) apparatus (column: Sunfire C18, eluent: acetonitrile:H2O with a formic acid
modifier). After removal of the solvent under a stream of nitrogen, the title compound was
afforded as a mixture of diastereomers an orange oil in 69% yield (283 mg, 1.38 mmol).120
major diastereomer 1H NMR (300 MHz, CDCl3) δH: 7.29-7.16 (4H, m, ArH ), 4.86 (1H,
187
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dt, J = 9.2, 1.9 Hz, CH ), 4.26 (2H, s, CH2N), 4.19 (2H, q, J = 7.1 Hz, CH2CH3), 2.85
(1H, dd, J = 15.8, 3.9 Hz, CHAHB), 2.61 (1H, dd, J = 15.8, 9.2 Hz, CHAHB), 2.26 (1H,
br. s, NH ), 1.27 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC:
172.25, 142.81, 141.37, 127.42, 126.98, 122.74, 122.11, 60.70, 59.97, 51.58, 41.67, 14.34;
IR (thinfilm) νmax (cm-1): 3364 br. (N-H), 1733 (C=O); HRMS (ESI): m/z calculated







To a solution of 3-(2-ethoxy-2-oxoethyl)-1H -isoindole 2-oxide 165 (110 mg, 0.5 mmol) in
THF (2 mL), was added tert-butyl acrylate (0.15 mL, 1.0 mmol). The reaction was stirred
overnight at room temperature. After removal of the solvent under reduced pressure, the
crude product was dissolved in 1:1 MeOH:DMSO 1 mL and purified using an MDAP
apparatus (column: Sunfire C18, eluent: acetonitrile:H2O with a formic acid modifier).
The solvent was dried under a stream of nitrogen using a Radleys blowdown apparatus,
to give the title compound as a yellow oil in 51% yield (177 mg, 0.26 mmol), as a mix-
ture of inseparable conformers. Analysis of the major product is as follows: 1H NMR
(600 MHz, CDCl3) δH: 7.31-7.16 (4H, m, ArH ), 4.48 (1H, d, J = 4.4 Hz, NCHCH2),
4.24-4.14 (2H, m, CH2CH3), 3.57 (1H, d, J = 16.7 Hz, CHAHBCO2Et), 3.14 (1H, d, J
= 16.7 Hz, CHAHBCO2Et), 2.94 (1H, dt, J = 12.3, 5.0 Hz, NCHCHAHB), 2.73 (1H,
dd, J = 9.3, 5.2 Hz, NCHCH2CH ), 1.79 (1H, dd, J = 12.3, 9.4 Hz, NCHCHAHBCH),
1.45 (9H, s, C(CH3)3), 1.27 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR (150 MHz
CDCl3) δC: 172.77, 171.16, 143.42 141.19, 127.47, 127.04, 120.76, 120.12, 81.16, 76.27,
68.42, 60.57, 46.53, 34.02, 30.82, 28.00, 14.20; IR (thinfilm) νmax (cm-1): 3231 br. (O-
H), 1732 (C=O), 1728 (C=O); HRMS (ESI): m/z calculated for C19H25NO5: requires:





To a solution of 2-bromonicotinaldehyde (0.32 mL, 2.69 mmol), (µ3-C3H5)2Pd2Cl2 (98
mg, 0.27 mmol) and (o-Tol)3P (164 mg, 0.54 mmol) in toluene (3.5 mL), was added ethyl
acrylate 162 (0.44 mL, 4.03 mmol) and sodium acetate (662 mg, 8.06 mmol). The reac-
tion mixture (a slurry) was stirred at 110 ◦C overnight. The reaction mixture was cooled
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to room temperature and the precipitates filtered. The filtrate was washed with water
(10 mL), NaHCO3 solution (10 mL) and 10% citric acid solution (10 mL), dried (MgSO4)
and the solvent removed under reduced pressure to give the crude product as a brown oil.
The crude product was purified using a Biotage SP4 (eluent: 70:30 cyclohexane:EtOAc;
50 g Biotage SNAP cartridge) to yield the title compound as an orange solid in 11%
yield (60 mg, 0.29 mmol).123 Rf (70:30 cyclohexane:EtOAc) = 0.41; 1H NMR (400 MHz,
CDCl3) δH: 10.45 (1H, s, CHO), 8.81 (1H, dd, J = 4.7, 1.6 Hz, NArH ), 8.46 (1H, d, J
= 15.4 Hz, ArCH=CH), 8.18 (1H, dd, J = 7.8, 1.8 Hz, ArH ), 7.46 (1H, dd, J = 7.8, 4.8
Hz, ArH ), 7.18 (1H, d, J = 15.4 Hz, ArCH=CH ), 4.31 (2H, q, J = 7.2 Hz, CH2CH3),
1.36 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (100 MHz CDCl3) δC: 190.07, 166.22,
153.64, 153.38, 138.20, 137.39, 129.30, 127.12, 124.30, 60.84, 14.21; IR (thinfilm) νmax
(cm-1): 1708 (H-C=O), 1683 (O-C=O), 1630 (C=C); HRMS (ESI): m/z calculated for






To a solution of 3-bromoisonicotinaldehyde (1.00 g, 5.38 mmol), Pd(OAc)2 (121 mg, 0.54
mmol, 10.0 mol%) and (o-Tol)3P (327 mg, 1.08 mmol, 20.0 mol%) in DMF, was added
ethyl acrylate 162 (0.88 mL, 8.06 mmol) and Et3N (1.14 mL, 8.06 mmol). The reaction
was heated to 120 ◦C and stirred for 5 hours. The reaction mixture was cooled to room
temperature and diluted with diethyl ether (25 mL). The resulting slurry was filtered
through Celite R©, dried (MgSO4), and the solvent removed under vacuum to give the
crude product as a brown oil. The crude product was purified by column chromatography
(eluent: cyclohexane/EtOAc (80:20)) and recrystallisation from Et2O:cyclohexane. The
title compound was isolated as a cream solid in 16% yield (187 mg, 0.88 mmol). m.p.
55-56 ◦C; 1H NMR (400 MHz, CDCl3) δH: 10.37 (1H, s, CHO), 8.96 (1H, s, ArH ), 8.87
(1H, d, J = 5.1 Hz, ArH ), 8.36 (1H, d, J = 15.9 Hz, ArCH=CH), 7.70 (1H, d, J = 5.1
Hz, ArH ), 6.48 (1H, d, J = 15.9 Hz, ArCH=CH ), 4.32 (2H, q, J = 7.1 Hz, CH2CH3),
1.37 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR (100 MHz CDCl3) δC: 190.78, 165.55,
151.54, 149.75, 138.53, 137.37, 130.02, 125.07, 123.00, 61.06, 14.25; IR (thinfilm) νmax
(cm-1): 1703 (C=O), 1637 (C=C); HRMS (ESI): m/z calculated for C11H12NO3: re-
quires: 206.0817 for [M+H]+; found: 206.0811.






General procedure E was followed using ethyl (E)-3-(3-formylpyridin-2-yl)acrylate 256
(410 mg, 2.00 mmol). The title compound was formed as a red oil in 89% yield (392
mg, 1.78 mmol) and required no further purification. 1H NMR (600 MHz, CDCl3) δH:
8.56 (1H, d, J = 5.1 Hz, NArH ), 7.62 (1H, d, J = 7.3 Hz, ArH ), 7.23 (1H, dd, J =
7.7, 5.1 Hz, ArH ), 5.03 (2H, s, ArCH2N), 4.22 (2H, q, J = 7.3 Hz, CH2CH3), 3.96 (2H,
s, CH2C=O), 1.27 (3H, t, J = 7.3 Hz, CH2CH3); 13C{1H} NMR (150 MHz CDCl3) δC:
167.15, 155.12, 150.03, 142.15, 128.47, 127.99, 121.88, 64.66, 61.62, 28.76, 14.09; IR (thin-
film) νmax (cm-1): 1728 (C=O); HRMS (ESI): m/z calculated for C11H12N2O3: requires:
243.0789 for [M+Na]+; found: 243.0770.
Ethyl 2-(2-hydroxy-2H -pyrrolo[3,4-c] pyridin-3-yl)acetate, 259
N N OH
CO2Et
General procedure E was followed using ethyl (E)-3-(4-formylpyridin-3-yl)acrylate 257
(410 mg, 2.00 mmol). The title compound was isolated as a cream solid in 76% yield (335
mg, 1.52 mmol) and required no further purification. m.p. 123-125 ◦C; 1H NMR (600
MHz, CDCl3) δH: 8.41 (1 H, s, H -C=N), 7.35 (2H, d, J = 6.6 Hz, N-CH=CH), 7.33 (1H,
s, HCN-OH), 7.25 (1H, d, J = 7.0 Hz, N-CH=CH ), 4.11 (2H, s, CH2C=O), 4.07 (2H,
q, J = 7.3 Hz, CH2CH3), 1.14 (3H, t, J = 7.2 Hz, CH2CH3); 13C{1H} NMR (150 MHz
CDCl3) δC: 169.84, 132.33, 123.31, 121.20, 118.50, 114.88, 111.55, 110.76, 61.20, 29.74,
14.08; IR (thinfilm) νmax (cm-1): 3306 (O-H), 1727 (C=O); HRMS (ESI): m/z calculated







To a solution of 3-(2-ethoxy-2-oxoethyl)-3,4-dihydroisoquinoline 2-oxide 227 (467 mg, 2.0
mmol) in toluene was added DMAD (0.49 mL, 4.0 mmol) in one portion. The reaction
was stirred at reflux for 3 hours, dried (MgSO4) and the solvent removed under reduced
pressure to afford a yellow oil. Purification by column chromatography (eluent: DCM)
afforded the title compound as a yellow oil in 42% yield (360 mg, 0.84 mmol). Rf (DCM)
= 0.30; 1H NMR (300 MHz, CDCl3) δH: 8.10-8.05 (1H, m, ArH ), 7.31-7.27 (2H, m, ArH ),
7.23-7.18 (1H, m, ArH ), 5.74-5.67 (1H, m, CH ), 4.07 (2H, q, J = 7.1 Hz, CH2CH3), 3.89
(3H, s, OCH3), 3.82 (3H, s, OCH3), 3.79 (3H, s, OCH3), 3.26 (1H, dd, J = 16.0, 5.7 Hz,
ArCHACHB), 3.03 (1H, dd, J = 16.0, 1.3 Hz, ArCHACHB), 2.56 (1H, dd, J = 16.0, 3.5,
CHACHBCO2Et), 2.32 (1H, dd, J = 16.0, 10 2 Hz, CHACHBCO2Et), 1.18 (3H, t, J =
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7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 170.07, 166.34, 163.71, 159.81,
135.76, 131.34, 129.69, 128.73, 128.03, 127.23, 126.90, 125.70, 118.48, 110.77, 60.79, 52.64,
52.22, 51.88, 48.98, 36.11, 32.88, 14.04; IR (thinfilm) νmax (cm-1): 1708 br. (C=O); HRMS







To a solution of 3-(2-ethoxy-2-oxoethyl)-3,4-dihydroisoquinoline 2-oxide 227 (467 mg, 2.00
mmol) in toluene was added DMAD (0.49 mL, 4.0 mmol) in one portion. The reaction was
stirred at room temperature for 3 hours, dried (MgSO4) and the solvent removed under
reduced pressure to afford an orange oil. Purification by column chromatography (eluent:
DCM) afforded the title compound as an inseparable mixture of diastereomers (1:0.15 ra-
tio) in 83% yield (623 mg, 1.66 mmol). Rf (DCM) = 0.33; major diastereomer 1H NMR
(300 MHz, CDCl3) δH: 7.42-7.39 (1H, m, ArH ), 7.23-7.20 (2H, m, ArH ), 7.10-7.07 (1H,
m, ArH ), 5.83 (1H, s, HC-N), 4.21-4.11 (3H, CH2CHCH2, CH2CH3), 3.85 (3H, s, OCH3),
3.72 (3H, s, OCH3), 3.22 (1H, dd, J = 16.1, 4.2 Hz, ArCHACHB), 2.66 (1H, dd, J = 16.3,
5.0 Hz, ArCHACHB), 2.50 (1H, dd, J = 15.7, 6.8 Hz, CHACHBCO2Et), 2.26 (1H, dd, J =
15.7, 7.3 Hz, CHACHBCO2Et), 1.24 (3H, t, J = 7.3 Hz, CH2CH3); 13C{1H} NMR (75.5
MHz CDCl3) δC: 170.94, 162.91, 159.15, 150.80, 132.57, 131.37, 129.04, 128.01, 127.40,
127.06, 112.42, 65.43, 60.90, 56.11, 53.21, 52.07, 37.24, 29.55, 14.27. minor diastere-
omer 1H NMR (300 MHz, CDCl3) δH: 7.49-7.46 (1H, m, ArH ), 7.42-7.07 (3H, m, ArH ),
5.92 (1H, s, HC-N), 4.25-4.05 (3H, CH2CHCH2, CH2CH3), 3.84 (3H, s, OCH3), 3.74 (3H,
s, OCH3), 3.12-2.95 (2H, m, ArCHAHB), 2.74-2.57 (2H, m, CHAHBCO2Et), 1.30-1.25
(3H, m, CH2CH3); 13C{1H} NMR (75.5 MHz CDCl3) δC: 171.29, 162.77, 159.21, 150.80,
134.62, 133.05, 128.94, 127.47, 127.33, 126.86, 112.42, 66.87, 58.74, 56.12, 53.22, 51.95,
38.56, 27.96, 14.31; IR (thinfilm) νmax (cm-1): 1725 br. (C=O), 1649 (C=C); HRMS
(ESI): m/z calculated for C19H21NO7: requires: 376.1396 for [M+H]+; found: 376.1420;





RuCl3.3H2O (20 mg, 0.08 mmol) and Zn-Cu couple (29 mg, 0.45 mmol) were placed in
a glass Schlenk tube which was filled with nitrogen. A solution of ethyl 2-(2-hydroxy-3-
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oxoisoindolin-1-yl)acetate 232 (353 mg, 1.50 mmol) in dehydrated EtOH (3.0 mL) was
added to the mixture, and the reaction mixture was refluxed at 100 ◦C for 3 hours.
The reaction mixture was cooled to room temperature and filtered to remove insoluble
materials. After removal of the solvent under reduced pressure, the residue was taken up
in EtOAc, and this solution filtered to remove insoluble materials. After removal of the
solvent under reduced pressure, the crude material was purified by column chromatogra-
phy (eluent: 100% DCM to 2% MeOH in DCM). The title compound was yielded as a
pale brown oil in 24% yield (79%, 0.36 mmol).142 Rf (1% MeOH in DCM) = 0.17; 1H
NMR (500 MHz, MeOD) δH: 7.77 (1H, dd, J = 7.5 Hz, ArH ), 7.64-7.58 (2H, m, ArH ),
7.52 (1H, t, J = 7.3 Hz, ArH ), 5.01 (1H, dd, J = 8.4, 5.0 Hz, CHCH2), 4.17 (2H, q,
J = 7.1 Hz, CH2CH3), 2.98 (1H, dd, J = 16.4, 5.0 Hz, CHCHAHB), 2.62 (1H, dd, J =
16.4, 8.1 Hz, CHCHAHB), 1.23 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (125 MHz
MeOD) δC: 173.60, 173.05, 149.07, 134.26, 133.78, 130.50, 125.25, 124.96, 62.86, 55.69,
40.83, 15.28; IR (thinfilm) νmax (cm-1): 3533 (N-H), 2967 (C-H), 1734 (O-C=O), 1689







To a solution of DMAD (0.12 mL, 1.00 mmol), in THF (2.0 mL) was added hydroxylamine
(50 wt% in H2O) (63 µL, 1.10 mmol) and the solution was stirred for 30 minutes at room
temperature. The solvent was removed under reduced pressure, to afford the title com-
pound as a yellow oil in 100% yield (175 mg, 1.00 mmol), which required no further purifi-
cation. 1H NMR (300 MHz, CDCl3) δH: 3.88 (3H, s, CO2CH3), 3.71 (3H, s, CH2CO2CH3),
3.71 (2H,s, CH2); 13C{1H} NMR (75.5 MHz CDCl3) δC: 168.55, 163.41, 146.04, 53.15,
52.60, 30.32; IR (thinfilm) νmax (cm-1): 3349 (O-H), 1725 br. (C=O); HRMS (ESI):
m/z calculated for C6H9NO5: requires: 176.0558 for [M+H]+; found: 176.0563; requires:





Procedure 1: To a solution of the 3-(2-ethoxy-2-oxoethyl)-1H -isoindole 2-oxide 165
(219 mg, 1.0 mmol) in THF (2 mL), was added DMAD (0.12 mL, 1.0 mmol), and the
reaction stirred for 30 minutes at 18 ◦C. The reaction mixture was dried (MgSO4) and
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the solvent removed under reduced pressure. The crude product was purified by column
chromatography (eluent: 70: 30 petrol:EtOAc), to afford the title compound as a yellow
oil in 87% yield (286 mg, 0.87 mmol).
Procedure 2: To a solution of the aldehyde (204.22 mg, 1.0 mmol) in THF (2 mL), was
added hydroxylamine (50 wt% in H2O) (62 µL, 1.0 mmol), and the reaction was stirred
for 30 minutes at 18 ◦C. To the solution was then added DMAD (0.25 mL, 2.0 mmol),
and the reaction stirred for a further 30 minutes. The resulting reaction mixture was
dried (MgSO4), and the solvent removed under reduced pressure. The crude product was
purified by column chromatography (eluent: 90:10 - 70:30 petrol:EtOAc) to afford title
compound as a yellow oil in 33% yield (110 mg, 0.33 mmol).
Rf (70:30 Petrol:EtOAc) = 0.29; 1H NMR (300 MHz, CDCl3) δH: 8.50 (1H, s, ArH ),
8.04 (1H, d, J = 8.5 Hz, ArH ), 7.94 (1H, d, J = 8.1 Hz, ArH ), 7.70-7.65 (1H, m, ArH ),
7.62-7.56 (1H, m, ArH ), 4.16-4.09 (4H, m, CH2CH3, ArCH2), 3.97 (3H, s, CO2CH3),
3.94 (3H, s, CO2CH3), 1.18 (3H, t, J = 7.1 Hz, CH2CH3); 13C{1H} NMR (75.5 MHz
CDCl3) δC: 170. 33, 169.82, 166.46, 133.97, 132.65, 131.85, 131.83, 130.11, 129.60, 129.51,
127.70, 125.20, 124.69, 61.27, 52.81, 52.72, 35.45, 14.18; IR (thinfilm) νmax (cm-1): 1724















Unit cell dimensions a = 14.2610(2)Å a = 90◦
- b = 4.7690(1)Å b = 102.805(1)◦
- c = 16.5160(3)Å g = 90◦
Volume 1095.33(3) Å3
Z 4
Density (calculated) 1.439 Mg/m3
Absorption coefficient 0.115 mm-1
F(000) 496
Crystal size 0.35 x 0.25 x 0.10 mm
Theta range for data collection 4.40 to 27.49◦
Index ranges -18<=h<=18; -6<=k<=6; -21<=l<=21
Reflections collected 20506
Independent reflections 2505 [R(int) = 0.0348]
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Crystal data and structure refinement for Nitrone 165 cont.
Identification code k10sdb2
Reflections observed (>2s) 2185
Data Completeness 0.996
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.978 and 0.920
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2505 / 0 / 156
Goodness-of-fit on F2 1.020
Final R indices [I>2s(I)] R1 = 0.0335 wR2 = 0.0841
R indices (all data) R1 = 0.0403 wR2 = 0.0901
Largest diff. peak and hole 0.240 and -0.163 eÅ-3
196
Table A.2: Bond lengths [Å] and angles [◦] for Nitrone 165
F(1)-C(3) 1.3526(13) O(1)-N(1) 1.2866(12)
O(2)-C(10) 1.2045(14) O(3)-C(10) 1.3368(13)
O(3)-C(11) 1.4567(14) N(1)-C(8) 1.3142(15)
N(1)-C(1) 1.4894(13) C(1)-C(2) 1.4945(15)
C(1)-H(1A) 0.9900 C(1)-H(1B) 0.9900
C(2)-C(3) 1.3720(15) C(2)-C(7) 1.4039(15)
C(3)-C(4) 1.3856(17) C(4)-C(5) 1.3923(17)
C(4)-H(4) 0.9500 C(5)-C(6) 1.3949(16)
C(5)-H(5) 0.9500 C(6)-C(7) 1.3912(16)
C(6)-H(6) 0.9500 C(7)-C(8) 1.4508(15)
C(8)-C(9) 1.4851(15) C(9)-C(10) 1.5090(16)
C(9)-H(9A) 0.9900 C(9)-H(9B) 0.9900
C(11)-C(12) 1.5082(17) C(11)-H(11A) 0.9900
C(11)-H(11B) 0.9900 C(12)-H(12A) 0.9800
C(12)-H(12B) 0.9800 C(12)-H(12C) 0.9800
- - - -
C(10)-O(3)-C(11) 116.39(9) O(1)-N(1)-C(8) 126.48(9)
O(1)-N(1)-C(1) 121.03(9) C(8)-N(1)-C(1) 112.47(9)
N(1)-C(1)-C(2) 101.27(8) N(1)-C(1)-H(1A) 111.5
C(2)-C(1)-H(1A) 111.5 N(1)-C(1)-H(1B) 111.5
C(2)-C(1)-H(1B) 111.5 H(1A)-C(1)-H(1B) 109.3
C(3)-C(2)-C(7) 118.33(10) C(3)-C(2)-C(1) 132.29(10)
C(7)-C(2)-C(1) 109.38(9) F(1)-C(3)-C(2) 119.39(10)
F(1)-C(3)-C(4) 118.89(10) C(2)-C(3)-C(4) 121.72(10)
C(3)-C(4)-C(5) 119.11(10) C(3)-C(4)-H(4) 120.4
C(5)-C(4)-H(4) 120.4 C(4)-C(5)-C(6) 121.12(11)
C(4)-C(5)-H(5) 119.4 C(6)-C(5)-H(5) 119.4
C(7)-C(6)-C(5) 117.97(10) C(7)-C(6)-H(6) 121.0
C(5)-C(6)-H(6) 121.0 C(6)-C(7)-C(2) 121.76(10)
C(6)-C(7)-C(8) 130.89(10) C(2)-C(7)-C(8) 107.35(9)
N(1)-C(8)-C(7) 109.33(9) N(1)-C(8)-C(9) 120.84(10)
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Bond lengths [Å] and angles [◦] for Nitrone 165 cont.
C(7)-C(8)-C(9) 129.81(10) C(8)-C(9)-C(10) 113.47(9)
C(8)-C(9)-H(9A) 108.9 C(10)-C(9)-H(9A) 108.9
C(8)-C(9)-H(9B) 108.9 C(10)-C(9)-H(9B) 108.9
H(9A)-C(9)-H(9B) 107.7 O(2)-C(10)-O(3) 123.76(10)
O(2)-C(10)-C(9) 125.83(10) O(3)-C(10)-C(9) 110.41(9)
O(3)-C(11)-C(12) 106.75(11) O(3)-C(11)-H(11A) 110.4
C(12)-C(11)-H(11A) 110.4 O(3)-C(11)-H(11B) 110.4
C(12)-C(11)-H(11B) 110.4 H(11A)-C(11)-H(11B) 108.6
C(11)-C(12)-H(12A) 109.5 C(11)-C(12)-H(12B) 109.5
H(12A)-C(12)-H(12B) 109.5 C(11)-C(12)-H(12C) 109.5
H(12A)-C(12)-H(12C) 109.5 H(12B)-C(12)-H(12C) 109.5
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Table A.3: Dihedral angles [◦] for Nitrone 165
Atom1 - Atom2 - Atom3 - Atom4 Dihedral
O(1) - N(1) - C(1) - C(2) -177.16(9)
C(8) - N(1) - C(1) - C(2) 4.51(12)
N(1) - C(1) - C(2) - C(3) 177.76(12)
N(1) - C(1) - C(2) - C(7) -3.23(11)
C(7) - C(2) - C(3) - F(1) 179.49(9)
C(1) - C(2) - C(3) - F(1) -1.57(18)
C(7) - C(2) - C(3) - C(4) -0.71(17)
C(1) - C(2) - C(3) - C(4) 178.23(11)
F(1) - C(3) - C(4) - C(5) -179.98(10)
C(2) - C(3) - C(4) - C(5) 0.22(18)
C(3) - C(4) - C(5) - C(6) 0.23(18)
C(4) - C(5) - C(6) - C(7) -0.16(17)
C(5) - C(6) - C(7) - C(2) -0.36(16)
C(5) - C(6) - C(7) - C(8) -179.77(11)
C(3) - C(2) - C(7) - C(6) 0.79(16)
C(1) - C(2) - C(7) - C(6) -178.38(10)
C(3) - C(2) - C(7) - C(8) -179.68(10)
C(1) - C(2) - C(7) - C(8) 1.16(12)
O(1) - N(1) - C(8) - C(7) 177.71(10)
C(1) - N(1) - C(8) - C(7) -4.07(13)
O(1) - N(1) - C(8) - C(9) -3.67(17)
C(1) - N(1) - C(8) - C(9) 174.56(9)
C(6) - C(7) - C(8) - N(1) -178.74(11)
C(2) - C(7) - C(8) - N(1) 1.78(12)
C(6) - C(7) - C(8) - C(9) 2.8(2)
C(2) - C(7) - C(8) - C(9) -176.69(11)
N(1) - C(8) - C(9) - C(10) 84.18(14)
C(7) - C(8) - C(9) - C(10) -97.50(14)
C(11) - O(3) - C(10) - O(2) -3.43(17)
C(11) - O(3) - C(10) - C(9) 176.45(9)
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Dihedral angles [◦] for Nitrone 165 cont.
Atom1 - Atom2 - Atom3 - Atom4 Dihedral
C(8) - C(9) - C(10) - O(2) 3.80(17)
C(8) - C(9) - C(10) - O(3) -176.08(9)
C(10) - O(3) - C(11) - C(12) -174.80(10)
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